Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# Microbix

Microbix

## Sitemaps

- [XML Sitemap](https://microbix.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Microbix Reports Results for Q3 Fiscal 2026](https://microbix.com/resources/uncategorized/microbix-reports-results-for-q3-fiscal-2026/) - Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, CANADA, August 13, 2026 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and nine months of fiscal 2026 ended June 30, 2026 (“Q3” and “YTD”). Results for Q3 and YTD
- [Microbix Schedules Release of Results for Q3 Fiscal 2026](https://microbix.com/resources/uncategorized/microbix-schedules-release-of-results-for-q3-fiscal-2026/) - Microbix Schedules Release of Results for Q3 Fiscal 2026 Results Release and Webinar Discussion on Morning of August 13, 2026 MISSISSAUGA, CANADA, August 6, 2026 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure
- [Episode 9: Diagnostics Beyond the Lab: Closing the Gap](https://microbix.com/resources/media-featured-podcast/diagnostics-beyond-the-lab-can-you-trust-your-test/) - 09
- [Episode 8: Diagnostics Beyond the Lab: Can You Trust Your Test?](https://microbix.com/resources/media-featured-podcast/diagnostics-beyond-the-lab-can-you-trust-your-test/) - 08
- [Episode 7: Diagnostics Beyond the Lab: From Fax Machines to Big Data](https://microbix.com/resources/media-featured-podcast/diagnostics-beyond-the-lab-from-fax-machines-to-big-data/) - 07
- [Episode 6: Diagnostics Beyond the Lab: Bringing testing Closer to home](https://microbix.com/resources/media-featured-podcast/diagnostics-beyond-the-lab-bringing-testing-closer-to-home/) - 06
- [Episode 5: Diagnostics Beyond the Lab: Bridging Policy and innovation for a healthier tomorrow](https://microbix.com/resources/media-featured-podcast/episode-5-diagnostics-beyond-the-lab-bridging-policy-and-innovation-for-a-healthier-tomorrow) - 05
- [Episode 4: Diagnostics Beyond the Lab: Ensuring Patient Health through EQA](https://microbix.com/resources/media/diagnostics-beyond-the-lab-ensuring-patient-health-through-eqa) - 04
- [Episode 3: Diagnostics: Beyond the lab - Self-Collection with Copan Italia](https://microbix.com/resources/media-featured-podcast/episode-3-diagnostics-beyond-the-lab-self-collection-with-copan-italia) - 03
- [Episode 2: Diagnostics: Beyond the Lab - AMR MGEN with Colin Denver from SpeeDx](https://microbix.com/resources/media-featured-podcast/diagnostics-beyond-the-lab-amr-mgen-with-colin-denver-from-speedx) - 02
- [Episode 1: Diagnostics: Beyond the lab - HPV with Larry Vaughn, BD and Dr. Cathy Popadiuk](https://microbix.com/resources/media-featured-podcast/podcast) - 01
- [Expected stability of REDx&#8482FLOQ	© SARS-CoV-2 Swab Positive Control and REDx&#8482FLOQ© SARS-CoV-2 Swab Negative Control in various sample transport media and storage conditions](https://microbix.com/resources/media-featured-white-paper/expected-stability-of-redxfloq-sars-cov-2-swab-positive-control-and-redxfloq-sars-cov-2-swab-negative-control-in-various-sample-transport-media-and-storage-conditions) - https://microbix.com/wp-content/QAP/White%20Papers/REDx_SARS%20Molecular_WhitePaper.pdf
- [Use of REDx™FLOQ	© SARS-CoV-2 Ag Swab Positive Control and REDx™FLOQ© Respiratory Swab Negative Control as Quality Control by POC devices in various testing conditions](https://microbix.com/resources/media-featured-white-paper/use-of-redxfloq-sars-cov-2-ag-swab-positive-control-and-redxfloq-respiratory-swab-negative-control-as-quality-control-by-poc-devices-in-various-testing-conditions) - https://microbix.com/wp-content/QAP/White%20Papers/REDx_WhitePaper_SARS_Ag-swab.pdf
- [High-Risk HPV Quality Controls are Needed to Uphold Clinical Laboratory Quality Standards](https://microbix.com/resources/media-featured-white-paper/high-risk-hpv-quality-controls-are-needed-to-uphold-clinical-laboratory-quality-standards) - https://microbix.com/wp-content/QAP/White%20Papers/HPV_White%20Paper.pdf
- [Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective quality controls](https://microbix.com/resources/media-featured-poster-publication/novel-neutralizing-anti-s1-sars-cov-2-human-monoclonal-antibody-formulation-for-use-as-a-cross-platform-eqa-sample-and-prospective-quality-controls/) - https://microbix.com/wp-content/QAP/Poster%20Publications/SARS/ECCMID2021_SARS%20Ab.pdf
- [Advanced SARS-CoV-2 nucleocapsid protein swab-based formulation for use as a cross-platform EQA sample and as a prospective Quality Control](https://microbix.com/resources/media-featured-poster-publication/advanced-sars-cov-2-nucleocapsid-protein-swab-based-formulation-for-use-as-a-cross-platform-eqa-sample-and-as-a-prospective-quality-control) - https://microbix.com/wp-content/QAP/Poster%20Publications/SARS/ECCMID2021%20SARS%20antigen.pdf
- [Novel Mycoplasma genitalium (Mgen) and AMR Mgen A2059G Materials for use in a Cross-Platform NAAT Quality Control](https://microbix.com/resources/media-featured-poster-publication/novel-mycoplasma-genitalium-mgen-and-amr-mgen-a2059g-materials-for-use-in-a-cross-platform-naat-quality-control) - https://microbix.com/wp-content/QAP/Poster%20Publications/MG/AACC2020%20MG.pdf
- [Novel Cross-Platform High-Risk (hr) HPV NAAT Positive Controls for Use in L1 and E6/E7 Targeted Nucleic ACID (DNA and RNA) Detection Methods](https://microbix.com/resources/media-featured-poster-publication/novel-cross-platform-high-risk-hr-hpv-naat-positive-controls-for-use-in-l1-and-e6-e7-targeted-nucleic-acid-dna-and-rna-detection-methods-2) - **https://microbix.com/wp-content/QAP/Poster%20Publications/HPV/HPV_Labquality_2020.pdf
- [Performance of NAAT that detect MGEN using Swab Quality Controls](https://microbix.com/resources/media-featured-poster-publication/performance-of-naat-that-detect-mgen-using-swab-quality-controls) - https://microbix.com/wp-content/ASM 2023_FINAL COMMERCIAL COPY June 12 2023.pdf
- [Evaluating the performance of STI POC assays using Swab format Quality Controls](https://microbix.com/resources/media-featured-poster-publication/evaluating-the-performance-of-sti-poc-assays-using-swab-format-quality-controls) - https://microbix.com//wp-content/AACC 2023 Final 21JUL2023.pdf
- [Simulated swab specimens for whole workflow quality control of SARS-CoV-2 molecular diagnostic testing](https://microbix.com/resources/media-featured-poster-publication/simulated-swab-specimens-for-whole-workflow-quality-control-of-sars-cov-2-molecular-diagnostic-testing) - https://microbix.com/wp-content/uploads/2022/06/AACC-PreAnalytical-conference-June-2022_revised-FINAL.pdf
- [Performance of full and extended genotyping assays using a new high-risk HPV multiplex panel](https://microbix.com/resources/media-featured-poster-publication/performance-of-full-and-extended-genotyping-assays-using-a-new-high-risk-hpv-multiplex-panel) - https://microbix.com/wp-content/uploads/2022/05/EUROGIN-2022_FINAL-March-29-2022.pdf
- [Respiratory virus multiplex formulations desiccated on Copan's FLOQSwab© for use as cross-platform compatible EQA samples - and laboratory Quality Control](https://microbix.com/resources/media-featured-poster-publication/respiratory-virus-multiplex-formulations-desiccated-on-copans-floqswab-for-use-as-cross-platform-compatible-eqa-samples-and-laboratory-quality-control) - https://microbix.com/wp-content/uploads/2022/05/ECCMID-2022-FINAL-March-29-2022.pdf
- [Respiratory virus multiplex formulations desiccated on Copan's FLOQSwab® for use as cross-platform compatible EQA samples and laboratory Quality Control](https://microbix.com/resources/media-featured-white-paper/respiratory-virus-multiplex-formulations-desiccated-on-copans-floqswab-for-use-as-cross-platform-compatible-eqa-samples-and-laboratory-quality-control-2) - https://microbix.com/wp-content/uploads/2022/05/ECCMID-2022-FINAL-March-29-2022.pdf
- [Microbix's Corporate Presentation](https://microbix.com/resources/presentation/microbix-corporate-presentation/) - Profitable growth from supporting next generation Diagnostics. Click below to download..
- [Microbix Reports Results for H1 & Q2 2026](https://microbix.com/resources/uncategorized/microbix-reports-results-for-h1-q2-2026/) - H1 Revenues of $7.6 million and Controlled Net Loss MISSISSAUGA, CANADA, May 14, 2026 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2026 ended March 31, 2026 (“Q2” and “H1”). Results for Q2 and H1
- [Microbix Schedules Release of Results for Q2 Fiscal 2026](https://microbix.com/resources/resources/news-releases/microbix_schedules_release_of_results_for_q2_fiscal_2026) - Microbix announces announces it will be attending and presenting at the 2026 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on April 21 and 22, 2026.
- [Microbix Product Results Being Presented at 2026 PASCV](https://microbix.com/resources/resources/news-releases/microbix_product_results_being_presented_at_2026_pascv) - Microbix announces announces it will be attending and presenting at the 2026 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on April 21 and 22, 2026.
- [Microbix Engages with Diagnostics Industry Experts](https://microbix.com/resources/resources/news-releases/microbix_engages_with_diagnostics_industry_experts) - Microbix announces announces it will be attending and presenting at the 2026 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on April 21 and 22, 2026.
- [Microbix Presenting at the 2026 Bloom Burton Conference](https://microbix.com/resources/resources/news-releases/microbix-presenting-at-bloom-burton-conference-2026) - Microbix announces announces it will be attending and presenting at the 2026 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on April 21 and 22, 2026.
- [Microbix Exhibiting & Presenting at ESCMID Global 2026](https://microbix.com/resources/resources/news-releases/microbix-exhibiting-presenting-at-escmid-global-2026) - Microbix announces that it will be exhibiting at ESCMID Global 2026 and presenting results of a novel quality assessment product (“QAP™”) to enable full-process quality management of molecular assays to detect an RNA-based virus (e.g., “RT-PCR” tests).
- [Microbix's AGM 2026](https://microbix.com/resources/microbix-virtual-agm-2026/) - Microbix will be hosting an AGM on March 25, 2026, at 1:00 pm (EST) at Hyatt Place Mississauga Centre, 5787 Hurontario Street, Mississauga, Ontario L4Z 2H7. The online link will allow shareholders to listen to the AGM and view a CEO presentation via Zoom. Shareholders without up-to-date computer access can listen-in via telephone by
- [Microbix Reports Record Product Sales for Q4 and Fiscal 2024](https://microbix.com/resources/resources/news-releases/microbix-reports-record-results-for-q4-fiscal-2024/) - reports results for its fiscal year and fourth quarter ended September 30, 2024 (“2024” and “Q4”) with record revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and devices businesses and that resulted in material net income for 2024 and Q4.
- [Microbix Presents HCV FLOQSwab® Format Test Control at ADLM](https://microbix.com/resources/resources/news-releases/microbix-presents-hcv-floqswab-format-test-control-at-adlm/) - Microbix Biosystems Inc. introduces a novel Quality Assessment Product (QAP™) for Hepatitis C Virus (HCV) POCTs at the ADLM conference. This swab-based, room-temperature stable control aims to enhance accessibility and accuracy of HCV testing, especially in low-resource settings.
- [Microbix Hosts Minister Nina Tangri to Open Capacity Expansions](https://microbix.com/resources/resources/news-releases/microbix-hosts-minister-nina-tangri-to-open-capacity-expansions/) - Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces its hosting of Associate Minister of Small Business of Ontario, the Honourable Nina Tangri, to celebrate the opening of two expansions to its medical devices manufacturing capacity at one of its three adjacent Mississauga sites.
- [Microbix Advances Test-Ingredient Manufacturing Capabilities](https://microbix.com/resources/resources/news-releases/microbix-advances-test-ingredient-manufacturing-capabilities/) - Microbix is a global leader in the production of native Antigens – preparations of purified and inactivated bacteria and viruses essential for the manufacture of “immunoassays.”
- [Microbix Reports Strong Results for Q2 Fiscal 2024](https://microbix.com/resources/resources/news-releases/microbix-reports-strong-results-for-q2-fiscal-2024/) - Revenues of $5.6 million and Net Income of $0.4 million MISSISSAUGA, CANADA, May 15, 2024 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2024 ended March 31, 2024 (“Q2” and “H1”), with strong growth in sequential
- [Microbix Announces Issuance of Stock Options](https://microbix.com/resources/media/announces-issuance-of-stock-options-2024/) - Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, CANADA, February 26, 2024 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain
- [Microbix Reports Record Results for Q1 Fiscal 2024](https://microbix.com/resources/resources/news-releases/microbix-reports-record-results-for-q1-fiscal-2024) - Record Revenues of $8.4 million and Record Net Income of $2.5 million MISSISSAUGA, CANADA, February 14, 2024 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of fiscal 2024 ended December 31, 2023 (“Q1”), with record quarterly revenues and a record quarterly
- [Microbix Reports Results for Q4 & Full-Year Fiscal 2023](https://microbix.com/resources/news-releases/microbix-reports-results-for-q4-full-year-fiscal-2023) - Full-Year Sales of $16.5 million and Net Loss of $0.04 million MISSISSAUGA, CANADA, December 21, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its year and fourth quarter ended September 30, 2023 (“2023” & “Q4”), with solid sales and a resumption of profitability
- [Season 1 Episode 5: Diagnostics Beyond the Lab: Bridging Policy and Innovation for a Healthier Tomorrow](https://microbix.com/resources/media/season-1-episode) - In this episode of Diagnostics: Beyond the Lab we talk to two very distinguished guests, Christine Elliott, who served as the deputy premier of Ontario and the Minister of Health from 2018 to 2022, and Ivy Parks, President of Becton Dickinson (BD, for short) Canada, one of the oldest and largest diagnostics companies.
- [Microbix Announces Annual and Special Meeting Voting Results - March 30, 2023](https://microbix.com/resources/media/microbix-announces-annual-and-special-meeting-voting-results-5) - MISSISSAUGA, March 30, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)( “Microbix®” or the Company”), a life sciences innovator, manufacturer, and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held on March 29, 2023. At the Meeting, 48.77% of the issued and
- [Microbix Annual General Meeting (AGM) Update](https://microbix.com/resources/media/microbix-annual-general-meeting-update) - Remote Access to the AGM Provided to Avoid Physical Attendance MISSISSAUGA, CANADA, March 22, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, provides an update about its Annual General Meeting (“AGM”). The
- [Microbix Announces Issuance of Stock Options - Feb 27th 2023](https://microbix.com/resources/media/announces-issuance-of-stock-options) - Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, CANADA, February 27, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain
- [About us](https://microbix.com/resources/blog/about-us) - ABOUT MICROBIXMicrobix: Who we are? Microbix Biosystems Inc. develops and commercializes proprietary biological and technological solutions for human health and well-being. We manufacture a wide range of biological materials for the global diagnostics industry, notably antigens used in immunoassays and Quality Assessment Products (QAPsTM). Microbix has 3 buildings with a total of 34,000 square feet
- [Microbix Reports Record Results for Q2 Fiscal 2021](https://microbix.com/resources/media/microbix-reports-record-results-for-q2-fiscal-2021) - Record Q2 Sales of $4.35 million, Record Net Earnings of $0.8 million MISSISSAUGA, May 13, 2021 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for its second quarter and first half of fiscal 2021 ending March 31, 2021 (“Q2” and “H1”), with record sales and earnings,
- [Microbix Announces Annual and Special Meeting Voting Results - March 31, 2021](https://microbix.com/resources/media/microbix-announces-annual-and-special-meeting-voting-results-3) - MISSISSAUGA, March 31, 2021 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)( “Microbix®” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held on March 30, 2021. At the Meeting, 43.29% of the issued and outstanding
- [Microbix Announces Issuance of Stock Options - Feb 18th 2021](https://microbix.com/resources/news-releases/microbix-announces-issuance-of-stock-options-3) - Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, February 18, 2021 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain its board
- [Microbix Reports Results for Fiscal 2020](https://microbix.com/resources/media/microbix-reports-results-for-fiscal-2020) - Full-Year Sales of $10.5 Million, QAPs Sales Grow by 41% MISSISSAUGA, December 18, 2020 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, reports results for its 2020 fiscal year ("2020") and fourth
- [Microbix Announces Board Changes](https://microbix.com/resources/media/microbix-announces-board-changes) - William J. Gastle Retiring, Martin Marino Nominated To Become Independent Chairman MISSISSAUGA, CANADA, September 15, 2020 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces that its founder and Executive Chairman William J. (Bill) Gastle has elected to retire effective October 15, 2020, and that Martin Marino has
- [Q3 Fiscal 2020](https://microbix.com/resources/media/q3-fiscal-2020) - Year-Over-Year QAPs Sales Growth of 141% for Q3 MISSISSAUGA, August 14, 2020 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, reports results for its third quarter and year to date fiscal 2020 (Q3 and YTD) ended June 30, 2020, with an increase of 141% in sales of Quality Assessment
- [Curious To See How We Perform A COVID Test?](https://microbix.com/resources/blog/curious-to-see-how-we-perform-a-covid-test) - Curious to see how we perform a COVID test? The video shows the laboratory steps involved in testing four patient samples along with one Control. The reagents and procedures are for the “CDC test” for SARS-CoV-2. Still, there is no difference in processing these patient samples from any sample evaluated for respiratory or sexually transmitted
- [Microbix Shares Become Available For U.S. Investors](https://microbix.com/resources/media/microbix-shares-become-available-for-u-s-investors) - OTC Markets Listing and DTC Electronic Clearance Eligibility MISSISSAUGA, ON, CANADA, July 14, 2020 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces that it has completed two processes to make its common shares available for U.S. investors to buy and sell; (i) the listing of its
- [Microbix COVID-19 QAPs Attain EU “CE Mark” Registration](https://microbix.com/resources/media/microbix-covid-19-qaps-attain-eu-ce-mark-registration) - Enables Usage of SARS-CoV-2 Controls by Clinical Labs across Europe MISSISSAUGA, CANADA, June 5, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, is pleased to announce the attainment of European Union “CE mark” (Conformité Européene) registration for its SARS-CoV-2 quality assessment products (QAPs™) – CE mark registration enables
- [Microbix Reports Results For Q2 Fiscal 2020](https://microbix.com/resources/media/microbix-reports-results-for-q2-fiscal-2020) - Timing of Product Shipments Affects Results MISSISSAUGA, May 14, 2020 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, reports results for its second quarter and first half of fiscal 2020 (“Q2” and “H1”) ended March 31, 2020, with the timing of product shipments to customers affecting Q2 results. Management
- [Microbix & Oneworld Create COVID-19 Test Quality Program](https://microbix.com/resources/media/microbix-oneworld-create-covid-19-test-quality-program) - Laboratory External Quality Assessment, Proficiency Testing, & Accreditation MISSISSAUGA, ONTARIO and VANCOUVER, BC, CANADA, April 9, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®) and Oneworld Accuracy (1WA) announce a strategic collaboration to provide a global external quality assessment (EQA) program to support clinically-effective COVID-19 testing. Based in Canada, this program will be made available
- [Microbix Announces Annual And Special Meeting Voting Results - April 2, 2018](https://microbix.com/resources/media/microbix-announces-annual-and-special-meeting-voting-results) - TORONTO, April 2, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces the voting results from the Annual and Special Meeting of Shareholders (the “Meeting”) that was held on March 28, 2018. At the Meeting, 42.78% of the issued and outstanding shares were represented. A majority of shareholders
- [Microbix Annual General Meeting Process Update](https://microbix.com/resources/media/microbix-annual-general-meeting-process-update) - Remote Access to the AGM Provided to Avoid Physical Attendance MISSISSAUGA, March 25, 2020 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, provides an update about its Annual General Meeting (“AGM”). The AGM
- [Microbix Reports Results For Q1 Fiscal 2020](https://microbix.com/resources/media/microbix-reports-results-for-q1-fiscal-2020) - Positive Cash Flow from Operations Achieved MISSISSAUGA, February 13, 2020 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, reports results for its first quarter of fiscal 2020 (“Q1”) ended December 31, 2019, with
- [Microbix Reports Results For Fiscal 2019](https://microbix.com/resources/media/microbix-reports-results-for-fiscal-2019) - Full-Year Sales of $13.4 Million, Progress Toward Sustained Profitability MISSISSAUGA, December 20, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, reports results for its fiscal year (“2019”) and fourth quarter (“Q4”) ended
- [EUROGIN 2019](https://microbix.com/resources/events/eurogin-2019) - CLICK TO DOWNLOAD.
- [Microbix Presenting At StableView TECH19 Conference](https://microbix.com/resources/events/microbix-presenting-at-stableview-tech19-conference) - Meetings with Growth-Oriented Investors, October 3, 2019 MISSISSAUGA, October 1, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and quality control medical devices, announces that it will be presenting to investors about Microbix at the StableView TECH19 conference, organized by StableView Asset Management and being held at the Arcadian
- [Microbix Presenting At Muskoka Capital Conference - 2019](https://microbix.com/resources/events/microbix-presenting-at-muskoka-capital-conference) - Meetings with Growth-Oriented Investors, September 27-29, 2019 MISSISSAUGA, September 25, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and medical devices for test quality control, announces that it will be presenting to investors about Microbix at the Muskoka Capital Conference, organized by Capital Event Conferences and being held at
- [Microbix Reports Results For Q3 Fiscal 2019](https://microbix.com/resources/media/microbix-reports-results-for-q3-fiscal-2019) - Q3 Sales of $3.1 Million and $9.8 Million Year-To-Date TORONTO, August 12, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its third quarter and nine months of fiscal 2019, the three-month and nine-month periods ending June 30, 2019 (“Q3” & “YTD”), with record YTD sales,
- [FedDev Ontario Supports New Microbix Facility In Mississauga](https://microbix.com/resources/media/feddev-ontario-supports-new-microbix-facility-in-mississauga) - Contribution of $2.75 Million to Scale-up, Meet Demand, and Create Highly-Skilled Jobs MISSISSAUGA, July 30, 2019 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce the execution of a contribution agreement with the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). Today, the Honourable Navdeep
- [EMMD 11th Edition](https://microbix.com/resources/events/emmd-11th-edition)
- [Microbix Reports Results For Q2 Fiscal 2019](https://microbix.com/resources/media/microbix-reports-results-for-q2-fiscal-2019) - Record Sales of $4.25 Million, Sales Growth of 42%, and Material Net Earnings TORONTO, May 13, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its second quarter and first half of fiscal 2019, the three-month and six-month periods ending March 31, 2019 (“Q2” & “H1”),
- [Microbix Will Be Exhibiting At The 29th Annual ECCMID](https://microbix.com/resources/events/microbix-will-be-exhibiting-at-the-29th-annual-eccmid) - Microbix will be exhibiting at the 29th annual ECCMID (European Congress of Clinical Microbiology and Infectious Disease) in Amsterdam on April 13-16th. We are showcasing our recently launched line of QAPs™ (Quality Assessment Products) used in a range of infectious disease diagnostics control applications. Featured products include the broadest line of HPV control products available
- [Microbix Announces Issuance Of Stock Options - Feb 25th 2020](https://microbix.com/resources/media/microbix-announces-issuance-of-stock-options-2) - Using Shareholder-Approved Plan to Incentivize and Retain TORONTO, February 25, 2020 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the
- [Microbix Reports Results For Q1 Fiscal 2019](https://microbix.com/resources/media/microbix-reports-results-for-q1-fiscal-2019) - Lower Sales, Improving Gross Margin, Positive Cash Flow from Operations TORONTO, February 12, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its first quarter of fiscal 2019, the three-month period ending December 31, 2018 (“Q1”), with lower sales, improving percentage gross margin, improving and positive
- [Microbix Reports Results For Fiscal 2018](https://microbix.com/resources/media/microbix-reports-results-for-fiscal-2018) - Full-Year Sales Growth of 23%, Progress Toward Sustained Profitability TORONTO, December 21, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its fourth quarter of fiscal 2018, the three-month period ending September 30, 2018 (“Q4”), with strong sales and progress toward its operational goals. Management Discussion
- [Microbix Exhibiting At MEDICA Trade Fair](https://microbix.com/resources/events/microbix-exhibiting-at-medica-trade-fair) - Showcasing Antigen and Quality Assessment Products TORONTO, November 6, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it will be exhibiting its antigens and quality assessment products at MEDICA, a leading international trade fair for the medical sector. The 2018 MEDICA fair is being held at
- [Microbix To Present At Muskoka Capital Conference - Conference Introduces Growth Companies to Investors, September 28-30, 2018](https://microbix.com/resources/events/microbix-to-present-at-muskoka-capital-conference) - TORONTO, September 27, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it will be presenting to investors about Microbix at the Muskoka Capital Conference, organized by Capital Event Conferences and being held at the JW Marriott Rosseau Muskoka, in Minett, Ontario from September 28-30, 2018.
- [Microbix Exhibiting At AACC Exposition](https://microbix.com/resources/events/microbix-exhibiting-at-aacc-exposition) - Showcasing New Quality Assessment Products TORONTO, July 26, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it will be exhibiting its Quality Assessment Products (QAPs™) at the 70th annual clinical laboratory exposition of the American Association of Clinical Chemistry (AACC). The 2018 AACC exposition is being
- [Microbix To Present At Bloom Burton Conference](https://microbix.com/resources/events/microbix-to-present-at-bloom-burton-conference-2) - Healthcare Investor Conference in Toronto on April 30 & May 1 TORONTO, April 29, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that its CEO, Cameron Groome, has been invited to present at the 2019 Bloom Burton & Co. Healthcare Investment Conference, being held at the Metro
- [Microbix Reports Record First Quarter Sales - Year-Over-Year Sales Growth Of 48%](https://microbix.com/resources/media/microbix-reports-record-first-quarter-sales-year-over-year-sales-growth-of-48) - TORONTO, February 14, 2018 ‐ Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports financial results for its first quarter of fiscal 2018, the three‐ month period ending December 31, 2017 (“Q1”), with record sales and improving margins and earnings. First Quarter Financial Results Total Q1 revenue was $2,885,567, an
- [Microbix Expands Quality Assessment Product Family](https://microbix.com/resources/media/microbix-expands-quality-assessment-product-family) - 48 New Products Being Added, Under PTDx™ and PROCEEDx™ Brands TORONTO, January 18, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces the expansion of its quality assessment product family, with 48 new products being completed and made available for sale under its PTDx™ and PROCEEDx™ brands.
- [Microbix Announces End Of Legal Dispute – Allegations By ZeptoMetrix Withdrawn](https://microbix.com/resources/media/microbix-announces-end-of-legal-dispute-allegations-by-zeptometrix-withdrawn) - OCTOBER 11, 2017 TORONTO, October 11, 2017 – Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, is pleased to announce the withdrawal of legal claims alleging patent infringement that were filed in Canadian Federal Court against Microbix by ZeptoMetrix Corporation in October, 2016. The allegations by ZeptoMetrix have been withdrawn, following
- [Microbix Reports Record Third Quarter & Nine Month Sales – Year-Over-Year Sales Growth Exceeding 20%](https://microbix.com/resources/media/microbix-reports-record-third-quarter-nine-month-sales-year-over-year-sales-growth-exceeding-20) - TORONTO, August 14, 2017 – Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reports financial results for its fiscal third quarter and nine months ended June 30, 2017 (“Q3” and “9 Mo.”). Third Quarter Financial Results Total Q3 revenue was $2,773,365, an increase of 23% compared to the same quarter
- [Microbix Announces Annual Meeting Voting Results](https://microbix.com/resources/resources/news-releases/microbix-announces-annual-meeting-voting-results-2) - Microbix announces the voting results from the Annual Meeting of Shareholders of the Company (the “Meeting”) which was held on March 25, 2026.
- [Microbix Presents Reference-Material Innovations at EUROGIN](https://microbix.com/resources/resources/news-releases/microbix-presents-reference-material-innovations-at-eurogin) - Microbix announces that it is presenting results of novel QUANTDx™ reference materials designed to emulate real-life human papillomavirus (“HPV”) patient-samples and thereby better support the validation of molecular (e.g., “PCR”) tests for infection. Microbix is presenting at EUROGIN, an international conference and exhibition focused upon innovations in HPV research and global cancer solutions taking place in Vienna, Austria from March 18 to 21, 2026.
- [Microbix’s Clot-Buster Drug Project Advances](https://microbix.com/resources/resources/news-releases/microbix-clot-buster-drug-project-advances-2026) - Microbix announces that the contract development and manufacturing organization (“CDMO”) engaged by its funding and commercialization partner, Sequel Pharma, LLC (“Sequel”), has modernized production methods for the active ingredient (i.e., “Drug Substance”) of Kinlytic® urokinase (“Kinlytic”), a biologic for dissolving blood clots.
- [Microbix Announces Issuance of Stock Options](https://microbix.com/resources/resources/news-releases/microbix-announces-issuance-of-stock-options-7) - Microbix announces the issuance of stock options under its shareholder-approved stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain its board of directors, executives, and managers.
- [Microbix - KRC Insights FQ1 2026 Update](https://microbix.com/resources/resources/news-releases/krc-insights-q1-2026) - KRC Insights published an update report on Microbix’s FQ1 2026 financial results. All of KRC’s previous research reports, including this latest one.
- [Microbix Reports Results for Q1 2026](https://microbix.com/resources/resources/news-releases/microbix-reports-results-for-q1-2026-2/) - Microbix reports results for its first quarter of fiscal 2026 ended December 31, 2025 (“Q1”). Results for Q1 demonstrated the Company’s efforts to rebuild revenues back above its breakeven point following two client setbacks in mid-2025, with revenue growth of 13% compared to Q4 fiscal 2025. Q1 revenues and net loss were as-budgeted for fiscal 2026.
- [Microbix Welcomes The College of American Pathologists as a Client](https://microbix.com/resources/resources/news-releases/microbix-welcomes-the-college-of-american-pathologists-as-a-client/) - Microbix is pleased to welcome the College of America Pathologists (“CAP”) as a customer for Microbix quality assessment products (“QAPs™”) for use in CAP clinical laboratory proficiency-testing (“PT”) programs, also commonly known as External Quality Assessments (“EQA”).
- [Microbix Schedules Release of Results for Q1 Fiscal 2026](https://microbix.com/resources/resources/news-releases/microbix-schedules-release-of-results-for-q1-fiscal-2026/) - Microbix announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its first quarter of fiscal 2026 ended December 31, 2025 (“Q1 2026”) prior to the start of trading on February 12, 2026.
- [Microbix Updates Investor Presentation on its Website](https://microbix.com/resources/resources/news-releases/microbix-updates-investor-presentation-on-its-website/) - Microbix announces that it has updated the investor presentation on its corporate website in response to comments of staff of the Ontario Securities Commission (OSC & OSC Staff) in relation to its usage of earnings before interest, taxes, depreciation, and amortization (EBITDA), a measure of financial results not formally-defined by International Financial Reporting Standards (IFRS).
- [Microbix Presents Molecular Pathology Platform Results](https://microbix.com/resources/resources/news-releases/microbix-presents-molecular-pathology-platform-results/) - Microbix announces that it is presenting results of its novel Quality Assessment Products (“QAPs™”) and platform technology for supporting the quality management and reproducibility of Molecular Pathology derived diagnoses of infectious diseases at Labquality Days, a lab diagnostics conference taking place in Helsinki, Finland from February 5 to 6, 2026.
- [Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen](https://microbix.com/resources/resources/news-releases/microbix-commercializes-sars-cov-2-covid-recombinant-antigen/) - Microbix announces the commercial usage of its first recombinant antigen product, the nucleocapsid protein of the SARS-CoV-2 virus (COVID-19), in its quality assessment products (“QAPs™”) and its availability at commercial scale for test manufacturers.
- [Microbix Reports Results for Q4 and Fiscal 2025](https://microbix.com/resources/resources/news-releases/microbix-reports-results-for-q4-and-fiscal-2025/) - Full-Year Revenues of $18.6 million and Net Loss of $2.2 million MISSISSAUGA, CANADA, December 18, 2025 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal year and fourth quarter ended September 30, 2025 (“2025” and “Q4”) with revenues for those periods reflecting
- [Microbix Schedules Release of Results for Q4 Fiscal 2025](https://microbix.com/resources/resources/news-releases/microbix-schedules-release-of-results-for-q4-fiscal-2025/) - Results Release and Webinar Discussion on Morning of December 18, 2025 MISSISSAUGA, CANADA, December 11, 2025 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its fourth quarter of
- [Microbix Launches New Products to Support H3N2 Flu Testing](https://microbix.com/resources/resources/news-releases/microbix-launches-new-products-to-support-h3n2-flu-testing/) - Test-Controls & Reference Materials for Labs & Test-Makers MISSISSAUGA, CANADA, December 10, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of QAPs™ quality assessment products and availability of QUANTDx™ reference materials to support antigen or molecular tests for H3N2 strains of
- [Microbix Announces Initiation of Normal Course Issuer Bid](https://microbix.com/resources/resources/news-releases/microbix-announces-initiation-of-normal-course-issuer-bid-4/) - For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, December 4, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®) (“Microbix” or the “Company”), a life sciences innovator, manufacturer, and exporter, announces the initiation of a Normal Course Issuer Bid (“NCIB”) program for the repurchase and cancellation
- [Microbix & Seegene Mexico Collaborate to Improve Test Accuracy](https://microbix.com/resources/news-releases/microbix/seegene/mexico/collaborate/to/improve/test/accuracy/) - announce that Microbix external third-party quality assessment products (QAPs®) will be used to support the clinical use of the Allplex™ and Anyplex™ molecular multiplex assays of Seegene Mexico for detecting infection with high-risk types of the human papilloma virus (HPV).
- [Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests](https://microbix.com/resources/news-releases/microbix/partners/with/sekisui/to/support/covidflu/tests/) - announce that Microbix external third-party quality assessment products (REDx™FLOQ® QAPs®) will be used to support SEKISUI’s U.S. commercialization of the molecular point-of-care assay for diagnosis of COVID/Flu A/Flu B using the Metrix® platform from Aptitude Medical Systems, Inc. (Aptitude).
- [Microbix Presenting at Muskoka Capital Event](https://microbix.com/resources/news-releases/microbix/presenting/at/muskoka/capital/event/) - Microbix announces that it will be presenting to investors at the Muskoka Capital Event, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 26 to 28, 2025.
- [Microbix Assisting EMQN with Second Genetic-Test EQA Program](https://microbix.com/resources/news-releases/microbix/assisting/emqn/with/second/genetic/test/eqa/program/) - and EMQN CIC (EMQN), a global supplier of laboratory external quality assessment (“EQA”) schemes for human genomic testing, announce the go-live of a program to support rapid and accurate identification of patients who carry gene-variants associated with faster and slower than normal metabolism of the widely-prescribed antiplatelet (anti-clotting) drug Clopidogrel (brand named Plavix®).
- [Microbix Hosts Ontario Minister Stephen Crawford](https://microbix.com/resources/news-releases/microbix/hosts/ontario/minister/stephen/crawford/) - Microbix Biosystems announces its hosting of the Honourable Stephen Crawford, Ontario’s Minister of Public and Business Service Delivery and Procurement, for a site visit to tour the company’s advanced biotechnology development and manufacturing facilities and discuss how next generation diagnostics can improve health outcomes while reducing healthcare costs for Ontarians.
- [Microbix Reports Results for Q3 Fiscal 2025](https://microbix.com/resources/news-releases/microbix/reports/results/for/q3/fiscal/2025/) - Microbix Biosystems reports results for its third quarter and nine months of fiscal 2025 ended June 30, 2025 (“Q3” and “YTD”). Sales for Q3 were down for both Antigens and QAPs™, while YTD Antigens were up and QAPs were down YTD.
- [Microbix Schedules Release of Results for Q3 Fiscal 2025](https://microbix.com/resources/news-releases/microbix/schedules/release/of/results/for/q3/fiscal/2025/) - Microbix Biosystems announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its third quarter of fiscal 2025 ended June 30, 2025 (“Q3 2025”) prior to the start of trading on August 14, 2025
- [Microbix Launches QUANTDx™ Characterized Reference Materials](https://microbix.com/resources/news-releases/microbix/launches/quantdx/characterized/reference/materials/) - Microbix Biosystems Inc. announces the commercial launch of QUANTDx™, a new product line of well-characterized reference materials designed to support the development and validation of diagnostic assays.
- [Microbix Schedules Release of Results for Q1 Fiscal 2025](https://microbix.com/resources/news-releases/microbix-schedules-release-of-results-for-q1-fiscal-2024/) - announces that it expects to file the financial statements and management disclosure and analysis for its first quarter of fiscal 2025 ended December 31, 2024 (“Q1 2025”) prior to the start of trading on February 13, 2025
- [Microbix Reports Strong Revenues & Earnings for Q1 Fiscal 2025](https://microbix.com/resources/news-releases/microbix-reports-strong-revenues-and-earnings-for-q1-fiscal-2025/) - reports results for its first quarter of fiscal 2025 ended December 31, 2024 (“Q1”).
- [Microbix Exhibiting & Presenting at ADLM](https://microbix.com/resources/news-releases/microbix/exhibiting/at/adlm/) - Microbix Biosystems Inc. will be attending, exhibiting, and presenting at the Association for Diagnostic & Laboratory Medicine (“ADLM”) conference taking place in Chicago, Illinois July 28 to 31, 2025.
- [Microbix & Bulgaria’s NCIPD Execute Supply Agreement](https://microbix.com/resources/news-releases/microbix/to/develope/new/products/) - Microbix Biosystems Inc. and the National Center for Infectious and Parasitic Diseases of Bulgaria (“NCIPD”), announce an agreement whereby NCIPD will supply a portfolio of pathogen seedstocks for production of Microbix quality assessment products (“QAPs™”).
- [Microbix Attending & Presenting at Asia Pacific POC 2025](https://microbix.com/resources/news-releases/microbix-attending-and-presenting-at-asia-pacific-2025/) - Microbix Biosystems Inc. announces that it is attending and presenting at the 2nd Asia Pacific Conference on Point of Care Testing for Infectious Diseases, taking place in Bangkok, Thailand from 19 to 21 June, 2025 (“POC2025”).
- [Imagine there’s no cervical cancer. It’s easy, if we try.](https://microbix.com/resources/article/imagine/if/theres/no/cervical/cancer/) - In Ontario, health expenditures now exceed $87 billion per year and comprise over 40 per cent of overall spending. Such expenses are growing faster than our per capita productivity and show no signs of slowing down.
- [Microbix & Aurevia Introduce Novel EQA Scheme](https://microbix.com/resources/news-releases/microbix-aurevia-introduce-novel-eqa-scheme/) - Microbix & Aurevia announce a pilot external quality assessment (“EQA”) program to help clinical laboratories establish their proficiency at using molecular diagnostic methods (e.g., PCR tests) to diagnose bacterial vaginosis (“BV”).
- [Microbix Reports Results for Q2 Fiscal 2025](https://microbix.com/resources/news-releases/microbix-reports-results-for-q2-fiscal-2025/) - Microbix reports results for its second quarter and first half of fiscal 2025 ended March 31, 2025 (“Q2” and “H1”). Sales for Q2 and H1 reflected differential growth between Antigens (up) and QAPs™ (down), alongside a markedly-improved gross margin.
- [Microbix Supporting Australian Point-of-Care Testing Program](https://microbix.com/resources/media/microbix-supporting-australian-point-of-care-testing-program) - QAPs used in Diagnostic Testing for STIs in Remote Communities MISSISSAUGA, CANADA, March 1, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its Quality Assessment Products (“QAPs™”) are now supporting test accuracy within a program to provide Point-of-Care Testing (“PoCT”) for Sexually-Transmitted Infections (“STIs”)
- [Microbix Schedules Release of Results for Q2 Fiscal 2025](https://microbix.com/resources/news-releases/microbix-schedules-release-of-results-for-q2/) - Microbix announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its second quarter of fiscal 2025 ended March 31, 2025 (“Q2 2025”) prior to the start of trading on May 15, 2025.
- [Microbix Exhibiting at ESCMID Global 2025](https://microbix.com/resources/news-releases/microbix-exhibits-at-escmid-conference-vienna-2025/) - announces that it will be attending and exhibiting at ESCMID Global 2025 and that a customer and collaborator will be presenting results of a pilot External Quality Assessment (EQA) program enabled by Microbix Quality Assessment Products (QAPs™).
- [Microbix’s Clot-Buster Drug Project Advances](https://microbix.com/resources/news-releases/microbix-clot-buster-project-advances/) - Microbix announces that its funding and commercialization partner, Sequel Pharma, LLC (“Sequel”), has executed an agreement with a leading international contract development and manufacturing organization (“CDMO”) for production of the formulated and packaged drug (i.e., “Drug Product”) of Kinlytic® urokinase (“Kinlytic”), a biologic drug for dissolving blood clots.
- [Microbix Presenting at the 2025 Bloom Burton Conference](https://microbix.com/resources/news-releases/microbix-presenting-at-bloom-burton-conference/) - announces it will be attending and presenting at the 2025 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on Monday and Tuesday, May 5 & 6, 2025.
- [Microbix Schedules Release of Results for Q4 Fiscal 2024](https://microbix.com/resources/resources/news-releases/microbix-schedules-release-of-results-for-q4-fiscal-2024/) - announces that it expects to file the financial statements and management disclosure and analysis for its fourth quarter of fiscal 2024 ended September 30, 2024 (“Q4 2024”) prior to the start of trading on December 19, 2024. At 11:00 AM ET on that day, Microbix intends to hold a webinar discussion of Q4 2024 results with its CEO, CFO, and COO.
- [Microbix Participating In COVID-19 Virtual Conference](https://microbix.com/resources/events/microbix-participating-in-covid-19-virtual-conference) - Presentation and Panel Participation at Adelaide Capital Event on April 23 MISSISSAUGA, CANADA, April 21, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it will be participating in the “Virtual COVID & Healthcare Mini Conference” being hosted by Adelaide Capital on April 23 from 12:00-5:00 PM
- [Microbix Provides Business Updates](https://microbix.com/resources/news-releases/microbix-provides-business-updates/) - provides an update on U.S. and reciprocal tariff outcomes as well as business conditions and its outlook for the balance of its fiscal 2025.
- [Microbix Announces Annual and Special Meeting Voting Results](https://microbix.com/resources/news-releases/microbix-announces-annual-voting-results/) - announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held on March 26, 2025.
- [Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific](https://microbix.com/resources/news-releases/microbix-and-acpcc-support-efforts-to-eliminate-cervical-cancer-in-indo-pacific/) - announce that they have signed a Memorandum Of Understanding (MOU) under which Microbix will supply its PROCEEDx™FLOQ® brand Quality Assessment Products (QAPs™) to support quality management of testing for high-risk Human Papillomavirus (HPV) infections, which cause most cases of cervical cancer.
- [Microbix Further Optimizes Capital Usage and Availability](https://microbix.com/resources/news-releases/microbix-further-optimizes-capital-usage-and-availability/) - announces the further optimization of the structure and utilization of its capital via the repayment of mortgage debt and expansion of its bank line of credit – Moves that reduce interest expenses while maintaining strategic flexibility and resilience.
- [2022 AMMI Canada-CACMID Annual Conference - April 5-8](https://microbix.com/resources/events/2022-ammi-canada-cacmid-annual-conference) - The time has come again for the Canadian annual meeting in infectious diseases and diagnostic microbiology. The AMMI Canada – CACMID Annual Conference is returning in a hybrid format: in-person in Vancouver, BC, and online via our virtual platform. The AMMI Canada – CACMID Annual conference continues to be successful in accomplishing its objectives for delivering a
- [Microbix Reports Results for Q3 Fiscal 2023](https://microbix.com/resources/media/microbix-reports-results-for-q3-fiscal-2023) - Strong Sales of $5.5 million alongside Drug Partnering Agreement MISSISSAUGA, August 10, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and YTD fiscal 2023 ended June 30, 2023 (“Q3” and “YTD”), a period in which strong revenues were realized along
- [Microbix Creates Further COVID-19 Quality Assessment Products](https://microbix.com/resources/media/microbix-creates-further-covid-19-quality-assessment-products) - QAPs™ To Support Accuracy Of COVID-19 Antigen-Test Workflows MISSISSAUGA, CANADA, October 20, 2020 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces its creation, external verification, initial sales, and first shipments of a new class of quality assessment products (QAPs™) to help implement or ensure workflow accuracy of antigen-based
- [Microbix Reports Results for Q2 Fiscal 2023](https://microbix.com/resources/media/microbix-reports-results-for-q2-fiscal-2023) - Sales of $4.2 million and Profitability MISSISSAUGA, May 11, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2023 ended March 31, 2023 (“Q2” and “H1”), a period in which a loss was incurred in the
- [Microbix Reports Record Sales for Fiscal 2022](https://microbix.com/resources/media/microbix-reports-record-sales-for-fiscal-2022) - Record Sales of $19.1 million, Net Earnings of $1.8 million MISSISSAUGA, December 22, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its year and fourth quarter ended September 30, 2022 (“2022” and “Q4”), with record sales and continued positive net earnings, plus ongoing
- [Microbix Presenting at Florida Capital Event Conference](https://microbix.com/resources/media/microbix-presenting-at-florida-capital-event-conference) - Meetings with Growth-Oriented Investors, November 17 to 19, 2023 MISSISSAUGA, CANADA, November 17, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Florida Capital Event Conference, organized by Capital Event Management Ltd. and being hosted at the
- [Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market](https://microbix.com/resources/media/microbix-clot-buster-drug-fully-funded-for-return-to-u-s-market) - Sequel Pharma Reconfirms Kinlytic® urokinase Support for Catheter Clearance Indication MISSISSAUGA, CANADA, November 16, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the reconfirmation of its agreement (“Agreement”) with Sequel Pharma, LLC (“Sequel”) to return Kinlytic® urokinase (“Kinlytic”) to market, initially for dissolving blood clots
- [Microbix Schedules Release of Results for Q3 Fiscal 2024](https://microbix.com/resources/resources/news-releases/microbix-schedules-release-of-results-for-q3-fiscal-2024/) - Microbix Biosystems Inc. announces that it expects to file the financial statements and management disclosure and analysis for its third quarter of fiscal 2024 ended June 30, 2024 (“Q3 2024”) prior to the start of trading on August 14, 2024.
- [Microbix Reports Continued Strong Results for Q3 Fiscal 2024](https://microbix.com/resources/resources/news-releases/microbix-reports-continued-strong-results-for-q3-fiscal-2024/) - Microbix Biosystems Inc. reports results for its third quarter and first nine months of fiscal 2024 ended June 30, 2024 (“Q3” and “YTD”) with strong revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and devices businesses and resulting in material net income for Q3 and YTD.
- [Microbix Schedules Release of Results for Q1 Fiscal 2024](https://microbix.com/resources/resources/news-releases/microbix-schedules-release-of-results-for-q1-fiscal-2024) - Results Release and Webinar Discussion on Morning of February 14, 2024 MISSISSAUGA, CANADA, February 7, 2024 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its first quarter of fiscal 2024 ended December
- [Microbix Reports Results for Q3 Fiscal 2022](https://microbix.com/resources/media/microbix-reports-results-for-q3-fiscal-2022) - Q3 Sales of $5.0 million, Q3 Net Earnings of $0.6 million MISSISSAUGA, August 11, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and year-to-date fiscal 2022 ended June 30, 2022 (“Q3” and “YTD”), with strong sales and continued positive net
- [Microbix Schedules Release of Results for Q2 Fiscal 2024](https://microbix.com/resources/resources/news-releases/microbix-schedules-release-of-results-for-q2-fiscal-2024/) - Results Release and Webinar Discussion on Morning of May 15, 2024 MISSISSAUGA, CANADA, May 8, 2024 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its second quarter of fiscal 2024 ended March
- [Microbix Reports Record Results for Fiscal 2021](https://microbix.com/resources/media/microbix-reports-record-results-for-fiscal-2021) - Record Sales of $18.6 million, Record Net Earnings of $3.2 million MISSISSAUGA, December 23, 2021 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for its year and fourth quarter ended September 30, 2021 (“2021” and “Q4”), with record sales and earnings, plus progress upon its strategic
- [Microbix Reports Results for Q1 Fiscal 2023 - Sales of $2.5 million, Net Loss of $1.3 million](https://microbix.com/resources/media/microbix-reports-results-for-q1-fiscal-2023) - Sales of $2.5 million, Net Loss of $1.3 million MISSISSAUGA, February 9, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter ended December 31, 2022 (“Q1”), a period in which reduced sales across two major product lines resulted in the first
- [Microbix Reports Record Results for Q3 Fiscal 2021](https://microbix.com/resources/media/microbix-reports-record-results-for-q3-fiscal-2021) - Record Sales of $5.5 million, Record Net Earnings of $1.5 million MISSISSAUGA, August 12, 2021 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for its third quarter and nine months of fiscal 2021 ending June 30, 2021 (“Q3” and “YTD”), with record sales and earnings, plus
- [Microbix Hosts Ontario Premier Doug Ford & Team](https://microbix.com/resources/news-releases/microbix-hosts-ontario-premier-doug-ford-and-team-2025/) - was pleased to host Government of Ontario candidates Premier Doug Ford (Etobicoke North riding) and local MPP Deepak Anand (Mississauga-Malton riding). During their site visit on the morning of February 27 — Ontario’s Provincial Election Day — our team had great conversations about how next-generation diagnostic tests can improve health outcomes for patients while also reducing healthcare costs.
- [KOL Collaborators Present Microbix HPV Test-Control Results](https://microbix.com/resources/resources/news-releases/kol-collaborators-present-microbix-hpv-test-control-results/) - announces that key opinion leader (“KOL”) collaborators are presenting results of a Microbix Quality Assessment Product (“QAP™”) for controlling testing for high-risk types of Human Papilloma Virus (“HPV”) at the 36th annual International Papillomavirus Conference (“IPVC”) taking place in Edinburgh, Scotland, November 12 to 15, 2024.
- [Microbix & API Ensuring Flu Tests Can Detect H5N1 Strain](https://microbix.com/resources/news-releases/microbix-and-api-ensuring-flu-tests-detect-h5n1-strain/) - Microbix and American Proficiency Institute (API), a groundbreaking supplier of proficiency testing (“PT”) to over 20,000 clinical laboratories, announce the start of a pilot PT program to ensure that molecular diagnostic (“MDx”) assays can detect the emerging H5N1 strain of the Influenza A virus (“H5N1 Flu”).
- [Microbix Announces Issuance of Stock Options](https://microbix.com/resources/news-releases/microbix-announces-issuance-of-stock-options-2025/) - announces the issuance of stock options under its shareholder-approved stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain its board of directors, executives, and managers.
- [Microbix Presenting at Investor Conference in B.C.](https://microbix.com/resources/news-releases/microbix-presents-at-investor-conference-in-british-columbia/) - announces that it will be presenting to equity investors at the Whistler Capital Event conference, organized by Capital Event Management Ltd. and being hosted at the Fairmont Chateau Whistler, in Whistler, British Columbia, February 21 to 23, 2025.
- [Microbix Receives $2.4 Million from Exercise of Warrants](https://microbix.com/resources/news-releases/microbix-recieves-2.4million-from-exercise-of-warrants/) - announces that it has received C$ 2.4 million in new equity capital from the partial exercise of expiring share purchase warrants.
- [Microbix Expanding Addressable Market Share with Test Makers](https://microbix.com/resources/news-releases/microbix-expanding-addressable-market-share-with-test-makers/) - announces its intentions to broaden its platform capabilities to enable production of a wider range of test ingredients (“Antigens”) by using recombinant production technologies.
- [Microbix Assisting EMQN with Novel Genetic-Test EQA Program](https://microbix.com/resources/resources/news-releases/microbix-assisting-emqn-with-novel-genetic-test-eqa-program/) - with EMQN announce the go-live of a program to support the accurate identification of patients who carry a gene-variant associated with increased susceptibility to hearing loss following treatment with a widely-used class of antibiotics.
- [Microbix Announces Initiation of Normal Course Issuer Bid](https://microbix.com/resources/resources/news-releases/microbix-announces-initiation-of-normal-course-issuer-bid/) - announces the initiation of a Normal Course Issuer Bid (“NCIB”) program for the repurchase and cancellation of outstanding common shares.
- [Microbix Presents Novel HSV Test Control at EMMD](https://microbix.com/resources/resources/news-releases/microbix-presents-novel-hsv-test-control-at-emmd/) - announces that it is presenting results of a novel Quality Assessment Product (“QAP™”) for supporting patient diagnosis and tissue analysis relating to infection with the Herpes Simplex Virus (“HSV”) at the European Meeting on Molecular Diagnostics (“EMMD”) taking place in Noordwijk, The Netherlands, October 9 to 11, 2024.
- [Microbix Achieves Essential EU Regulatory Accreditations](https://microbix.com/resources/resources/news-releases/microbix-achieves-essential-eu-regulatory-accreditations/) - Microbix announces that it has upgraded its European Union (“EU”) regulatory compliance for its diagnostic assay quality assessment products (“QAPs™”).
- [Microbix Presenting at Muskoka Capital Conference](https://microbix.com/resources/resources/news-releases/microbix-presenting-at-muskoka-capital-conference-5/) - Microbix will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 27 to 29, 2024. Microbix will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 27 to 29, 2024.
- [Microbix To Amend Share Purchase Warrant Terms](https://microbix.com/resources/media/microbix-to-amend-share-purchase-warrant-terms) - TORONTO August 24 2017 – Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces it has applied to the TSX to amend the terms of 1,500,000 common share purchase warrants (the “Warrants”) issued in connection with a non-brokered private placement and held by one of its independent directors. The
- [Microbix Announces First Shipment Of Bioreactor Antigen](https://microbix.com/resources/media/microbix-announces-first-shipment-of-bioreactor-antigen) - Microbix Announces First Shipment Of Bioreactor Antigen
- [Microbix Completes Brokered Private Placement – Gross Proceeds Of $2.3 Million](https://microbix.com/resources/media/microbix-completes-non-brokered-private-placement-of-2-3-million) - TORONTO, October 19, 2017 – Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), a developer and marketer of biological products and technologies, announces that it has completed a brokered private placement financing totaling $2.33 million dollars, resulting in the issue of 7,784,500 million units (“Units”) at a price of $0.30 per unit. Each Unit
- [Microbix Completes Second Tranche Of Brokered Private Placement Tranche Gross Proceeds Of $1,164,640, Total Proceeds Of $3,500,000](https://microbix.com/resources/media/microbix-completes-second-tranche-of-brokered-private-placement-tranche-gross-proceeds-of-1164640-total-proceeds-of-3500000) - TORONTO, October 27, 2017 – Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), a developer and marketer of biological products and technologies, announces that it has completed a second and final tranche of the brokered private placement financing announced on October 19, 2017. An aggregate of 7,784,500 Units were issued in the first tranche
- [Microbix Confirms Ramp-Up Of Production – Bioreactor Capacity Increasing By 500%](https://microbix.com/resources/media/microbix-confirms-ramp-up-of-production-bioreactor-capacity-increasing-by-500) - TORONTO, November 27, 2017 – Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, confirms its production ramp-up, with a 500% increase in bioreactor capacity and other processing upgrades. Microbix’ revenues are mainly from sales of its antigens as critical components for makers of tests that diagnose infectious diseases. Antigens
- [Microbix Reports Full Year And Fourth Quarter Results – Record Sales Of $10.2 Million Achieved For Fiscal 2017](https://microbix.com/resources/blog/microbix-reports-full-year-and-fourth-quarter-results-record-sales-of-10-2-million-achieved-for-fiscal-2017) - TORONTO, December 21, 2017 – Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, reports financial results for its fiscal year and fourth quarter ended 30 September, 2017 (“2017” and “Q4”). Management Discussion In 2017, the Company achieved a number of notable milestones, including attaining record sales of over $10 million. Operational
- [Cantech Investor Conference](https://microbix.com/resources/events/cantech-investor-conference) - JANUARY 29, 2018 Celebrating the 5th anniversary of Canada’s largest technology investment conference. We are excited to bring over 3500 engaged investors together with 100+ leading technology companies. Visit us at the Metro Toronto Convention Center on January 31 from 8 AM to 7 PM For more information, http://cambridgehouse.com/e/cantech-investment-conference-2018-72
- [Microbix Featured At Cantech Investment Conference](https://microbix.com/resources/events/microbix-featured-at-cantech-investment-conference) - Invited onto Panel about Managing Canadian Healthcare Companies for Growth TORONTO, January 29, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces its participation as a panelist and exhibitor at the Cantech Investment Conference, being held at the Metro Toronto Convention Centre on January 31, 2018. Celebrating its
- [ECCMID Madrid, Spain April 21-24](https://microbix.com/resources/events/eccmid-madrid-spain-april-21-24) - Join us at ECCMID in Madrid in April. It will be our first time exhibiting there and our QAPs™ lines will be our highlighted. For more information, visit http://www.eccmid.org/
- [Microbix Announces Annual And Special Meeting Voting Results - , April 2, 2018](https://microbix.com/resources/media/microbix-announces-annual-and-special-meeting-voting-results-2) - TORONTO, April 2, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces th...
- [Microbix Engages Drug Licensing Advisor](https://microbix.com/resources/media/microbix-engages-drug-licensing-advisor) - Torreya Partners to Assist with Kinlytic® urokinase TORONTO, April 26, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces the engagement of Torreya Partners LLC of New York to assist it in reaching an agreement that enables the re-launch of its clot-buster drug, Kinlytic® urokinase, into the United
- [Microbix Completes Multiple Facility Upgrades](https://microbix.com/resources/media/microbix-completes-multiple-facility-upgrades) - Production Capacity Increased to Support Growth Objectives TORONTO, May 8, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces the completion of multiple upgrades to its production facility, to improve its revenue capacity and in support of corporate growth objectives. About Microbix’ Antigens & Quality Products Business Microbix
- [Microbix Reports Record Second Quarter Sales](https://microbix.com/resources/media/microbix-reports-record-second-quarter-sales) - Microbix Reports Record Second Quarter Sales
- [Microbix To Present At Okanagan Capital Conference](https://microbix.com/resources/events/microbix-to-present-at-okanagan-capital-conference) - Conference Introduces Growth Companies to Investors, July 12-14, 2018 TORONTO, July 12, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it will be presenting to investors about Microbix at the Okanagan Capital Conference, organized by Capital Event Conferences and being held at the Delta Grand Okanagan
- [Microbix Reports Record Third Quarter Sales](https://microbix.com/resources/media/microbix-reports-record-third-quarter-sales) - Microbix Reports Record Third Quarter Sales Year-Over-Year Sales Growth of 24% in First Nine Months TORONTO, August 14, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports financial results for its third quarter of fiscal 2018, the three-month period ending June 30, 2018 (“Q3”), with record sales
- [Microbix Wins Business Award Of Excellence](https://microbix.com/resources/media/microbix-wins-business-award-of-excellence) - Recognized with 2018 Business Innovation Award by MBOT TORONTO, November 19, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has been recognized with the 2018 Business Innovation Award by the Mississauga Board of Trade (MBOT). The award was provided to Microbix at the MBOT Business
- [Microbix Enhances Quality Management System](https://microbix.com/resources/media/microbix-enhances-quality-management-system) - ISO 13485:2016 Medical Devices Certification Attained TORONTO, December 24, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has attained the ISO 13485:2016 Medical Devices certification – an enhancement to its quality management system that is expected to accelerate the growth of its QAPs™ lines of
- [Microbix Provides Quality Assessment Products Update](https://microbix.com/resources/media/microbix-provides-quality-assessment-products-update) - New Customers, More Products, and Expanding Capacity TORONTO, February 5, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on the expansion of its quality assessment product lines, announcing the addition of new customers, more products, and steps to expand its production capacity. Microbix’s quality assessment
- [Annual General Meeting (AGM) - March 27th, 2019](https://microbix.com/resources/events/annual-general-meeting-agm-march-27th-2019) - Shareholders and other interested parties, please note Microbix will hold its annual general meeting (AGM) at the Toronto University Club located at 380 University Avenue, Toronto, M5G 1R6 on Wednesday March 27th at 1 PM. Click here for INFO CIRCULAR
- [Microbix Announces Annual Meeting Voting Results - March 28, 2019](https://microbix.com/resources/media/microbix-announces-annual-meeting-voting-results) - TORONTO, March 28, 2019 - Microbix Biosystems Inc. (TSX: MBX, “Microbix” or the “Company”), an innovator of biological products and technol...
- [Microbix Announces Management Changes](https://microbix.com/resources/media/microbix-announces-management-changes) - Ken Hughes Appointed COO, Kathryn Froh Retiring TORONTO, April 18, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has appointed Dr. Kenneth (Ken) Hughes as its Chief Operating Officer (“COO”) and that Mrs. Kathryn Froh, its Vice President, Diagnostics is retiring from her full-time role,
- [Microbix To Present At Bloom Burton Conference - Healthcare Investment Conference in Toronto on May 2 & 3, 2018](https://microbix.com/resources/events/microbix-to-present-at-bloom-burton-conference) - Healthcare Investment Conference in Toronto on May 2 & 3, 2018 TORONTO, April 30, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has been invited to present to investors about Microbix at the Bloom Burton & Co. Healthcare Investment Conference, being held at the Toronto
- [Microbix Will Be Exhibiting At The 35th Annual ASM Clinical Virology Symposium](https://microbix.com/resources/events/microbix-will-be-exhibiting-at-the-35th-annual-asm-clinical-virology-symposium) - Microbix will be exhibiting at the 35th annual ASM/CVS (Clinical Virology Symposium) in Savannah on May 04-08th. We are showcasing our recently launched line of QAPs (Quality Assessment Products) used in a range of infectious disease diagnostics control applications. Featured products include the broadest line of HPV control products available today, along with a wide range of
- [Microbix Provides Bioreactor Update](https://microbix.com/resources/media/microbix-provides-bioreactor-update) - Largest Customer Confirms Conversion Timetable & Provides Full-Scale Order TORONTO, August 1, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on the conversion of its highest-selling product into bioreactors – that the largest customer for that antigen has confirmed its intended timetable for conversion of
- [Microbix Quality Products Attain European Registration](https://microbix.com/resources/media/microbix-quality-products-attain-european-registration) - Four IVD Controls to Support Performance of Human Papilloma Virus (HPV) Tests MISSISSAUGA, September 5, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce European registration for four innovative in-vitro diagnostic (IVD) control products for evaluating performance, procedures, and workflow of laboratory tests that detect
- [Microbix Quality Products Enter U.S. Market](https://microbix.com/resources/media/microbix-quality-products-enter-u-s-market) - Four IVD Controls to Support Performance of Human Papilloma Virus (HPV) Tests MISSISSAUGA, September 19, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce U.S. availability of four innovative in-vitro diagnostic (IVD) control products for evaluating performance, procedures, and workflow of laboratory tests that detect
- [Microbix Presenting Product Results At Industry Conference](https://microbix.com/resources/events/microbix-presenting-product-results-at-industry-conference) - Two Abstracts on IVD Controls at EMMD, October 9-11, 2019 Download PDF Download MS Word
- [Microbix Wins Ontario Business Award](https://microbix.com/resources/media/microbix-wins-ontario-business-award) - 2019 “OBAA” for Excellence in Export Strategy MISSISSAUGA, November 18, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices (QAPs™) that help ensure test accuracy, announces it has been awarded the “Beyond Borders” Ontario Business Achievement Award (OBAA)
- [Microbix Invited To Present Product Results At HPV Congress](https://microbix.com/resources/events/microbix-invited-to-present-product-results-at-hpv-congress) - IVD Controls Data at EUROGIN, December 4-7, 2019 MISSISSAUGA, December 2, 2019 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces it has been invited to present the performance of its in-vitro diagnostics
- [Microbix Completes Non-Brokered Private Placement Of $2.3 Million](https://microbix.com/resources/media/microbix-completes-non-brokered-private-placement-of-2-3-million) - TORONTO, October 19, 2017 – Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), a developer and marketer of biological products and technologies, announces that it has completed a brokered private placement financing totaling $2.33 million dollars, resulting in the issue of 7,784,500 million units (“Units”) at a price of $0.30 per unit. Each Unit
- [Annual General Meeting (AGM) - March 31st, 2020 UPDATE!](https://microbix.com/resources/events/annual-general-meeting-agm-march-31st-2020-update) - The AGM will still be held on March 31, 2020 at 1:00 pm, however due to the closure of our planned venue and alternative venues, we will be proceeding with access being provided online or via teleconference only. Due to the COVID-19 pandemic, Microbix also wants to avoid the need for in-person attendees at this
- [Microbix Announces Issuance Of Stock Options - Sep 13th 2017](https://microbix.com/resources/media/microbix-announces-issuance-of-stock-options) - Microbix Announces Issuance Of Stock Options - Sep 13th 2017
- [Microbix Announces Quality Products Distribution Agreement - Appointment of Alpha-Tec Systems, Inc. for the United States](https://microbix.com/resources/media/microbix-announces-quality-products-distribution-agreement-4) - Appointment of Alpha-Tec Systems, Inc. for the United States MISSISSAUGA, June 4, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Alpha-Tec Systems, Inc. (Alpha-Tec), a Calibre Scientific Inc. firm, as distributor of its Quality Assessment Products (QAPs™) for the United States. Under an agreement
- [Microbix Creates Quality Assessment Product For COVID-19 Tests](https://microbix.com/resources/media/microbix-creates-quality-assessment-product-for-covid-19-tests) - Whole-genome QMS Support Tool on COPAN® FLOQSwabs® MISSISSAUGA, CANADA, March 30, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®) announces the creation, verification, and imminent commercial availability of a quality assessment product (QAP™) to help ensure the accuracy of COVID-19 disease testing. By creating this unique product, Microbix is contributing to the development of new
- [Understanding COVID-19 Mortality Rates](https://microbix.com/resources/blog/understanding-covid-19-mortality-rates)
- [How Microbix Core Competency Leads To COVID-19 Products](https://microbix.com/resources/blog/how-microbix-core-competency-leads-to-covid-19-products) - https://www.mbot.com/news/cameron-groome-mississauga-company-contributes-covid-19-solution-podcast/
- [Microbix Attains Health Canada Establishment Licensing](https://microbix.com/resources/media/microbix-attains-health-canada-establishment-licensing) - Enables Immediate Usage of SARS-CoV-2 Controls by Clinical Labs across Canada MISSISSAUGA, CANADA, April 21, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator and exporter, announces that it has attained medical devices establishment licensing from Health Canada, enabling the immediate usage of its quality assessment products (QAPs™) by clinical laboratories, including
- [Microbix Announces Quality Products Distribution Agreement - Appointment of R-Biopharm AG for 11 Countries](https://microbix.com/resources/media/microbix-announces-quality-products-distribution-agreement-3) - Appointment of R-Biopharm AG for 11 Countries MISSISSAUGA, May 15, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of R-Biopharm AG (R-Biopharm) as distributor of its Quality Assessment Products (QAPs™) in eleven (11) countries. Under an agreement between the parties, R-Biopharm has been appointed as
- [Microbix Begins Providing COVID-19 Test Quality Products](https://microbix.com/resources/media/microbix-begins-providing-covid-19-test-quality-products) - SARS-CoV-2 Controls for Canadian Labs in Swab and Vial Formats MISSISSAUGA, CANADA, May 6, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has begun providing its REDx™FLOQ® SARS-CoV-2 swab-format and REDx™ SARS-CoV-2 vial format quality assessment products (QAPs™) as controls to clinical laboratories in Canada.
- [Microbix COVID-19 QAPs Now Available for U.S. Labs](https://microbix.com/resources/media/microbix-covid-19-qaps-now-available-for-u-s-labs-2) - Registration Enables Immediate Usage of SARS-CoV-2 Controls by U.S. Clinical Labs MISSISSAUGA, CANADA, May 7, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, is pleased to announce U.S. availability of its SARS-CoV-2 quality assessment products (QAPs™) – FDA registration enabling immediate usage by U.S. clinical laboratories to evaluate
- [Microbix Announces Quality Products Distribution Agreement - Appointment of D.I.D. S.p.A. of Milan for Italy](https://microbix.com/resources/media/microbix-announces-quality-products-distribution-agreement-2) - Appointment of D.I.D. S.p.A. of Milan for Italy MISSISSAUGA, May 12, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Diagnostic International Distribution S.p.A. of Milan (D.I.D.) as distributor of its Quality Assessment Products (QAPs™) for Italy. Under an agreement between the parties, D.I.D. has
- [Microbix Reports Record Second Quarter Sales - Year-Over-Year Sales Growth of 28% in First-Half](https://microbix.com/resources/media/microbix-reports-record-second-quarter-sales-2) - Year-Over-Year Sales Growth of 28% in First-Half TORONTO, May 14, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports financial results for its second quarter of fiscal 2018, the three-month period ending March 31, 2018 (“Q2”), with record sales and progress toward its operational goals. Second Quarter Financial
- [Microbix Announces Quality Products Distribution Agreement - Appointment of Labquality Oy of Finland for 7 Countries](https://microbix.com/resources/media/microbix-announces-quality-products-distribution-agreement) - Appointment of Labquality Oy of Finland for 7 Countries MISSISSAUGA, April 27, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Labquality Oy (Labquality) as a distributor of its Quality Assessment Products (QAPs™) in seven (7) countries. Under an agreement between the parties, Labquality has
- [Microbix Achieves Full Utilization Of Its Bioreactors](https://microbix.com/resources/media/microbix-achieves-full-utilization-of-its-bioreactors) - Six Units in Ongoing Use for Foreseeable Future, Seventh Ordered MISSISSAUGA, CANADA, May 19, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has achieved full utilization of the six bioreactor units it installed for manufacturing the “antigens” which are at the core of immunoassays that
- [Microbix Expanding QAPs™ Production Capacity](https://microbix.com/resources/media/microbix-expanding-qaps-production-capacity) - Build-out to Support Tenfold Increase Now Underway MISSISSAUGA, CANADA, May 27, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has begun a build-out of its second facility that is initially intended to support a tenfold increase of production capacity for its QAPs™ quality assessment products
- [Microbix Engaged To Develop & Supply Custom QAPs™](https://microbix.com/resources/media/microbix-engaged-to-develop-supply-custom-qaps) - Instrument-Specific Controls to Support Rapid Tests for Viral Respiratory Pathogens MISSISSAUGA, June 1, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has been engaged to develop and supply custom quality assessment products (QAPs™) to support the registration and sales of a new point-of-care instrument and
- [Microbix Announces Quality Products Distribution Agreement - Appointment of Medical Supply Company of Ireland](https://microbix.com/resources/news-releases/curious-to-see-how-we-perform-a-covid-test-2) - Appointment of Medical Supply Company of Ireland MISSISSAUGA, March 24, 2020 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces the appointment of The Medical Supply Company of Ireland (MSC) as a distributor.
- [2020 AGM Meeting Notice](https://microbix.com/resources/media/2020-agm-meeting-notice-2-2) - Please note, due to the global circumstances, this year's Microbix Annual General Meeting will be held as a virtual meeting. Please stay tuned for link and instructions.
- [Microbix’s REDx™ Controls Attain Australian TGA Registration](https://microbix.com/resources/media/microbixs-redx-controls-attain-australian-tga-registration) - Enables Use of COVID-19 and HPV Products by Australian Clinical Labs MISSISSAUGA, CANADA, September 10, 2020 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, is pleased to announce attainment of Australian Therapeutic Goods Administration (TGA) registration for its COVID-19 and high-risk HPV quality assessment products (QAPs™) –
- [Microbix Announces Extension Of Warrant Expiry Dates](https://microbix.com/resources/media/microbix-announces-extension-of-warrant-expiry-dates) - Applies For 12-Month Term Extension Of October 2015 And October 2017 Warrants MISSISSAUGA, CANADA, September 17, 2020 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces it has applied to the TSX to extend the term of an aggregate of 7,413,052 common share purchase warrants (“Warrants”) which were
- [Microbix Presenting COVID-19 Product Results To Industry](https://microbix.com/resources/media/microbix-presenting-covid-19-product-results-to-industry) - Abstract Reports Multi-Platform Utility Of IVD SARS CoV-2 Lab Workflow Control MISSISSAUGA, CANADA, September 22, 2020 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces it is has been invited to present about the performance of its COVID-19 in-vitro diagnostics (IVD) quality assessment products at “ECCVID,” a virtual
- [Ontario Helps Microbix Ensure Provincial COVID Testing Capacity](https://microbix.com/resources/media/ontario-helps-microbix-ensure-provincial-covid-testing-capacity) - Grant Of $1.45 Million For Ontario-Based Production Of Critical Test Reagents MISSISSAUGA, October 13, 2020 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce the execution of a grant agreement with the Ontario Together Fund (OTF) of the Ministry of Economic Development, Job Creation and Trade
- [Microbix Discloses New Products, Sales, And Capacity](https://microbix.com/resources/media/microbix-discloses-new-products-sales-and-capacity) - Sales Of QAPs™ Kits To Help Qualify Multi-Pathogen Respiratory Test Systems MISSISSAUGA, CANADA, October 29, 2020 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the availability and initial material sales of “onboarding” kits of its quality assessment products (QAPs™), designed to help testing sites with the successful installation and qualification
- [Microbix Announces Addition to Board of Directors](https://microbix.com/resources/media/blogs-news-microbix-announces-addition-to-board-of-directors) - Appointment of Anthony J. Giovinazzo, Accomplished Life Sciences Leader MISSISSAUGA, CANADA, December 7, 2020 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that Mr. Anthony J. Giovinazzo, an accomplished leader in the international life sciences industry, has joined its Board of Directors. Mr. Giovinazzo joined the Board
- [Microbix Presenting Product Results at AACC - Reporting on Test-Workflow Controls for Important Sexually-Transmitted Infections](https://microbix.com/resources/news-releases/microbix-presenting-product-results-at-aacc) - Reporting on Test-Workflow Controls for Important Sexually-Transmitted Infections MISSISSAUGA, CANADA, December 15, 2020 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces it has been invited to present about the performance of two types of its test-workflow Quality Assessment Products (QAPs™) at the 2020 virtual Scientific Meeting and
- [Microbix & Copan Italia Execute Strategic Agreement](https://microbix.com/resources/media/microbix-copan-italia-execute-strategic-agreement) - For FLOQ devices & QAPs Co-branding, IP licensing, Co-marketing, Purchase, and Supply MISSISSAUGA, CANADA and BRESCIA, ITALY, December 21, 2020 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and Copan Italia S.p.A. (Copan®), the global leader in specimen collection technologies, announce their execution of a strategic agreement (Agreement)
- [Microbix Viral Transport Medium Now Available](https://microbix.com/resources/media/microbix-viral-transport-medium-now-available) - Initial Capacity of 50,000 Vials/Week under Health Canada Regulation MISSISSAUGA, January 28, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce the commercial availability of its viral transport medium (VTM) to support Canadian RT-PCR (molecular) testing for the virus causing COVID-19 disease. At the
- [Microbix Announces Material First Sales of Viral Transport Medium](https://microbix.com/resources/media/microbix-announces-material-first-sales-of-viral-transport-medium) - Initial Production of 50,000 Vials Entirely Sold MISSISSAUGA, February 9, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce material first sales of its viral transport medium (generically known as VTM and branded as DxTM™) that supports Canadian RT-PCR (molecular) testing for the virus
- [Microbix Reports Results for Q1 Fiscal 2021](https://microbix.com/resources/media/3346-2) - Record Q1 Sales, With Nearly 3,600% Year-Over-Year QAPs Growth MISSISSAUGA, February 11, 2021 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for the first quarter of its fiscal 2021, the three-months ended December 31, 2020 ("Q1"), with record sales and continued progress upon its strategic goals.
- [Microbix Announces Quality Products Distribution Agreement - Oneworld Accuracy as a Non-Exclusive Distributor for Africa and Other Territories](https://microbix.com/resources/news-releases/microbix-announces-quality-products-distribution-agreement-5) - Oneworld Accuracy as a Non-Exclusive Distributor for Africa and Other Territories MISSISSAUGA, February 16, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces an agreement (Agreement) with Oneworld Accuracy Inc. (1WA) to distribute Microbix’s Quality Assessment Products (QAPs™) on a non-exclusive basis across the continent of Africa,
- [Microbix Antigen-test QAPs Now Available For Clinical Use](https://microbix.com/resources/media/microbix-antigen-test-qaps-now-available-for-clinical-use) - REDxFLOQ SARS-CoV-2 Antigen as IVD Controls in Canada, the EU, and the U.S. MISSISSAUGA, March 11, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the availability of more of its Quality Assessment Products (QAPs™) as In-Vitro Diagnostic “IVD” Controls – to monitor the workflow accuracy of
- [Microbix & Seegene Canada Form COVID-Variant Collaboration](https://microbix.com/resources/media/microbix-seegene-canada-form-covid-variant-collaboration) - Focus on Supporting Canadian Labs with Variant-related Assays and QAPs MISSISSAUGA & TORONTO, March 15, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and Seegene Canada Inc. (Seegene®), a provider of leading-edge molecular diagnostics assays and instruments (made by Seegene Inc. of Seoul, Korea), are pleased to
- [Virtual AGM on March 30, 2021](https://microbix.com/resources/events/virtual-agm-on-march-30-2021) - Once again, due to COVID -19 Pandemic, Microbix will be hosting a virtual AGM on March 30, 2021 at 1:00 pm. The online link will allow shareholders to listen to the AGM and view a CEO presentation via Zoom. Shareholders without up-to-date computer access can listen-in via telephone by using the teleconference numbers. Details for
- [Microbix to Present at Bloom Burton Investor Conference](https://microbix.com/resources/events/microbix-to-present-at-bloom-burton-investor-conference) - Virtual Healthcare Investor Conference on April 20 & 21 MISSISSAUGA, April 19, 2021 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that its CEO, Cameron Groome, has been invited to present at the 2021 Bloom Burton & Co. Healthcare Investor Conference, being held virtually from Toronto, Ontario,
- [Microbix Receives $4.25 Million Order For Viral Transport Medium](https://microbix.com/resources/media/microbix-announces-quality-products-distribution-agreement-7) - An Initial Order From Government Of Ontario Procurement Authorities MISSISSAUGA, April 23, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has received an initial order of CDN$ 4.25 million for its viral transport medium (generically known as “VTM” and branded as “DxTM™” by Microbix).
- [Microbix & SpeeDx Form Exclusive Collaboration](https://microbix.com/resources/media/microbix-speedx-form-exclusive-collaboration) - Focus on Diagnostics and Controls for Anti-Microbial Resistant Infections MISSISSAUGA, CANADA and EVELEIGH, AUSTRALIA April 26, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and SpeeDx Pty. Ltd. (SpeedDx), a developer of innovative molecular diagnostics solutions, are pleased to announce the formation of a collaboration under which
- [Microbix Announces $6.0 Million of Financings](https://microbix.com/resources/media/microbix-announces-6-0-million-of-financings) - $5.0 Million Bought-Deal Public Offering and $1.0 Million Private Placement - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - MISSISSAUGA, April 28, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce it has entered into an agreement with iA
- [Microbix Announces Closing of Offering and Private Placement](https://microbix.com/resources/media/microbix-announces-closing-of-offering-and-private-placement) - $6.9 Million of Gross Proceeds Received - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - MISSISSAUGA, May 19, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces it has closed its previously-announced bought-deal public offering (the “Offering”) and concurrent private placement (the
- [Microbix Announces Quality Products Distribution Agreement - Appointment of SDT Molecular of Singapore](https://microbix.com/resources/media/microbix-announces-quality-products-distribution-agreement-6) - Appointment of SDT Molecular of Singapore MISSISSAUGA, May 31, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the appointment of SDT Molecular Pte Ltd (SDT) as distributor of Microbix’s quality assessment products (QAPs™) for four Asia-Pacific territories. Under an agreement between the parties, SDT has been
- [Microbix Secures Third Ontario Manufacturing Site](https://microbix.com/resources/media/3809-2) - Leasing and Equipping 10,000 Square Foot Building Adjacent to Current Sites MISSISSAUGA, June 3, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has secured a third manufacturing site in Mississauga, Ontario, by way of a long-term lease agreement for a property adjacent to its
- [Microbix Announces Quality Products Distribution Agreement - Appointment of Thomas Scientific as U.S. Distributor](https://microbix.com/resources/media/microbix-announces-quality-products-distribution-agreement-5) - Appointment of Thomas Scientific as U.S. Distributor MISSISSAUGA, July 7, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the appointment of Thomas Scientific LLC as distributor of Microbix’s quality assessment products (QAPs™) for the United States. Under an agreement between the parties, Thomas Scientific has been
- [Microbix Presenting Product Results to Industry](https://microbix.com/resources/media/microbix-presenting-product-results-to-industry) - Two Abstracts Reporting on Cross-Platform Utility of Antigen & Serological QAPs™ MISSISSAUGA, CANADA, July 8, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has been invited to present about the performance of its COVID-19 test quality assessment products (QAPs™) at “ECCMID 2021” the 31st
- [Microbix Posters at 31st ECCMID 2021](https://microbix.com/resources/events/microbix-posters-at-31st-eccmid-2021) - Two Posters Reporting on Cross-Platform Utility of Antigen & Serological QAPs™ Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective Quality Controls Advanced SARS-CoV-2 nucleocapsid protein swab based formulation for use as cross-platform EQA sample and as a prospective Quality Control
- [Microbix Upgrades U.S. OTC Market & Investor Relations](https://microbix.com/resources/media/microbix-upgrades-u-s-otc-market-investor-relations) - Trading Upgrade to OTCQX Best Market and Torrey Hills Capital Engaged MISSISSAUGA, ON, August 3, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has undertaken two actions to improve its profile with United States (U.S.) based investors and to improve its trading liquidity in
- [Microbix Presenting at Muskoka Capital Conference - Meetings with Growth-Oriented Investors, September 24-26, 2021](https://microbix.com/resources/events/microbix-presenting-at-muskoka-capital-conference-2) - Meetings with Growth-Oriented Investors, September 24-26, 2021 MISSISSAUGA, September 23, 2021 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in
- [Microbix Presenting Product Results at AACC - QAPs to Support Testing for COVID Viral Variants](https://microbix.com/resources/media/microbix-presenting-product-results-at-aacc) - QAPs to Support Testing for COVID Viral Variants MISSISSAUGA, CANADA, September 27, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has been invited to present about the performance of its COVID-19 test quality assessment products (QAPs™) at “AACC” the annual scientific meeting & clinical
- [Microbix Makes Early Repayment of 9% Interest Debenture](https://microbix.com/resources/media/microbix-makes-early-repayment-of-9-interest-debenture) - $1.3 million balance repaid, improving cash flow and resulting in non-cash charge MISSISSAUGA, CANADA, October 4, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has completed the early repayment of a debenture series on which it owed C$ 1.3 million and was paying an
- [Microbix Poster Covering SARS-CoV-2 Variants of Concern (VOC) QAPs at AACC 2021](https://microbix.com/resources/events/microbix-poster-covering-sars-cov-2-variants-of-concern-voc-qaps-at-aacc-2021) - Advanced SARS-CoV-2 Variants of Concern (VOC) whole genome materials for use as verification, external quality assessment (EQA) and prospective quality control samples Click below to download the poster:
- [Microbix Receives $2.7 Million from Exercise of Warrants](https://microbix.com/resources/media/microbix-receives-2-7-million-from-exercise-of-warrants) - Further Capital to Assist with Increasing Capacity and Efficiency MISSISSAUGA, CANADA, October 27, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has received C$ 2.7 million from the partial exercise of two series of expiring share purchase warrants. The first series of such warrants
- [Microbix Expands Pandemic Test Controls (QAPs™) Portfolio](https://microbix.com/resources/media/microbix-expands-pandemic-test-controls-qaps-portfolio) - Helping Ensure Workflow Accuracy of PCR Tests for COVID “Variants of Concern” MISSISSAUGA, CANADA, November 17, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio of Quality Assessment Products (“QAPs™”) to include controls that support PCR tests for each of the four
- [Microbix Launches Multiplex Respiratory PCR-Test Control](https://microbix.com/resources/media/microbix-launches-multiplex-respiratory-pcr-test-control) - Helping Ensure Workflow Accuracy of Tests for COVID, Flu A, Flu B, and RSV MISSISSAUGA, CANADA, December 20, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio of Quality Assessment Products (“QAPs™”) to include single-unit swab-formatted controls that simultaneously support PCR tests
- [Microbix Receives $4.7 Million Order for Viral Transport Medium](https://microbix.com/resources/media/microbix-receives-4-7-million-order-for-viral-transport-medium) - Follow-on Order from Government of Ontario Procurement Authorities MISSISSAUGA, CANADA, December 24, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces receipt of a follow-on order of C$ 4.7 million for its viral transport medium (generically known as “VTM” and branded “DxTM™” by Microbix). DxTM is a
- [Microbix Launches Omicron Variant Test Control](https://microbix.com/resources/media/microbix-launches-omicron-variant-test-control) - Helping Ensure Workflow Accuracy of Tests for Respiratory Viruses MISSISSAUGA, CANADA, February 1, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio of Quality Assessment Products (“QAPs™”) to include a swab-formatted control that helps validate the accuracy and integrity of the workflows
- [Microbix Reports Record Results for Q1 Fiscal 2022](https://microbix.com/resources/media/microbix-reports-record-results-for-q1-fiscal-2022) - Record Q1 Sales of $4.9 million, Record Q1 Net Earnings of $0.9 million MISSISSAUGA, February 10, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for its first quarter ended December 31, 2021 (“Q1”), with record sales and earnings, plus ongoing progress upon its strategic goal
- [Microbix Advances Commissioning of Sites Two and Three](https://microbix.com/resources/media/microbix-advances-commissioning-of-sites-two-and-three) - Expansion of Capacity for Manufacturing of QAPs & DxTM MISSISSAUGA, CANADA, February 15, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces progress with expanding manufacturing capacity of its portfolio of Quality Assessment Products (“QAPs™”) and its “DxTM™” brand viral transport medium – via renovating and equipping
- [Microbix Presenting at Capital Conference in B.C.](https://microbix.com/resources/media/microbix-presenting-at-capital-conference-in-b-c) - Meetings with Growth-Oriented Investors, February 18-20, 2022 MISSISSAUGA, CANADA, February 17, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it will be presenting to equity investors at the Whistler Capital Conference, organized by Capital Event Management Ltd. and being hosted at the Fairmont Chateau Whistler,
- [Microbix Announces Nomination to Board of Directors](https://microbix.com/resources/media/microbix-announces-nomination-to-board-of-directors) - For Appointment of Jennifer Stewart, Accomplished Business Leader MISSISSAUGA, CANADA, February 22, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that Ms. Jennifer Stewart, an accomplished leader in Canadian business, government, and public affairs, has been nominated to become a member of its Board of Directors.
- [Microbix Announces Issuance of Stock Options - Feb 22nd 2022](https://microbix.com/resources/media/microbix-announces-issuance-of-stock-options-4) - Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, CANADA, February 24, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain its
- [2022 ECCMID - European Congress of Clinical Microbiology & Infectious Diseases - April 23-26](https://microbix.com/resources/eventsupcoming/2022-eccmid-european-congress-of-clinical-microbiology-infectious-diseases) - ECCMID, as the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from many fields to present their latest findings, guidelines and experiences to an audience of over 14,000 colleagues. This year, the congress will feature a hybrid format to facilitate an onsite and online experience for attendees allowing for remote and face-to-face
- [2022 Labquality Days – International Congress on Quality in Laboratory Medicine - April 20-21](https://microbix.com/resources/eventsupcoming/2022-labquality-days-international-congress-on-quality-in-laboratory-medicine) - Labquality Days offers an extensive and diverse exhibition on top of congress. The exhibition offers companies excellent marketing and networking opportunities. Labquality Days congress gathers together medical laboratory and quality management professionals and offers exhibitors the possibility to exchange ideas and introduce new products and services. Companies have a wide range of opportunities to participate in the event: become a partner, advertise on a mobile
- [2022 EUROGIN International Multidisciplinary HPV Congress - April 10-13](https://microbix.com/resources/events/2022-eurogin-international-multidisciplinary-hpv-congress) - The EUROGIN 2022 Organizing Committee is happy to welcome the HPV community to gather again in person in Düsseldorf on April 10-12, 2022, after a difficult period owing to the COVID-19 pandemic. EUROGIN Conference 2022 is the first large international in-person conference in the field of HPV-related diseases. This highly awaited event is expected to be
- [Virtual AGM on March 30, 2022](https://microbix.com/resources/events/virtual-agm-on-march-30-2022) - Once again, due to COVID -19 Pandemic, Microbix will be hosting a virtual AGM on March 30, 2022 at 1:00 pm. The online link will allow shareholders to listen to the AGM and view a CEO presentation via Zoom. Shareholders without up-to-date computer access can listen-in via telephone by using the teleconference numbers. Details for
- [Microbix Invests to Further Scale Its Business](https://microbix.com/resources/media/microbix-invests-to-further-scale-its-business) - Implementing MasterControl® and NetSuite® Solutions to Enable Rapid Growth MISSISSAUGA, CANADA, March 29, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces investment in programs to upgrade, digitize and fully-integrate its Quality Management System (“QMS”) and its Enterprise Resource Planning (“ERP”) platforms – to better enable its
- [Microbix Announces Annual and Special Meeting Voting Results - March 31, 2022](https://microbix.com/resources/media/microbix-announces-annual-and-special-meeting-voting-results-4) - Microbix Announces Annual and Special Meeting Voting Results MISSISSAUGA, CANADA, March 31, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the voting results from its Annual and Special Meeting of Shareholders (the “Meeting”) which was held on March 30, 2022. At the Meeting, 44.84% of the
- [Microbix Presenting HPV Product Results at EUROGIN](https://microbix.com/resources/media/microbix-presenting-hpv-product-results-at-eurogin) - QAPs Supporting Screening-Tests for High-Risk Human Papilloma Viruses MISSISSAUGA, CANADA, April 8, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces it will present performance results of its Quality Assessment Products (“QAPs™”) supporting Human Papillomavirus (“HPV”) molecular-diagnostic screening-tests at the 2022 annual congress of the European Research
- [Microbix Presenting Respiratory Virus Controls Data at Two Events](https://microbix.com/resources/media/microbix-presenting-respiratory-virus-controls-data-at-two-events) - QAPs Supporting Tests That Simultaneously Detect Multiple Respiratory Viruses MISSISSAUGA, CANADA, April 19, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be presenting performance results of its quality assessment products (“QAPs™”) that support molecular-diagnostic (“MDx”) screening-tests for respiratory viruses at two industry congresses
- [Microbix Presenting at the 2022 Bloom Burton Conference](https://microbix.com/resources/media/microbix-presenting-at-the-2022-bloom-burton-conference) - Healthcare Investor Conference in Toronto on May 2 & 3, 2022 MISSISSAUGA, CANADA, April 28, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto Convention
- [Microbix Presenting Omicron Test Control Results at CVS](https://microbix.com/resources/media/microbix-presenting-omicron-test-control-results-at-cvs) - QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant MISSISSAUGA, CANADA, April 29, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will present performance results of its Quality Assessment Products (“QAPs™”) supporting molecular-diagnostic tests for the Omicron variant of the SARS-CoV-2 virus (“Omicron”) at the
- [Microbix Reports Record Results for Q2 Fiscal 2022](https://microbix.com/resources/media/microbix-reports-record-results-for-q2-fiscal-2022) - Record Q2 Sales of $4.9 million, Q2 Net Earnings of $0.7 million MISSISSAUGA, May 12, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2022 ended March 31, 2022 (“Q2” and “H2”), with record sales and
- [Microbix Presenting Test Validation Methods at AACC](https://microbix.com/resources/media/microbix-presenting-test-validation-methods-at-aacc) - Usage of QAPs to Validate Whole Workflow Quality Control of Testing MISSISSAUGA, CANADA, June 3, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it is presenting about the utility of its Quality Assessment Products (“QAPs™”) to monitor the end-to-end diagnostic process, including the impact of
- [CEM Florida - November 11-13](https://microbix.com/resources/eventsupcoming/cem-florida-november-11-13) - Florida Capital Event November 11-13 3555 S Ocean Dr Hollywood, FL 33019 USA
- [Microbix Presenting STI Multiplex Test Controls at AACC](https://microbix.com/resources/media/microbix-presenting-sti-multiplex-test-controls-at-aacc) - Quality Control Materials for Genital Ulcer Disease Molecular Assays MISSISSAUGA, CANADA, July 26, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it is presenting about the utility of its multi-pathogen (“multiplex”) and swab-formatted Quality Assessment Products (“QAPs™”) to monitor molecular assays that detect and distinguish
- [Microbix Executes Substantial QAPs Supply Agreement](https://microbix.com/resources/media/microbix-executes-substantial-qaps-supply-agreement) - Microbix QAPs to Support Molecular & Antigen Test Platforms for Multiple Diseases MISSISSAUGA, CANADA, August 10, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the execution of a purchase and supply agreement (“Agreement”) by which Microbix “QAPs™” quality assessment products will support assays on industry-leading
- [Microbix Presenting at Muskoka Capital Conference - Meetings with Growth-Oriented Investors, September 23-25, 2022](https://microbix.com/resources/media/microbix-presenting-at-muskoka-capital-conference-3) - Meetings with Growth-Oriented Investors, September 23-25, 2022 MISSISSAUGA, CANADA, September 21, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau
- [Microbix Reports Results for Q1 Fiscal 2023](https://microbix.com/resources/media-features-news-releases/microbix-reports-results-for-q1-fiscal-2023-2) - https://microbix.com/wp-content/uploads/2023/02/MBX-NR-Q1-2023-Results-V5-CLEAN-2023-1-31.pdf
- [Microbix Announces Initiation of Normal Course Issuer Bid - 2022](https://microbix.com/resources/media/microbix-announces-initiation-of-normal-course-issuer-bid) - Microbix to Repurchase up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, September 28, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the initiation of a Normal Course Issuer Bid (“NCIB”) program for the repurchase and cancellation of outstanding common shares. Specifically,
- [Microbix Presenting Test-Workflow Validation Results at EMMD](https://microbix.com/resources/media/microbix-presenting-test-workflow-validation-results-at-emmd) - MSwab® & PROCEEDx™FLOQ® Supporting Self-Collection for HPV Screening Programs MISSISSAUGA, CANADA, October 6, 2022 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that, on behalf of Santina Castriciano of Copan Italia S.p.A. and in collaboration with Victorian Cytology Service of the Australian Centre for the Prevention
- [Emerging requirements for infectious disease IVD quality control materials](https://microbix.com/resources/media-featured-global/3d-slide-1) - https://microbix.com/wp-content/QAP/Poster%20Publications/FluRSV/EMMD2019%20Flu_RSV.pdf
- [Cross-Platform High-Risk (hr) Low Occurrence HPV NAAT Positive Samples of Use in Nucleic Acid Detection Testing as Prospective External Quality Assessment Samples and User Defined Quality Control](https://microbix.com/resources/media-featured-global/cross-platform-high-risk-hr-low-occurrence-hpv-naat-positive-samples-of-use-in-nucleic-acid-detection-testing-as-prospective-external-quality-assessment-samples-and-user-defined-quality-controls) - https://microbix.com/wp-content/QAP/Poster%20Publications/HPV/EUROGIN2021_HPV.pdf
- [Novel Cross-Platform High-Risk (hr) HPV NAAT Positive Controls for Use in L1 and E6 / E7 Targeted Nucleic ACID (DNA and RNA) Detection Methods](https://microbix.com/resources/media-featured-global/novel-cross-platform-high-risk-hr-hpv-naat-positive-controls-for-use-in-l1-and-e6-e7-targeted-nucleic-acid-dna-and-rna-detection-methods) - https://microbix.com/wp-content/QAP/Poster%20Publications/HPV/HPV_Labquality_2020.pdf
- [Microbix Corporate Presentation - October 2022](https://microbix.com/resources/media-featured-investor-info/microbix-corporate-presentation-october-2022-2) - https://microbix.com/wp-content/uploads/2022/10/MBX-Corporate-Presentation-2022-10-24.pdf
- [Microbix Corporate Presentation - September 2022](https://microbix.com/resources/media-featured-investor-info/microbix-corporate-presentation-september-2022) - https://microbix.com/wp-content/MBX%20Corporate%20Presentation%20-%202022-9-19.pdf
- [AGM PRESENTATION 2022](https://microbix.com/resources/media-featured-investor-info/https-microbix-com-agm-presentation-2022) - https://microbix.com/wp-content/MBX%20Corporate%20Presentation%20-%202022-9-19.pdf
- [AGM Presentation - March 2022](https://microbix.com/resources/media-featured-investor-info/agm-presentation-march-2022-2) - https://microbix.com/wp-content/MBX%20-%20AGM%20PPT%20-%20V4%20-%202022-03-30.pdf
- [MBX Investor Update Webinar](https://microbix.com/resources/media-featured-investor-info/mbx-investor-update-webinar-2) - Cameron Groome, CEO of Microbix (TSX: MBX), provides an update on operations and opportunities amid the COVID-19 crisis. https://www.youtube.com/watch?v=xqqvuN6C7WY
- [Novel SARS-CoV-2 Full-Genome Material for Use in a Swab-Based Formulation as a Multi-Platform NAAT Quality Control](https://microbix.com/resources/media-featured-poster-publication/novel-sars-cov-2-full-genome-material-for-use-in-a-swab-based-formulation-as-a-multi-platform-naat-quality-control) - https://microbix.com/wp-content/QAP/Poster%20Publications/SARS/ECCVID%202020%20SARS.pdf
- [Advanced SARS-CoV-2 Variants of Concern (VOC) whole-genome materials for use as verification, external quality assessment (EQA) and prospective quality control samples](https://microbix.com/resources/media-featured-poster-publication/advanced-sars-cov-2-variants-of-concern-voc-whole-genome-materials-for-use-as-verification-external-quality-assessment-eqa-and-prospective-quality-control-samples) - https://microbix.com/wp-content/QAP/Poster%20Publications/SARS/AACC%202021%20VOC.pdf
- [2022 Q1 Financial Report](https://microbix.com/resources/media-featured-financial-reports/2022-q1-financial-report) - https://microbix.com/wp-content/uploads/2022/02/Microbix-QR_1-2022-PRINT-VERSION.pdf
- [Cross-Platform High-Risk (hr) Low Occurrence HPV NAAT Positive Samples of Use in Nucleic Acid Detection Testing as Prospective External Quality Assessment Samples - and User Defined Quality Controls](https://microbix.com/resources/media-featured-poster-publication/cross-platform-high-risk-hr-low-occurrence-hpv-naat-positive-samples-of-use-in-nucleic-acid-detection-testing-as-prospective-external-quality-assessment-samples-and-user-defined-quality-controls-2) - https://microbix.com/wp-content/QAP/Poster%20Publications/HPV/EUROGIN2021_HPV.pdf
- [2022 Q3 Financial Report](https://microbix.com/resources/media-featured-financial-reports/2022-q3-financial-report) - https://microbix.com/wp-content/uploads/2022/08/Microbix-QR_3-2022-v3-FINAL-PRINT.pdf
- [2022 Financial Report - Annual Report and AIF](https://microbix.com/resources/media-featured-financial-reports/2022-annual-report-and-aif) - https://microbix.com/financial-reports/
- [2022 Q2 Financial Report](https://microbix.com/resources/media-featured-financial-reports/2022-q2-financial-report) - https://microbix.com/wp-content/uploads/2022/05/Microbix-QR_2-2022-v3-FINAL-PRINT.pdf
- [Microbix Corporate Presentation - November 2022](https://microbix.com/resources/media-featured-investor-info/microbix-corporate-presentation-november-2022) - Download the Microbix Corporate Presentation - November 2022
- [Blog: Episode 1](https://microbix.com/resources/blog/blog-episode-1) - Diagnostics: Beyond the Lab In this episode we discuss the Human papillomavirus or HPV, vaccines, testing and cervical cancer. What is HPV and what is the way forward for testing?Joining us for this discussion is Larry Vaughan, director scientific affairs integrated diagnostic solutions at Becton Dickinson, one of the largest global medical technologies in the
- [Blog: Episode 2](https://microbix.com/resources/blog/blog-episode-2) - In this episode of Diagnostic: Beyond the lab, we talk to Colin Denver, CEO of SpeeDX about antimicrobial resistance and using diagnostics to target treatment.
- [Blog: Episode 3](https://microbix.com/resources/blog/blog-episode-3) - In this episode of Diagnostics: Beyond the Lab we talk to Giorgio Triva, CEO and Strategic Project Manager of Copan Group, based in Italy, about what his company and the work it has done to become a global leader in sample collection, transport and test accuracy for infectious diseases.
- [Upcoming Events: Coming Soon](https://microbix.com/resources/blog/upcoming-events) - Here are all of Microbix's upcoming events including conferences, trade shows, presentations, and more! Make sure to check regularly to stay up to date with the latest news from us!
- [Microbix Launches QAP to Support “Monkeypox” Testing](https://microbix.com/resources/media/microbix-launches-qap-to-support-monkeypox-testing) - Driven by Customer Requests, Mpox Test Control Now Available MISSISSAUGA, CANADA, January 30, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is launching a new quality assessment product (“QAP™”) to support molecular diagnostic (“MDx”) testing for the Non-Variola Orthopoxvirus (“Mpox”), the cause of
- [Upcoming Events 2023](https://microbix.com/resources/media-featured-upcoming-events/upcomingevents2023) - https://microbix.com/upcoming-events-2/
- [Microbix Presenting Results of Collaboration with Health PEI](https://microbix.com/resources/media/microbix-presenting-results-of-collaboration-with-health-pei) - QAPs for HPV Test Verification within Cervical Cancer Screening Program MISSISSAUGA, CANADA, February 6, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting results of its collaboration with the Microbiology Laboratory of the Queen Elizabeth Hospital of Health PEI (“Health PEI”),
- [CEM Muskoka - September 23-25](https://microbix.com/resources/eventsupcoming/cem-muskoka-september-23-25) - Muskoka Capital Event September 23-25 1050 Paignton House Road Minett, ON P0B 1G0 Canada
- [Diagnostics Explained: AMR](https://microbix.com/resources/blog/diagnostics-explained-amr) - The Antimicrobial Resistance (AMR) crisis and how we can overcome it Antimicrobial Resistance (AMR) Antimicrobial resistance or AMR occurs when microorganisms build resistance to an antibiotic drug. With AMR on the rise, the World Health Organization has deemed this a top 10 global public health threat. This is not only an issue for humans but
- [Diagnostics Explained: HPV](https://microbix.com/resources/blog/diganostics-explained-hpv-2) - The Role of Diagnostics in HPV Screening The Importance of HPV Screening Human papillomavirus (HPV) is a common sexually transmitted infection that is linked to the development of cervical cancer. The primary screening for HPV infection is an important tool in the prevention of cervical cancer, as it enables the identification of individuals who are
- [Governments of Ontario and Canada Invest in Microbix](https://microbix.com/resources/media/governments-of-ontario-and-canada-invest-in-microbix) - $ 1.68 Million in Funding for Capabilities and Capacity Expansions MISSISSAUGA, CANADA, March 20, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is undertaking further expansions to its capabilities and capacity for manufacturing specialized products relating to diagnostic testing for infectious diseases. The
- [Revolutionizing Pandemic Preparedness with Self-Collection](https://microbix.com/resources/blog/diagnostics-self-collection) - Lessons from the COVID-19 Pandemic The COVID-19 pandemic has taught us that pandemics can be incredibly disruptive to our society, economy, and daily lives. In order to be better prepared for future pandemics, the whole industry has invested in scaling up the production of everything that would be needed. However, this strategy cannot be left
- [The Importance of External Quality Assessment (EQA) in Laboratory Testing](https://microbix.com/resources/blog/industry-educational-series-eqa-1) - Laboratory testing requires accuracy and reliability for patient care. External Quality Assessment (EQA) is an effective tool to ensure testing accuracy and reliability. EQA compares laboratory test results with peer groups or reference labs worldwide. This article discusses the importance of EQA, its benefits, and limitations.
- [Meet our Guests- Episode 4: Ensuring Patient health through EQA](https://microbix.com/resources/blog/meet-our-guests1) - Get to know these outstanding guest speakers: Daniel Taylor from 1WA, Danielle Casey from API, and Heidi Berghäll from Labquality! Discover their expertise and insights on healthcare, technology, and more.
- [Breaking the Stigma: Managing STIs for Better Sexual Health](https://microbix.com/resources/blog/educational-series-breaking) - Sexually transmitted infections (STIs) affect millions of people globally, yet there remains a significant amount of stigma around these infections. This stigma prevents people from discussing their STI status, leading to negative health outcomes and further spread of the infection. In this blog post, we'll explore the stigma surrounding STIs, the importance of testing and
- [Syphilis on the Rise in Canada: A Call to Action for Public Health and Individuals](https://microbix.com/resources/blog/industry-educational22) - Syphilis is a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. The infection can cause serious health problems if left untreated, including blindness, deafness, and even death. In Canada, syphilis rates have been on the rise in recent years, which is a concerning trend for public health officials.
- [Microbix's Multiplex Quality Control for STI Diagnosis](https://microbix.com/resources/blog/microbixs2) - STIs: A public health issue Sexually transmitted infections (STIs) are a significant public health issue, with millions of new cases diagnosed each year. Accurate and timely diagnosis is crucial to prevent the spread of these infections and ensure that patients receive appropriate treatment. Multiplex CT/NG/TV/MGEN is a molecular diagnostic test that can detect several of
- [Microbix Presenting at the 2023 Bloom Burton Conference](https://microbix.com/resources/media/microbix-presenting-at-the-2023-bloom-burton-conference) - MISSISSAUGA, CANADA, April 20, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Center, North Building, on April 25th and 26th, 2023.
- [The Silent Killer: Exploring the Alarming Rise of Antimicrobial Resistance](https://microbix.com/resources/blog/the-silent-killer2) - Antimicrobial resistance (AMR) is a serious global health issue that is affecting millions of people every year. It refers to the ability of microorganisms to resist the effects of antimicrobial drugs, such as antibiotics. This phenomenon has been on the rise in recent years, and it poses a significant threat to public health and the
- [The Lowdown on STI Testing: What You Need to Know](https://microbix.com/resources/blog/the-lowdown) - Did you know that sexually transmitted infections (STIs) are shockingly common? Millions of cases are diagnosed every year, with young people and men who have sex with men being particularly at risk. And the scariest part? Many people don't even know they have an STI because they don't always have symptoms. In fact, up to
- [Trichomonas Vaginalis: Why Early Detection is Crucial](https://microbix.com/resources/blog/trichomonas-vaginalis1) - Trichomonas vaginalis, also known as trich, is a sexually transmitted infection (STI) caused by a parasitic protozoan. According to WHO more than 1 million new STIs are acquired every day and approximately 357 million people contract STIs each year. Despite its prevalence, trichomoniasis often goes undiagnosed, leading to serious health consequences if left untreated.
- [Enhancing STI testing accuracy and reliability with Microbix's External Quality Controls](https://microbix.com/resources/blog/enhancing-sti-testing-accuracy-and-reliability-with-microbixs-external-quality-controls) - Point of care (POC) testing has revolutionized the way we diagnose and manage various infectious diseases, including sexually transmitted infections (STIs). The ability to obtain rapid, accurate results from POC tests has led to improved patient outcomes, reduced treatment delays, and decreased transmission rates. However, as with any diagnostic test, accuracy and reliability are critical
- [The Essential Role of Multiplex Quality Control in In Vitro Diagnostics for Infectious Diseases](https://microbix.com/resources/blog/the-essential-role-of-multiplex-quality-control-in-in-vitro-diagnostics-for-infectious-diseases) - In vitro diagnostics play a critical role in diagnosing and monitoring infectious diseases. Accurate and reliable test results are essential for guiding patient treatment and improving outcomes. However, with the increasing complexity of diagnostic tests, ensuring the quality of these tests has become a major challenge. Multiplex quality control is a critical aspect of maintaining
- [Microbix Secures Funded Drug Commercialization Agreement](https://microbix.com/resources/media/microbix-secures-funded-drug-commercialization-agreement) - Kinlytic® urokinase to be developed for re-entry into U.S. market MISSISSAUGA, CANADA, May 16, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces execution of an agreement (“Agreement”) to return Kinlytic® urokinase (“Kinlytic”) to market, initially for dissolving blood clots in venous catheters in the United
- [Enhancing STI testing accuracy and reliability with Microbix's External Quality Controls](https://microbix.com/resources/blog/enhancing-sti-testing2) - Point of care (POC) testing has revolutionized the way we diagnose and manage various infectious diseases, including sexually transmitted infections (STIs). The ability to obtain rapid, accurate results from POC tests has led to improved patient outcomes, reduced treatment delays, and decreased transmission rates. However, as with any diagnostic test, accuracy and reliability are critical
- [Microbix Announces Extension of Warrant Expiry Date](https://microbix.com/resources/media/microbix-announces-extension-of-warrant-expiry-date) - Applies for 12-month Term Extension of May 2021 Warrants MISSISSAUGA, CANADA, May 18, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it has applied to the TSX to extend the term of an aggregate of 5,750,000 common share purchase warrants (“Warrants”) which were issued in
- [The Essential Role of Multiplex Quality Control in In Vitro Diagnostics for Infectious Diseases](https://microbix.com/resources/blog/the-essential-r1) - In vitro diagnostics play a critical role in diagnosing and monitoring infectious diseases. Accurate and reliable test results are essential for guiding patient treatment and improving outcomes. However, with the increasing complexity of diagnostic tests, ensuring the quality of these tests has become a major challenge. Multiplex quality control is a critical aspect of maintaining
- [Microbix Presents Results of STI Test Controls at ASM Microbe](https://microbix.com/resources/media/microbix-presents-results-of-sti-test-controls-at-asm-microbe) - FLOQSwab-formatted QAPs supporting PCR Tests for Antibiotic-Resistant Pathogens MISSISSAUGA, CANADA, June 13, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter announces that it is presenting results of its Quality Assessment Products (“QAPs™”) for supporting the clinical use and accuracy of tests for antimicrobial-resistant (“AMR”) sexually-transmitted infections
- [Microbix & Labquality Create Novel Testing Accreditation Program](https://microbix.com/resources/media/microbix-labquality-create-novel-testing-accreditation-program) - Innovative “EQA” Program to Qualify Labs for Genital Ulcer Disease Testing MISSISSAUGA, CANADA & HELSINKI, FINLAND – June 20, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter and Labquality Oy (Labquality), a global provider of laboratory external quality assessment (“EQA”) programs, announce their creation of the
- [Unveiling the Significance of Proficiency Testing and EQA in Ensuring Reliable Infectious Test Results](https://microbix.com/resources/blog/the-essential-role-of-multiplex-quality-control-in-in-vitro-diagnostics-for-infectious-diseases-2) - So…you got your Respiratory infection test results back from the doctor. Should you trust them? Well, the answer is YES! Why? There is a sophisticated quality assurance ecosystem supporting diagnostic testing in most healthcare systems, ensuring reliable and accurate results for you. There are several types of programs including operator training regimens, equipment calibration and
- [Microbix QAPs Supporting HPV Testing Across The Netherlands](https://microbix.com/resources/media/microbix-qaps-supporting-hpv-testing-across-the-netherlands) - Distribution Partner Secures Contract Relating to Cervical Cancer Screening MISSISSAUGA, CANADA, July 5, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its quality assessment products (“QAPs™”) have been selected to support a screening program for Human Papilloma Virus (“HPV”) using molecular diagnostic (“MDx”) technology
- [Microbix Presents Results of STI Test Controls at AACC](https://microbix.com/resources/media/microbix-presents-results-of-sti-test-controls-at-aacc) - FLOQSwab-formatted QAPs Supporting Fourplex PCR Tests for Bacterial STIs MISSISSAUGA, CANADA, July 24, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of its Quality Assessment Products (“QAPs™”) for supporting the clinical use and accuracy of multiplex tests for four of
- [Microbix Successfully Upgrades Logistics Software Systems](https://microbix.com/resources/media/microbix-successfully-upgrades-logistics-software-systems) - Achieves “Go-Live” with New ERP and eQMS Solutions MISSISSAUGA, CANADA, August 4, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces its successful adoption of software to upgrade, digitize, and integrate its Enterprise Resource Planning (“ERP”) platform and electronic Quality Management System (“eQMS”). These logistics IT
- [Microbix Honours the Passing of its Founder William J. Gastle – 1948 to 2023](https://microbix.com/resources/media/microbix-honours-the-passing-of-its-founder-william-j-gastle) - Microbix Honours the Passing of its Founder William J. Gastle – 1948 to 2023 MISSISSAUGA, CANADA, September 13, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, honours the passing of its founder, William J. (Bill) Gastle, surrounded by family in Edmonton, Alberta on September 6, 2023.
- [Guest for Season 1- Episode 5: Diagnostics Beyond the Lab](https://microbix.com/resources/blog/season-1-episode-5-d1) - In this episode we're going to talk about current and emerging diagnostics technologies, how they're viewed by government leaders, and how we can encourage their optimal use.
- [Microbix Achieves New QAPs Sales Record](https://microbix.com/resources/media/microbix-achieves-new-qaps-sales-record) - Over C$ 1 Million in Orders from Leading Diagnostics Industry Test-Maker MISSISSAUGA, CANADA, September 27, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has secured record purchase orders (“P.Os.”) for over one million Canadian Dollars (“C$ 1 Million”) of its quality assessment products
- [Microbix Presenting at Muskoka Capital Conference - 2023](https://microbix.com/resources/media/microbix-presenting-at-muskoka-capital-conference-4) - Meetings with Growth-Oriented Investors, September 29 to October 1, 2023 MISSISSAUGA, CANADA, September 29, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the
- [Microbix QAPs Supporting HPV Testing in Ireland](https://microbix.com/resources/media/microbix-qaps-supporting-hpv-testing-in-ireland) - Distribution Partner Secures Contract Relating to Cervical Cancer Screening MISSISSAUGA, CANADA, October 27, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its quality assessment products (“QAPs™”) are supporting a testing program for Human Papilloma Virus (“HPV”) using molecular diagnostic (“MDx”) technology at Dublin’s The
- [Battling Flu Season: Quality Control and Microbix](https://microbix.com/resources/media/battling-flu-season-2) - Flu season is upon us, and with it comes the annual threat of influenza, respiratory syncytial virus (RSV), and more recently, the coronavirus, SAR-CoV-2. These viruses pose serious health risks to individuals around the world. The flu, in particular, can lead to a range of health complications and even death. In this blog, we'll delve
- [Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays](https://microbix.com/resources/media/microbix-ulisse-biomed-collaborate-on-hpv-controls-assays) - Onboarding Tools and Quality Controls for Extended Genotype HPV Assays MISSISSAUGA, CANADA & TRIESTE, ITALY, November 10, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces a collaboration with Ulisse Biomed S.p.A. (BIT: UBM, Ulisse), a company developing innovative diagnostics, theranostics, and therapeutics. The companies are
- [Microbix Announces Initiation of Normal Course Issuer Bid -2023](https://microbix.com/resources/news-releases/microbix-announces-initiation-of-normal-course-issuer-bid-2) - For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, December 6, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the initiation of a Normal Course Issuer Bid ("NCIB") program for the repurchase and cancellation of outstanding common shares. Specifically,
- [Microbix & BioGX Collaborate on real-time PCR Assays & Controls](https://microbix.com/resources/news-releases/microbix-biogx-collaborate-on-real-time-pcr-assays-controls) - Quality Controls for Respiratory Viral, Pharyngitis, and Genital Ulcer Disease Panels MISSISSAUGA, CANADA & BIRMINGHAM, ALABAMA, December 7, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces a collaboration with BioGX, Inc. (“BioGX”), a global provider of easy molecular diagnostic solutions. The companies are collaborating to
- [Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy](https://microbix.com/resources/news-releases/microbix-seegene-usa-jointly-enhancing-lab-test-accuracy) - Expanded Collaboration to Improve Syndromic Infectious Disease Testing MISSISSAUGA, CANADA & IRVINE, CALIFORNIA, December 14, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces a collaboration with Seegene USA, Inc. (“Seegene USA”), a leading developer of multiplex molecular assays and automated solutions for U.S. labs. Under
- [Microbix Achieves Further QAPs Sales Record](https://microbix.com/resources/news-releases/microbix-achieves-further-qaps-sales-record) - Over C$ 1 Million in One Shipment to a Leading Lab Accreditation Agency MISSISSAUGA, CANADA, January 3, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it has sold and shipped over one million Canadian Dollars (“C$ 1 Million”) of its quality assessment products (“QAPs™”) to
- [Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen](https://microbix.com/resources/resources/news-releases/microbix-unveils-test-control-for-gastric-ulcer-disease-pathogen) - FLOQSwab-formatted QAP Supporting MDx Tests for H. pylori MISSISSAUGA, CANADA, February 6, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of a Quality Assessment Product (“QAP™”) for supporting the clinical use and accuracy of molecular (“MDx”) tests for infection with
- [Microbix Enhances Quality Management System](https://microbix.com/microbix-virtual-agm-2024) - ISO 13485:2016 Medical Devices Certification Attained TORONTO, December 24, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has attained the ISO 13485:2016 Medical Devices certification – an enhancement to its quality management system that is expected to accelerate the growth of its QAPs™ lines of
- [Microbix Unveils Test Controls for Head and Neck Cancer](https://microbix.com/resources/news-releases/microbix-unveils-test-controls-for-head-and-neck-cancer) - HPV-related Tissue-Sample Mimics for QC of histology and PCR analyses MISSISSAUGA, CANADA, March 11, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of Quality Assessment Products (“QAPs™”) for supporting the quality control (“QC”) of histology and PCR-based tests driven by
- [Microbix’s Clot-Buster Drug Project Advances](https://microbix.com/resources/news-releases/microbixs-clot-buster-drug-project-advances) - Sequel Pharma Executes Agreement with CDMO for Drug Substance Production MISSISSAUGA, CANADA, March 14, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“Sequel”), has executed, with support from Microbix, an agreement with a leading international contract
- [Microbix Announces Annual and Special Meeting Voting Results](https://microbix.com/resources/resources/news-releases/microbix-announces-annual-and-special-meeting-voting-results-6/) - MISSISSAUGA, April 1, 2024 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held on March 27, 2024. At the Meeting, 42.64% of the issued and outstanding
- [Microbix Presenting at the 2024 Bloom Burton Conference](https://microbix.com/resources/resources/news-releases/microbix-presenting-at-the-2024-bloom-burton-conference/) - MISSISSAUGA, CANADA, April 11, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Center, North Building, on April 16 and 17, 2024.
- [Microbix Collaborator Introduces New Lab Accreditation Program](https://microbix.com/resources/resources/news-releases/microbix-collaborator-introduces-new-lab-accreditation-program/) - Microbix Product Supporting Testing for Drug-Resistant Sexually-Transmitted Infection MISSISSAUGA, CANADA, April 25, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that Labquality Ltd., a collaborator and customer, is presenting results of its use of Microbix Quality Assessment Products (“QAPs™”) for accreditation of clinical labs for

## Pages

- [Microbix Biosystems | Infectious Disease Antigens & External Quality Controls (QAPs) New](https://microbix.com/) - We offer cutting-edge biological and technical infectious disease diagnostic solutions and vial filling solutions for the global diagnostics industry.
- [Financial Reports | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/financial-reports) - Financial Reports In keeping with our ongoing commitment to good governance, transparency and proactive disclosure, we post all of our financial statements for the previous fiscal years. All reports from previous years are listed below for you to read through and get a better understanding of our company. 2026 REPORTS Q1 Q2 Q3 2025 REPORTS Q1
- [Respiratory Viral Control Products: Laboratory Tools for Enhanced Health Safeguarding](https://microbix.com/products/external-quality-controls/respiratory-viral-panel) - Choose our respiratory viral control products for consistent, room-temperature stable external quality controls designed for nucleic acid and antigen detection assays. Manufactured under ISO 13485:2016 with global regulatory compliance.
- [Resources](https://microbix.com/resources) - Media Room The Microbix media room Listen to our podcast, read the latest news, browse poster publications and download investor materials — everything we publish, in one place. BROWSE: Podcast News releases Poster publications White papers Investor presentations Financial reports FEATURED PODCAST Diagnostics: Beyond the Lab Hosted by Shitika Kulshreshtha In this podcast we go
- [Careers with Microbix](https://microbix.com/about/careers) - CAREERS WITH MICROBIX Microbix Biosystems is a fast growing biotechnology company based in Mississauga. Founded in 1988 as a producer of infectious disease antigens, primarily for the diagnostics market, Microbix invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies.
- [GI External Quality Controls – Assuring Test Accuracy & Reliability 2](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel) - Gastrointestinal External Quality Controls DOWNLOAD BROCHURE CONTACT US Setting the Gold Standard for Infectious Disease Diagnostic Standards Ready to use External Quality Controls Microbix is the only supplier licensed to manufacture External Quality Controls using Copan’s FLOQSwab® . These controls are room-temperature stable and offer a 2-year shelf life from the date of manufacture when
- [Contact | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/contact) - Get in touch with us for any inquiries about our products, services or general information. We're always ready to assist you.
- [Presentations](https://microbix.com/presentations) - Microbix Corporate Presentation This presentation contains forward-looking statements about trends and objectives. Risks and uncertainties relating to such statements could cause actual outcomes to differ materially. Such risks include, among others, those related to operations, customers, or markets, growth drivers, products or technologies, roduct pricing or costs, development projects, financial results, regulatory matters,
- [Quality](https://microbix.com/about/quality) - Discover how our commitment to quality drives us to deliver the best medical diagnostic solutions in the industry. Trust Microbix for your critical biological materials.
- [Reference Materials](https://microbix.com/products/reference-materials/) - Microbix’s reference materials (RefDx) are inactivated, traceable pathogen formulations used to evaluate assay sensitivity, specificity, and LOD throughout test development.
- [TECHNICAL RESOURCES](https://microbix.com/products/external-quality-controls/infectious-disease-technical-resources) - Review our collection of white papers, offering comprehensive studies and analysis on infectious diseases, their causes, effects, and the latest treatment options.
- [Assay Development](https://microbix.com/products/external-quality-controls/diagnostic-assay-development/) - Accelerate diagnostic assay development with Microbix’s end-to-end support—from assay design to scale-up and commercialization. We provide IVD manufacturers with fully characterized viral and bacterial raw materials, custom-developed sample and process controls, third-party quality controls, and reference standards.
- [Microbix 2025 Most Popular Sellers](https://microbix.com/three-most-popular-microbix-qaps-2026) - Microbix 2026 Most Popular Sellers Microbix offers multiplex external quality controls for a variety of infectious disease diagnostic panels, including but not limited to Gastrointestinal Panel, HPV Panel and Sexually Transmitted Infection Panel. These multiplex controls are designed to be compatible with numerous diagnostic platforms and workflows, thereby providing clinical laboratories and end-users with the necessary
- [Vaginal Infection External Quality Controls](https://microbix.com/products/external-quality-controls/vaginal-infection-panel/) - Microbix vaginal infection external quality controls on Copan’s FLOQSwab®, which are stable at room temperature, easy to use, and simulate patient specimen formats. These products are designed for nucleic acid amplification tests that detect the most common causes of vaginal infections.
- [Microbix Products - Infectious Disease Antigen Catalogue](https://microbix.com/products) - External Quality Controls SARS Complete Panel Respiratory Viral Panel STI Panel HPV Panel Gastrointestinal Panel ONBOARDx Kits Proficiency Testing Genital Ulcer Panel DxTM Viral Transport Medium Custom Vial Filling Solutions Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions “Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that
- [Childhood Disease Antigen Products - Advanced Solutions for Pediatric Diagnostics](https://microbix.com/products/antigens/childhood-disease) - Microbix is at the leading edge of manufacturing native childhood disease antigens. Our native antigens are purified and inactivated for infectivity, not antigenicity, ensuring safety & satisfaction.
- [Native Dengue Antigens - Precision Immunology for Diagnostic Laboratories](https://microbix.com/products/antigens/dengue) - Microbix native dengue antigens excel as positive quality controls for diagnostic assays, providing superior identification of envelope glycoprotein E and NS1 proteins critical for serological testing. Available in all 4 serotypes with 2-year guaranteed shelf life from shipment date.
- [STI Antigens - Ensuring Accuracy & Reliability](https://microbix.com/products/antigens/sti) - Our range of STI antigen materials support critical diagnostic work in the field of sexually transmitted infections. Contact us to select from our comprehensive collection today.
- [ToRCH Antigen Products - Precision Diagnostic Reagents for Diagnostic Applications](https://microbix.com/products/antigens/torch) - Microbix has been the commercial leader in producing native ToRCH antigen products for over 20 years. View our full catalogue of antigen products.
- [Respiratory Antigen Products - Premium Diagnostic Solutions](https://microbix.com/products/antigens/respiratory) - Our comprehensive range of respiratory antigen products are designed to provide superior detection and diagnosis of respiratory diseases, increase safety, and increase diagnostic speed.
- [Infectious Disease Antigen Products - Laboratory-Grade, Quality Assured Solutions](https://microbix.com/products/antigens/infectious-disease) - Our infectious disease antigen products are designed for laboratories and research centers looking for reliable diagnostic solutions.
- [Infectious Disease External Quality Controls - Ensuring Accuracy](https://microbix.com/products/external-quality-controls) - Infectious disease external quality controls are designed to ensure the accuracy and reliability of your laboratory's infectious disease testing procedures. Contact us today to take advantage of our professional services.
- [STI External Quality Control - Ensuring Accuracy & Reliability](https://microbix.com/products/external-quality-controls/sti-panel) - Our STI external quality control solutions help ensure the accuracy and reliability of your testing processes, providing you with confidence in your results.
- [HPV External Quality Controls - Advanced Laboratory Standards](https://microbix.com/products/external-quality-controls/hpv-panel) - We provide external quality controls for HPV testing. Our standards ensure the precision and accuracy of your lab’s HPV assays to improve patient care.
- [RUO Kits - Pioneered Advancements for Diagnostic Laboratories](https://microbix.com/products/external-quality-controls/onboardx-kits) - ONBOARDx™ RUO kits provide clinical laboratories with a complete solution for assay validation and verification. Achieve exceptional diagnostic quality, customizable options, and room-temperature stability for infectious disease diagnostics. Download the full product brochure today.
- [Laboratory Proficiency Testing Samples - Professional Quality Control](https://microbix.com/products/external-quality-controls/laboratory-proficiency-testing) - Our laboratory proficiency testing samples are designed to help labs improve their analytical performance, ensuring high-quality and accurate results.
- [Genital Ulcer Panel Products - Accurate Diagnosis for STDs](https://microbix.com/products/external-quality-controls/genital-ulcer-panel) - Our genital ulcer panel products offer accurate diagnosis of sexually transmitted diseases. Trust us with your diagnostic needs, and contact us today to find out more.
- [Control Elution Buffer](https://microbix.com/products/control-elution-buffer/) - Our Control Elution Buffer (CEB) elution solutions offer the highest level of performance for your lab. Discover how our advanced biotechnology solutions can enhance your research.
- [Antigen Products - Research, Assays, Immunoassays & Development Controls](https://microbix.com/products/antigens) - Global diagnostics companies rely on Microbix for regulatory-compliant native antigens at commercial scale. Our antigen products meet stringent quality standards with proven stability, supporting immunoassay development from ELISA to automated platforms across 100+ manufacturers worldwide.
- [Vial Filling Services – Specialized Pharmaceutical Packaging Solutions](https://microbix.com/aseptic-custom-filling-services/) - Our vial filling services that provide accurate, high-speed solutions for your pharmaceutical packaging needs. We ensure safe and efficient delivery of your products.
- [Who We Work With](https://microbix.com/about/who-we-work-with/) - Microbix partners with industry leaders to solve complex diagnostic challenges. Our relationships with EQA organizations, assay developers, and global distributors help deliver cutting-edge controls for improved diagnostic reliability.
- [Opportunities | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/products/kinlytic-urokinase/) - KINLYTIC (UROKINASE) DOWNLOAD SUMMARY CONTACT US Kinlytic Executive Summary Kinlytic is a thrombolytic injectable drug, commonly known as a clot buster. It has been used to treat over 4 million patients with life-threatening pulmonary embolism and clot obstructed intravenous catheters. Microbix owns the rights to the drug, which is approved in the United States
- [Investor](https://microbix.com/investors) - Microbix Biosystems Inc. develops and commercializes proprietary biological and technological solutions for human health and wellbeing. We manufacture a wide range of critical biological materials for the global diagnostics industry, notably antigens used in immunoassays and Quality Assessment and Proficiency (QAPs™) testing products. Financial Reports Stock Info Corporate Presentations Analyst Coverage Corporate Governance
- [About Microbix](https://microbix.com/about) - Learn more about Microbix Biosystems, a leading manufacturer of critical biological materials for the global diagnostics industry. Discover our history, values and commitment to providing high-quality products and services.
- [QAP Technical Resources](https://microbix.com/qap-technical-resources) - Technical Resources Poster Publications Respiratory Viral Infections Emerging requirements for infectious disease IVD quality control material Human Papillomavirus (HPV) Infections Cross-Platform High-Risk (hr) Low Occurrence HPV NAAT Positive Samples of Use in Nucleic Acid Detection Testing as Prospective External Quality Assessment Samples and User Defined Quality Controls Novel Cross-Platform High-Risk (hr) HPV NAAT Positive Controls
- [Antigen Video](https://microbix.com/antigen-video)
- [About Video](https://microbix.com/about-video)
- [QAP Video](https://microbix.com/qap-video)
- [Request Brochure](https://microbix.com/request-brochure/) - Get the Complete QAPs™ Brochure Unlock detailed insights into Microbix’s industry-leading Quality Assessment Products (QAPs™). This comprehensive brochure covers all available panels — including respiratory, STI, gastrointestinal, HPV, and more — along with product formats, performance specifications, and intended uses. Whether you're in assay development, lab operations, or external quality assessment, our QAPs™ brochure will
- [Quality Control Coupon](https://microbix.com/quality-control-coupon/) - Thank you for ordering our ONBOARDx™ Kits! Please complete the form below for 25%* off your next order! Check out our REDx™ IVD External Quality Controls for ongoing QC, and our PROCEEDx™ RUO for verification/validation studies and operator training. Perfect for routine use after onboarding your assay! DOWNLOAD BROCHUREGet a QUOTE today! 1
- [Request HPV Catalogue](https://microbix.com/request-hpv-catalogue/) - Complete this form to receive your copy of the Microbix HPV Product Catalogue! Designed to simulate patient specimen formats in the context of HPV self-collection workflows. The panel includes single- and multi-target HPV-positive samples desiccated on a Copan FLOQSwab, including HPV16/18/45, HPV31/33/66, and HPV39/51/52 positive swab samples. All products are formulated with inactivated whole-genome samples that contain
- [Accessibility Policy](https://microbix.com/accessibility-policy/) - TABLE OF CONTENTS MESSAGE FROM THE CEOINTRODUCTIONFEEDBACK PROCESS ACCESSIBILITY POLICYTHE POLICYTHE PRINCIPLESMEETING THE INTEGRATED ACCESSIBILITY STANDARDS REGULATIONDEFINITIONS MULTI-YEAR ACCESSIBILITY PLANINTEGRATED ACCESSIBILITY STANDARDS REGULATIONCUSTOMER SERVICE STANDARD – ONTARIO REGULATIONWORKPLACE EMERGENCY RESPONSEINFORMATION AND COMMUNICATION STANDARDSTRAINING STANDARDSEMPLOYMENT PRACTICES MESSAGE FROM CEO At Microbix, we strive to provide an environment where individuals can thrive as they achieve their goals
- [Thank You - Contact Form Page](https://microbix.com/thank-you-contact-form-page/) - Thank you for your interest in Microbix products and services One of our representatives will be in contact with you within 1 - 2 business days. Here's the latest from Microbix...
- [Contact Us - Form 7](https://microbix.com/contact-us-form-7/) - Request a Quote I am very interested in the following types of Microbix Products and Services: XExternal Quality Controls (QAPs) XAntigens XDXTM Viral Transport Medium XONBOARDx KITS - RUO XAseptic Custom Vial Filling Services XControl Elution Buffer Full Name Phone Number Email Company City Message Which of the following best describe you? Clinical Laboratory or
- [Blog](https://microbix.com/resources/blog) - Stay informed with the latest updates, insights, and discussions on our Microbix blog. Explore topics across the global diagnostics industry.
- [Resources](https://microbix.com/resources-old)
- [Battling Flu Season: Quality Control and Microbix](https://microbix.com/resources-old/blog/battling-flu) - FollowFollowFollowFollow Battling Flu Season: Quality Control and Microbix 3-minute read Flu season is upon us, and with it comes the annual threat of influenza, respiratory syncytial virus (RSV), and more recently, the coronavirus, SAR-CoV-2. These viruses pose serious health risks to individuals around the world. The flu, in particular, can lead to a range
- [Season 1 Episode 5: Bridging Policy and Innovation for a Healthier Tomorrow](https://microbix.com/resources/media/season-1-episode) - Season 1 Episode 5 Diagnostics: Beyond the Lab In this episode of Diagnostics: Beyond the Lab we talk to two very distinguished guests, Christine Elliott, who served as the deputy premier of Ontario and the Minister of Health from 2018 to 2022, and Ivy Parks, President of Becton Dickinson (BD, for short) Canada, one of
- [Season 1 Episode 5](https://microbix.com/resources/media/season-1-episode-5) - Season 1 Episode 5 Diagnostics: Beyond the Lab In this episode of Diagnostics: Beyond the Lab we talk to two very distinguished guests, Christine Elliott, who served as the deputy premier of Ontario and the Minister of Health from 2018 to 2022, and Ivy Parks, President of Becton Dickinson (BD, for short) Canada, one of
- [Upcoming Events 2023 and 2024](https://microbix.com/upcoming-events-2023-and-2024) - MICROBIX BIOSYSTEMS INC. Events over the next few months Here are all of Microbix's upcoming events including conferences, trade shows, presentations, and more! Make sure to check regularly to stay up to date with the latest news from us! FollowFollowFollowFollowEvents/Conferences of 2023 and 2024 SCASM 87th Annual Meeting— October 27-28, 2023 During the Meeting, you
- [The Essential Role of Multiplex Quality Control in In Vitro Diagnostics for Infectious Diseases](https://microbix.com/resources-old/blog/the-essential-role-of-multiplex-quality-control-in-in-vitro-diagnostics-for-infectious-diseases-2) - FollowFollowFollowFollowUnveiling the Significance of Proficiency Testing and EQA in Ensuring Reliable Infectious Test Results 4-minute read So…you got your Respiratory infection test results back from the doctor. Should you trust them? Well, the answer is YES! Why? There is a sophisticated quality assurance ecosystem supporting diagnostic testing in most healthcare systems, ensuring reliable and
- [Request Catalogue US](https://microbix.com/request-catalogue-us) - Complete this form to receive your copy of the Microbix Product Catalogue! First Name * Last Name * Company * Country * Phone * Company Email * Yes, I agree to receive offers, promotions and other valuable commercial messages from Microbix. Which of the following best describes you? * Lab or Hospital Diagnostic Manufacturer Distributor
- [The Essential Role of Multiplex Quality Control in In Vitro Diagnostics for Infectious Diseases](https://microbix.com/resources-old/blog/the-essential-role-of-multiplex-quality-control-in-in-vitro-diagnostics-for-infectious-diseases) - FollowFollowFollowFollowThe Essential Role of Multiplex Quality Control in In Vitro Diagnostics for Infectious Diseases In vitro diagnostics play a critical role in diagnosing and monitoring infectious diseases. Accurate and reliable test results are essential for guiding patient treatment and improving outcomes. However, with the increasing complexity of diagnostic tests, ensuring the quality of these
- [Enhancing STI testing accuracy and reliability with Microbix's External Quality Controls](https://microbix.com/resources-old/blog/enhancing-sti-point-of-care-testing-for-sti-diagnostic-accuracy-chlamydia-gonorrhea-hpv-syphilis-mycoplasma-genitalium-external-quality-controls-external-quality-assessment-naats-ready-to-us) - FollowFollowFollowFollowEnhancing STI testing accuracy and reliability with Microbix's External Quality Controls Point of care (POC) testing has revolutionized the way we diagnose and manage various infectious diseases, including sexually transmitted infections (STIs). The ability to obtain rapid, accurate results from POC tests has led to improved patient outcomes, reduced treatment delays, and
- [Trichomonas Vaginalis: Why Early Detection is Crucial](https://microbix.com/resources/blog/trichomonas-vaginalis) - FollowFollowFollowFollowTrichomonas Vaginalis: Why Early Detection is Crucial Trichomonas vaginalis, also known as trich, is a sexually transmitted infection (STI) caused by a parasitic protozoan. According to WHO more than 1 million new STIs are acquired every day and approximately 357 million people contract STIs each year. Despite its prevalence, trichomoniasis often goes undiagnosed, leading
- [The Lowdown on STI Testing: What You Need to Know](https://microbix.com/resources/blog/the-lowdown1) - FollowFollowFollowFollowThe Lowdown on STI Testing: What You Need to Know Did you know that sexually transmitted infections (STIs) are shockingly common? Millions of cases are diagnosed every year, with young people and men who have sex with men being particularly at risk. And the scariest part? Many people don't even know they
- [The Silent Killer: Exploring the Alarming Rise of Antimicrobial Resistance](https://microbix.com/resources/blog/the-silent-killer) - FollowFollowFollowFollowThe Silent Killer: Exploring the Alarming Rise of Antimicrobial Resistance Antimicrobial resistance (AMR) is a serious global health issue that is affecting millions of people every year. It refers to the ability of microorganisms to resist the effects of antimicrobial drugs, such as antibiotics. This phenomenon has been on the rise in recent years,
- [Microbix's Multiplex Quality Control for STI Diagnosis](https://microbix.com/resources-old/blog/microbix1) - FollowFollowFollowFollowMicrobix's Multiplex Quality Control for STI Diagnosis STIs: A public health issue Sexually transmitted infections (STIs) are a significant public health issue, with millions of new cases diagnosed each year. Accurate and timely diagnosis is crucial to prevent the spread of these infections and ensure that patients receive appropriate treatment. Multiplex
- [Breaking the Stigma: Managing STIs for Better Sexual Health](https://microbix.com/resources/blog/breaking-the-stigma-managing-stis-for-better-sexual-health) - FollowFollowFollowFollowBreaking the Stigma: Managing STIs for Better Sexual Health Sexually transmitted infections (STIs) affect millions of people globally, yet there remains a significant amount of stigma around these infections. This stigma prevents people from discussing their STI status, leading to negative health outcomes and further spread of the infection. In this blog
- [All QAPs](https://microbix.com/all-qaps-m) - Infectious Disease External Quality Controls (Microbix’s QAPs™) Description: REDx™ products are unassayed controls used for evaluating laboratory testing performance, procedures, and workflows Certifications: ISO 13485, IVD, CE Description: PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for RESEARCH USE ONLY!Certifications: ISO 9001, ISO 13485 Description: PTDx™ products are used as challenge
- [Syphilis on the Rise in Canada: A Call to Action for Public Health and Individuals](https://microbix.com/resources-old/blog/industry-educational-series1) - FollowFollowFollowFollowSyphilis on the Rise in Canada: A Call to Action for Public Health and Individuals http://microbix.com/wp-content/uploads/2023/04/Social-Media-Posts.mp4 Syphilis is a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. The infection can cause serious health problems if left untreated, including blindness, deafness, and even death. In Canada, syphilis rates have been on
- [Diagnostics: Beyond the Lab: Episode 4: Ensuring Patient health through EQA](https://microbix.com/resources/media/episode-4-self-collection) - Episode 4: EQA Diagnostics: Beyond the Lab Mar 29, 2023In this episode of Diagnostics: Beyond the Lab we talk to Daniel Taylor from 1WA, Danielle Casey from API; and Heidi Berghäll from Labquality, about a range of topics including the lab accreditation process, the importance of EQA/PT programs, new challenges and future trends in the
- [The Importance of External Quality Assessment (EQA) in Laboratory Testing](https://microbix.com/resources/blog/industry-educational-series-eqa-2) - FollowFollowFollowFollowThe Importance of External Quality Assessment (EQA) in Laboratory Testing Laboratory testing requires accuracy and reliability for patient care. External Quality Assessment (EQA) is an effective tool to ensure testing accuracy and reliability. EQA compares laboratory test results with peer groups or reference labs worldwide. This article discusses the importance of EQA,
- [Revolutionizing Pandemic Preparedness with Self-Collection](https://microbix.com/resources/blog/diagnostics-self-collection2) - FollowFollowFollowFollowRevolutionizing Pandemic Preparedness with Self-Collection Lessons from the COVID-19 Pandemic The COVID-19 pandemic has taught us that pandemics can be incredibly disruptive to our society, economy, and daily lives. In order to be better prepared for future pandemics, the whole industry has invested in scaling up the production of everything that would
- [Diagnostics Explained: HPV](https://microbix.com/resources/blog/diagnostics-explained-hpv) - FollowFollowFollowFollowThe Role of Diagnostics in HPV Screening The Importance of HPV Screening Human papillomavirus (HPV) is a common sexually transmitted infection that is linked to the development of cervical cancer. The primary screening for HPV infection is an important tool in the prevention of cervical cancer, as it enables the identification of
- [Diagnostics Explained: AMR](https://microbix.com/resources/blog/diagnostics-explained-amr-2) - FollowFollowFollowFollowThe Antimicrobial Resistance (AMR) crisis and how we can overcome it Antimicrobial Resistance (AMR) Antimicrobial resistance or AMR occurs when microorganisms build resistance to an antibiotic drug. With AMR on the rise, the World Health Organization has deemed this a top 10 global public health threat. This is not only an issue
- [Upcoming Events](https://microbix.com/upcoming-events-2) - MICROBIX BIOSYSTEMS INC. Events over the next few months Here are all of Microbix's upcoming events including conferences, trade shows, presentations, and more! Make sure to check regularly to stay up to date with the latest news from us! FollowFollowFollowFollowEvents/Conferences of 2023 ASM Microbe— JUNE 15TH -19TH, 2023 The American Society for Microbiology, ASM Microbe,
- [All Microbix QAPs](https://microbix.com/all-qaps) - Infectious Disease External Quality Controls (Microbix’s QAPs™) Description: REDx™ products are unassayed controls used for evaluating laboratory testing performance, procedures, and workflows Certifications: ISO 13485, IVD, CE Description: PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for RESEARCH USE ONLY!Certifications: ISO 9001, ISO 13485 Description: PTDx™ products are used as challenge
- [Episode 3: Self-Collection](https://microbix.com/resources/media/episode-3-self-collection) - Episode 3: Self-collection Diagnostics: Beyond the Lab Jan 13, 2023In this episode of Diagnostics: Beyond the Lab we talk to Giorgio Triva, CEO and Strategic Project Manager of Copan Group, based in Italy, about what his company and the work it has done to become a global leader in sample collection, transport and test accuracy
- [Episode 2: AMR](https://microbix.com/resources/media/episode-2-amr-2r-2) - Episode 2: AMR Diagnostics: Beyond the Lab Jan 10, 2023In this episode of Diagnostic: Beyond the lab, we talk to Colin Denver, CEO of SpeeDX about antimicrobial resistance and using diagnostics to target treatment. https://microbix.com/wp-content/uploads/2022/12/Podcast_Nov30_2022.m4aHosts & Guests Janet Silver Cameron Groome Colin Denver Podcast https://microbix.com/podcast/ FollowFollowFollowFollowMeet the Guests Colin Denver Colin is the Chief
- [Episode 1: HPV](https://microbix.com/resources/media/episode-1-hpv) - Episode 1: HPV Diagnostics: Beyond the Lab Nov 14, 2022On this episode we discuss the Human papillomavirus or HPV, vaccines, testing and cervical cancer. What is HPV and what is the way forward for testing?Joining us for this discussion is Larry Vaughan, director scientific affairs integrated diagnostic solutions at Becton Dickinson, one of the largest
- [3d blog posts](https://microbix.com/3d) - [caf_filter id=7069]
- [Microbix’s CEO in Media](https://microbix.com/resources/media) - Explore ongoing media updates and current events. Discover how Microbix is staying at the forefront of the global diagnostics industry. Learn more now.
- [Past Events](https://microbix.com/past-events) - PAST EVENTS Microbix Reports Results for Q3 Fiscal 2026Aug 13, 2026Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, CANADA, August 13, 2026 – Microbix Biosystems Inc. (TSX: MBX,… read more…Microbix Schedules Release of Results for Q3 Fiscal 2026Aug 6, 2026Microbix Schedules Release of Results for Q3 Fiscal 2026 Results Release and
- [Request Catalogue](https://microbix.com/request-catalogue) - Interested in our products? Request a catalogue to learn more about our offerings. Microbix delivers high-quality, innovative diagnostic solutions for your needs.
- [Microbix Biosystems - Detectable Delights | CAP TODAY | Feb 2022](https://microbix.com/microbix-biosystems-detectable-delights-cap-today-feb-2022) - Detectable Delights - RED CONTROLS Microbix Biosystems Inc. develops and commercializes quality assessment products (QAPs™) for infectious disease diagnostic assays. Our extensive product portfolio and high-quality samples provide laboratories with the necessary support to conduct assay verification/validation, laboratory personnel training, regular quality control, and more. Microbix’s unique expertise lies in designing elaborate SARS-CoV-2, HPV, and
- [DxTM Viral Transport Medium](https://microbix.com/products/dxtm-viral-transport-medium) - Contact us today to use our viral transport medium that ensures safe and effective sample collection, storage, and transport for the most accurate results in your laboratory testing.
- [Gastrointestinal](https://microbix.com/gastrointestinal) - Gastrointestinal Product Name EL Catalogue Number Product Description Borrelia burgdorferi EL-24-02 Description: Borrelia Burgdorferi native antigen is isolated from the B31 strain cultured in BSK 11 medium. Strain: B31 Buffer: PBS with magnesium Rotavirus Grade 3 EL-35-03 Description: Rotavirus native antigen is isolated from cultured MA104 cells that were infected with the Simian rotavirus SA11
- [ONBOARDx™ Kits](https://microbix.com/onboardx-kits) - ONBOARDx™ Kits ONBOARDx™ Kits are assemblies of our PROCEEDx™ Research Use Only (RUO) products. They are helpful tools for verifying the performance of new test systems and training lab personnel. These non-infectious samples are perfect surrogates for hazardous patient samples to confirm positive and negative detection of specific analytes. ONBOARDx™ Kits are available in liquid
- [HPV Panel](https://microbix.com/hpv-panel) - Human Papillomavirus (HPV) External Quality Controls & RUO (QAPs™) Single Analyte Products Product Name REDx™ (IVD) Catalogue Number PROCEEDx™ (RUO) Catalogue Number Product Description Product Brochure HPV 16 RED-62-16 VP-62-16 Application - PROCEEDx™ samples are Research use only (RUO) products for use in test system IQ/OQ/PQ, Verification & Validation and Training. REDx™ used for IVD
- [Respiratory Antigens](https://microbix.com/respiratory-antigens) - Respiratory Antigens Product Name EL Catalogue Number Product Description Adenovirus, Grade 2 EL-15-02 Description: Native adenovirus antigen preparation contains a high concentration of virus and viral components as well as some cellular material in MEM. Strain: Adenoid 6 Buffer: MEM RSV EL-07-03 Description: Native RSV antigen preparation contains a high concentration of virus and viral
- [Gastrointestinal and Other Antigens](https://microbix.com/gastrointestinal-and-other-antigens) - Gastrointestinal (GI) External Quality Controls & RUO (QAPs™) Single Analyte Products Product Name REDx™ (IVD) Catalogue Number PROCEEDx™ (RUO) Catalogue Number Product Description Cryptosporidium parvum Positive Coming soon VP-38-01 Application - PROCEEDx™ samples are Research use only (RUO) products for use in test system IQ/OQ/PQ, Verification & Validation and Training. REDx™ used for IVD
- [STI Antigens](https://microbix.com/sti-antigens) - STI Antigens Product Name EL Catalogue Number Product Description Chlamydia trachomatis, Grade 2 EL-12-02 Description: C. trachomatis grade 2 antigen contains a high concentration of elementary bodies and chlamydial components in PBS. The preparation contains no preservative or detergent. Residual host cellular material is present. Strain: C. trachomatis LGV type II strain 434 Buffer: Phosphate
- [ToRCH Antigens](https://microbix.com/torch-antigens) - ToRCH Antigens Product Name EL Catalogue Number Product Description Toxoplasma gondii, Grade IgG EL-18-07 Description: Native Toxoplasma gondii antigens are obtained by extracting and subsequently centrifuging Toxoplasma tachyzoites from infected cell cultures. Strain: RH Buffer: 1% Triton x-100, Phosphate Buffered Saline pH 7.4 Toxoplasma gondii, Grade IgM EL-18-08 Description: Toxoplasma Antigen, IgM Grade is produced
- [Dengue Antigens](https://microbix.com/dengue-antigens) - Dengue Antigens Product Name EL Catalogue Number Product Description Dengue Type 1 EL-52-02 Description: A purified preparation of native Dengue 1 virus particles suitable for use in assays for detection of the presence of antibodies against Dengue 1 virus, and as a positive control for the presence of the Dengue 1 virus antigens in a
- [Childhood Disease Antigens](https://microbix.com/products/antigens/childhood-disease2)
- [Sexual Wellness](https://microbix.com/sexual-wellness) - Sexually Transmitted Infections (STI) External Quality Controls & RUO (QAPs™) Single Analyte Products Product Name REDx™ (IVD) Catalogue Number PROCEEDx™ (RUO) Catalogue Number Product Description Product Brochure HSV 1 Positive Coming soon VP-02-M1 Application - PROCEEDx™ samples are Research use only (RUO) products for use in test system IQ/OQ/PQ, Verification & Validation and Training. REDx™ used
- [Other Respiratory Products](https://microbix.com/other-respiratory-products) - For COVID-19 External Quality Controls Products, click here Infectious Disease External Quality Controls Respiratory Viral Panel Single Analyte Products Product Name REDx™ (IVD) Catalogue Number PROCEEDx™ (RUO) Catalogue Number Download Brochure Adenovirus Positive Coming soon VP-15-01 Parainfluenza 3 Positive Coming soon VP-10-M1 RSV Positive RED-07-01 VP-07-01 RSV Positive Swab RED-S-07-01 VP-S-07-01 Respiratory NAAT RSV Positive Swab
- [COVID-19 Products](https://microbix.com/covid19-products) - Infectious Disease External Quality Controls SARS Complete Panel Single Analyte Products Product Name REDx™ (IVD) Catalogue Number PROCEEDx™ (RUO) Catalogue Number Download Brochure SARS-CoV-2 Positive RED-19-01 VP-19-01 SARS-CoV-2 Positive Swab RED-S-19-01 VP-S-19-01 SARS-CoV-2 Ag Positive Swab RED-S-19-02 VP-S-19-02 SARS-CoV-2 B.1.1.7 Positive Swab RED-S-19-03 VP-S-19-03 SARS-CoV-2 B.1.351 Positive Swab RED-S-19-04 VP-S-19-04 SARS-CoV-2 P.1 Positive Swab RED-S-19-05
- [Antigen](https://microbix.com/antigen)
- [Microbix Biosystems | Infectious Disease Antigens & External Quality Controls (QAPs)](https://microbix.com/home-new) - Leading Infectious Disease Biomaterial Manufacturer Copan FLOQSwab® and Liquid Control Products Clinical Diagnostics, Proficiency Programs, Training, Verification and Development Antigens for Diagnostic Test Manufacturers Viral Transport Medium – DxTM™ VTM? – LEARN MORE Microbix Reports Results for Q3 Fiscal 2026Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, CANADA, August 13, 2026 –
- [Microbix Biosystems | CAP TODAY | TEST FILE](https://microbix.com/microbix-biosystems-cap-today) - One quality control swab compatible with ANY platform! Microbix Biosystems Inc. develops and commercializes quality assessment products (QAPs™) formulated exclusively on Copan’s FLOQSwab®. The respiratory viral QAPs™ product line is specifically designed to support point-of-care and central laboratory testing for common viruses, including SARS-CoV-2, Influenza, and Respiratory Syncytial Virus, among others. The formulations contain inactivated
- [Microbix Biosystems | CAP TODAY](https://microbix.com/mmicrobix-biosystems-cap-today) - Microbix Biosystems Inc. is a global leader in quality management solutions for infectious disease diagnostic testing. Microbix began as a supplier of raw materials to OEMs in the diagnostics industry. In the mid-2000s this contribution broadened to include samples for external quality assessment (EQA) programs and recently expanded further with a range of Quality Assessment
- [DxTM VIRAL TRANSPORT MEDIUM](https://microbix.com/dxtm) - LEARN MORE ABOUT TRANSPORT MEDIUM FOR VIRUSES (DxTM™) Please fill the information below to download more information about Transport Medium For Viruses (DxTM™) Error: Contact form not found. DxTM VIRAL TRANSPORT MEDIUM Microbix's DxTMTM Viral Transport Medium is a Canadian-made, proprietary IVD Medical Device that is designed for use in the collection and transport of specimens
- [Analyst Coverage | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/analyst-coverage) - Analyst Coverage Company Analyst Downloads KRC Insights Bruce Krugel Q1 2026 Update Q3 2025 Update Q2 2025 Update Q1 2025 Update Q4 2024 Update Q3 2024 Update Q2 2024 UpdateQ1 2024 UpdateQ2 2023 UpdateKinlytic Urokinase ReportInitiation ReportQ1 2021 UpdateQ2 2021 UpdateQ3 2021 Update Bloom Burton & Co David Martin Espace Microcaps Philippe Lapointe Investment Thesis
- [Request a Quote](https://microbix.com/request-a-quote-2/) - [addify-quote-request-page]
- [Request a Quote](https://microbix.com/request-quote) - [yith_ywraq_request_quote]
- [infectious-disease-antigens2](https://microbix.com/infectious-disease-antigens2) - INFECTIOUS DISEASE ANTIGENS Microbix produces one of the world’s largest range of infectious disease antigens. These viral, bacterial and parasitic products are used in applications like Immunodiagnostic assays including ELISA, chemiluminescent automated immunoassays, immunohistochemistry; immunofluorescence; latex agglutination, rapid tests, and flow cytometry. They can also be used in controls for diagnostic assays, basic and applied
- [Privacy Statement | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/privacy-statement) - PRIVACY STATEMENT What Do We Do With Your Information? When you purchase something from Microbix.com, as part of the buying and selling process, we collect the personal information you give us such as your name, address and email address. When you browse our store, we also automatically receive your computer’s internet protocol (IP) address in
- [Terms & Conditions | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/terms-conditions) - TERMS & CONDITIONS OVERVIEW This website is operated by Microbix Biosystems Inc.. Throughout the site, the terms “we”, “us” and “our” refer to Microbix Biosystems Inc.. Microbix Biosystems Inc. offers this website, including all information, tools and services available from this site to you, the user, conditioned upon your acceptance of all terms, conditions, policies
- [COVID-19 Blog](https://microbix.com/covid-19-blog) - COVID-19 Blog Microbix Reports Results for Q3 Fiscal 2026Aug 13, 2026Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, CANADA, August 13, 2026 – Microbix Biosystems Inc. (TSX: MBX,… read more…Microbix Schedules Release of Results for Q3 Fiscal 2026Aug 6, 2026Microbix Schedules Release of Results for Q3 Fiscal 2026 Results Release and
- [Events](https://microbix.com/resources/events/) - Discover upcoming events and conferences in the world of global diagnostics that promotes discovery, innovation and collaboration. Learn more now.
- [News | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/resources-old/news-releases) - NEWS RELEASES Microbix Reports Results for Q3 Fiscal 2026Aug 13, 2026Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, CANADA, August 13, 2026 – Microbix Biosystems Inc. (TSX: MBX,… read more…Microbix Schedules Release of Results for Q3 Fiscal 2026Aug 6, 2026Microbix Schedules Release of Results for Q3 Fiscal 2026 Results Release and
- [Corporate Governance | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/corporate-governance) - Corporate Governance Modern Slavery Report 2024 Download Microbix Biosystems Articles of Incorporation Download Audit Committee Charter Download Majority Voting Policy Download By-law No. 4 – Regulation of Business and Affairs of the Corporation Download Microbix Biosystems by-law No. 5 - Nomination of Directors Download Corporate Social Responsibility Policy Download Corporate Environmental Policy Download Whistleblower Policy
- [covid-19](https://microbix.com/covid-19) - COVID-19 PRODUCTS Microbix has recently developed the COVID-19 Quality Assessment Products (QAPs) products below for External Quality Assessment and Proficiency Testing uses, for various Research Use Only (RUO) uses. Additionally, the products were registered for use as an external quality control for IVD use in multiple jurisdictions (FDA, CE, TGA and HC). As for all
- [quality-assessment-products](https://microbix.com/quality-assessment-products) - AT THE CORE OF QUALITY Why choose Microbix Quality Assessment Products (QAPs™)? Manufactured from native pathogens or synthetic whole genome of pathogens to be virtually identical to patient samples Pathogens are inactivated and non-hazardous Liquid material is in ready to use aliquots and swabs Stored at 2-8°C (vial) and 2-30°C (swab) Stable for up to
- [Proficiency Testing | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/products/external-quality-controls/laboratory-proficiency-testing) - EQA/PROFICIENCY TESTING Microbix has long provided viral and bacterial samples, for CAP-accredited and ISO 17043 certified external quality assessment and proficiency test (PT) programs. We are experts in cell culture, purification, and inactivation of infectious disease pathogens. We culture well-characterized strains that produce accurate, consistent results. Only available for purchase by accredited EQA program providers.
- [Our Senior Team | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/about/team) - Join our team at Microbix. Explore exciting career opportunities in the global diagnostics industry. Learn more today.
- [Board of Directors | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/about/board-directors) - Meet the leaders behind Microbix's success. Our diverse board of directors bring decades of experience and expertise in related fields and business strategy.
- [Quality | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/quality-old) - OUR COMMITMENT TO QUALITY Microbix strives to meet and exceed our customer expectations. Management and employees are committed to comply with customer and regulatory requirements for continuous improvement in everything we do. We apply our quality management system to all relevant activities. Senior Management reviews our Quality Management System on a regular basis to ensure
- [News Releases](https://microbix.com/resources/news-releases) - Stay up-to-date with all the latest news and updates from Microbix. From new product releases to company developments, we have you covered.
- [My account](https://microbix.com/my-account-2)
- [Checkout](https://microbix.com/checkout-2)
- [Cart](https://microbix.com/cart-2)
- [Subscribe now](https://microbix.com/subscribe-now/) - Join our Mailing list Do you want to stay up to date on new products, news, and all things Microbix? Of course you do! Please select what you'd like to receive from Microbix: First Name * Email * I'm interested in receiving... News Releases Upcoming Events Investor Information Blog Posts Which of the
- [Test page](https://microbix.com/test-page) - [cool-timeline layout="default" skin="default" date-format="F j" show-posts="10" animation="none" icons="NO" order="DESC" story-content="short"][cool-timeline layout="default" skin="default" date-format="F j" show-posts="10" animation="none" icons="NO" order="DESC" story-content="short"]
- [Shop](https://microbix.com/shop)
- [Shop](https://microbix.com/shop-2)
- [Sample Page](https://microbix.com/sample-page) - This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I'm a bike messenger
- [Request a Quote](https://microbix.com/request-a-quote/) - [addify-quote-request-page]
- [Quote Request](https://microbix.com/quote-request) - [gpls_woo_rfq_get_cart_sc]
- [Privacy Policy](https://microbix.com/privacy-policy-2) - Who we are Our website address is: http://microbix.com. What personal data we collect and why we collect it Comments When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection. An anonymized string created from
- [Placeholder](https://microbix.com/products/antigens/placeholder)
- [Antigens](https://microbix.com/products/antigens-2)
- [Dengue Antigens](https://microbix.com/products/antigens/dengue2)

## Certifications

- [Obelis Certificate EZ 9873 2020](https://microbix.com/resources/certification/obelis-certificate-ez-9873-2020/) - This CE marking notification authorizes Microbix's REDx STI controls including a Mycoplasma genitalium positive control and an STI negative control — for sale across Belgium and other EU/EEA Member States. Issued via Obelis S.A. under EU Directive 98/79/EC, it enables these NAAT-based quality controls to be used in European clinical and diagnostic laboratories.
- [Obelis Certificate EZ 9317 2020](https://microbix.com/resources/certification/obelis-certificate-ez-9317-2020/) - This CE marking notification authorizes four of Microbix's REDx SARS-CoV-2 nucleic acid controls — liquid positive and negative controls, and swab positive and negative controls — for distribution across Belgium and other EU/EEA Member States. Issued through Obelis S.A. under EU Directive 98/79/EC, these products support molecular diagnostic laboratories monitoring SARS-CoV-2 nucleic acid testing performance
- [Obelis Certificate EZ 8047 2019](https://microbix.com/resources/certification/obelis-certificate-ez-8047-2019/) - This CE marking notification, facilitated through Obelis S.A. as Microbix's European Authorized Representative, authorizes the placement of REDx HPV Controls (positive controls for types 16, 18, and 45, and a negative control) on the market across Belgium and other EU/EEA Member States. It confirms these NAAT-based in vitro diagnostic products meet the requirements of EU
- [Obelis Certificate EZ 0734 2021](https://microbix.com/resources/certification/obelis-certificate-ez-0734-2021/) - This CE marking notification, completed through Obelis S.A. under EU Directive 98/79/EC, authorizes Microbix's REDx FLOQ SARS-CoV-2 antigen swab controls covering positive and negative swab controls for immunodiagnostic assays for distribution across Belgium and other EU/EEA Member States. These products support laboratory performance monitoring for SARS-CoV-2 antigen detection workflows throughout Europe.
- [Health Canada Licence 12336](https://microbix.com/resources/certification/health-canada-licence-12336/) - Issued under the Medical Devices Regulations of Canada's Food and Drugs Act, this Medical Device Establishment Licence (No. 12336) authorizes Microbix to manufacture Class I medical devices for distribution within Canada, across two licensed facilities in Mississauga, Ontario. It demonstrates compliance with Health Canada's regulatory framework and supports Microbix's ability to supply diagnostic products to
- [BSI-ISO IVDR 780538-R000](https://microbix.com/resources/certification/bsi-iso-ivdr-780538-r000/) - Issued by BSI under EU Regulation 2017/746 (IVDR), this EU Quality Management System Certificate confirms Microbix's compliance with the most current European framework governing in vitro diagnostic medical devices. It authorizes Microbix to place Class B unassayed IVD controls intended to monitor the performance of assays for the detection of infectious agents on the EU
- [BSI-ISO 9001-2015](https://microbix.com/resources/certification/bsi-iso-9001-2015/) - Microbix's ISO 9001:2015 certification, issued by BSI (Certificate No. FM 552929), confirms that our quality management system meets the internationally recognized standard for consistent product and service quality. This certification covers the development, manufacture, and distribution of infectious disease antigens, and supports Microbix's ability to operate in global markets where ISO 9001 compliance is expected
- [BSI ISO 13485 2016](https://microbix.com/resources/certification/bsi-iso-13485-2016/) - ISO 13485:2016, issued by BSI (Certificate No. FM 660560), is the leading international standard for QMS specific to medical device manufacturers. This certification covers the design, development, manufacture, and distribution of sample transport media, Quality Assessment Products (QAPs) of infectious disease agents for proficiency testing, validation and verification panels, and clinical quality controls, enabling Microbix

## Products

- [Seasonal Coronavirus NL63 Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/seasonal-coronavirus-nl63-positive) - Microbix Seasonal Coronavirus NL63 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Seasonal Coronavirus NL63 whole genome nucleic acid and human cells suspended in a proprietary buffer. Microbix Seasonal Coronavirus NL63 Positive External Quality Controls have verified performance with Seegene Respiratory Panel 3 Assay, BIOFIRE® Respiratory
- [SARS-CoV-2 Negative Swab (REDx™FLOQ®)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-negative-swab-redxtmfloq/) - Microbix SARS-CoV-2 Negative Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells desiccated on a Copan FLOQSwab®. Intended Use The product is an unassayed control designed for ongoing external quality control, benchmarking laboratory testing performance, and end-to-end workflow evaluation. *REDx™ products are registered as Class
- [Respiratory Negative Swab (REDx™FLOQ®)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-negative-swab-redxfloq/) - Microbix Respiratory External Quality Swab Controls are unassayed, whole-workflow samples that mimic clinical specimens. Each control is formulated with inactivated respiratory pathogens and human cells to support consistent diagnostic performance.
- [SARS-CoV-2 Negative](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-negative/) - Microbix SARS-CoV-2 Negative External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells suspended in ThinPrep® PreservCyt®. Intended Use The product is an unassayed control designed for ongoing external quality control, benchmarking laboratory testing performance, and end-to-end workflow evaluation. *REDx™ products are registered as Class I medical
- [Group A Strep Positive Swab (M1) (Low Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/group-a-strep-positive-swab-m1/) - Microbix Group A Strep Positive Swab (M1) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Streptococcus pyogenes and human cells desiccated on a Copan FLOQSwab®. Microbix Group A Strep Positive Swab (M1) External Quality Controls have verified performance with Cepheid Xpert® Xpress Strep A Assay, Xfree™
- [Group A Strep Positive Swab (M2) (Medium Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/group-a-strep-positive-swab-m2/) - Microbix Group A Strep Positive Swab (M2) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Streptococcus pyogenes and human cells desiccated on a Copan FLOQSwab®. Microbix Group A Strep Positive Swab (M2) External Quality Controls have verified performance with Quidel Sofia Strep A FIA, BD Veritor™
- [Group A Strep Positive Swab (High Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/group-a-strep-positive-swab/) - Microbix Group A Strep Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Streptococcus pyogenes desiccated on a Copan FLOQSwab®. Microbix Group A Strep Positive Swab External Quality Controls have verified performance with Quidel Sofia Strep A FIA Assay, BD Veritor™ Group A Strep, Cepheid
- [SARS-CoV-2/FluA&B/RSV Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-flu-a-flu-b-rsv-positive-swab) - SARS-CoV-2/Flu A/ Flu B/ RSV Positive Swab
- [Respiratory Viral Panel 1 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-viral-panel-1-positive-swab-red) - Microbix Respiratory Viral Panel 1 Positive Swab External Quality Controls are unassayed, hole-workflow samples that simulate clinical specimens. These products are formulated with Human Metapneumovirus, Rhinovirus, Enterovirus, and Seasonal Coronavirus NL63 whole genome nucleic acids and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory Viral Panel 1 Positive Swab External Quality Controls have verified
- [Respiratory Viral Panel 1 Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-viral-panel-1-positive-red) - Microbix Respiratory Viral Panel 1 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Human Metapneumovirus, Rhinovirus, Enterovirus, and Seasonal Coronavirus NL63 whole genome nucleic acids and human cells suspended in a proprietary buffer. Microbix Respiratory Viral Panel 1 Positive External Quality Controls have verified performance with
- [Respiratory NAAT RSV and SARS-CoV-2 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-rsv-and-sars-cov-2-positive-swab/) - Microbix Respiratory NAAT RSV and SARS-CoV-2 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Respiratory Syncytial Virus (RSV), SARS-CoV-2 whole genome nucleic acid, and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT RSV and SARS-CoV-2 Positive Swab External Quality Controls have verified
- [Respiratory NAAT Influenza B and SARS-CoV-2 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-b-and-sars-cov-2-positive-swab/) - Microbix Respiratory NAAT Influenza B and SARS-CoV-2 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus, SARS-CoV-2 whole genome nucleic acid, and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza B and SARS-CoV-2 Positive Swab External Quality Controls have
- [Respiratory NAAT Influenza B and RSV Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-b-and-rsv-positive-swab/) - Microbix Respiratory NAAT Influenza B and RSV Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus, Respiratory Syncytial Virus (RSV), and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza B and RSV Positive Swab External Quality Controls have verified
- [Respiratory NAAT Influenza A and SARS-CoV-2 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-a-and-sars-cov-2-positive-swab/) - Microbix Respiratory NAAT Influenza A and SARS-CoV-2 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus, SARS-CoV-2 whole genome nucleic acid, and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza A and SARS-CoV-2 Positive Swab External Quality Controls have
- [Respiratory NAAT Influenza A and RSV Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-a-and-rsv-positive-swab/) - Microbix Respiratory NAAT Influenza A and RSV Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus, Respiratory Syncytial Virus (RSV), and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza A and RSV Positive Swab External Quality Controls have verified
- [Respiratory NAAT Influenza A and Influenza B Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/red-s-13-m2/) - Microbix Respiratory NAAT Influenza A and Influenza B Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A Virus, Influenza B virus, and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza A and Influenza B Positive Swab External Quality Controls have
- [Influenza A and Influenza B Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-influenza-b-positive-red-13-02) - Influenza A + Influenza B Positive - RED-13-02
- [Seasonal Coronavirus NL63 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/seasonal-coronavirus-nl63-positive-swab-red) - Microbix Seasonal Coronavirus NL63 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Seasonal Coronavirus NL63 whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix Seasonal Coronavirus NL63 Positive Swab External Quality Controls have verified performance with Seegene Respiratory Panel 3, BIOFIRE®
- [Seasonal Coronavirus NL63 Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/seasonal-coronavirus-nl63-positive-red) - Microbix Seasonal Coronavirus NL63 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Seasonal Coronavirus NL63 whole genome nucleic acid and human cells suspended in a proprietary buffer. Microbix Seasonal Coronavirus NL63 Positive External Quality Controls have verified performance with Seegene Respiratory Panel 3 Assay, BIOFIRE® Respiratory
- [SARS-CoV-2 B.1.1.529 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-b.1.1.529-positive-swab/) - Microbix SARS-CoV-2 B.1.1.529 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 B.1.1.529 whole genome and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 B.1.1.529 Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV Assay, Seegene Allplex™ 2019-nCov Assay, Seegene
- [SARS-CoV-2 B.1.617 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-b.1.617-positive-swab-red/) - Microbix SARS-CoV-2 B.1.617 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 B.1.617 whole genome and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 B.1.617 Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV Assay, EliTech Group SARS-CoV-2 Extended ELITe
- [SARS-CoV-2 P.1 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-p.1-positive-swab/) - Microbix SARS-CoV-2 P.1 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 P.1 whole genome and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 P.1 Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress® SARS-CoV-2/ Flu/RSV Assay, Seegene Allplex™ SARS-CoV-2 Variants
- [SARS-CoV-2 B.1.351 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-b.1.351-positive-swab/) - Microbix SARS-CoV-2 B.1.351 Positive Swab External Quality Controls are unassayed whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 whole genome and human cells, desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 B.1.351 Positive Swab External Quality Controls have verified performance with Abbott Alinity m SARS-CoV-2 Assay, Quidel Lyra SARS-CoV-2 Assay, BD Max™
- [SARS-CoV-2 B.1.1.7 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-b.1.1.7-positive-swab/) - Microbix SARS-CoV-2 B.1.1.7 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 B.1.1.7 whole genome and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 B.1.1.7 Positive Swab External Quality Controls have verified performance with Abbott Alinity m SARS-CoV-2 Assay, Quidel Lyra SARS-CoV-2 Assay, BD
- [SARS-CoV-2 Ag Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-positive-swab/) - Microbix SARS-CoV-2-Ag Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 nucleocapsid (N) protein desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2- Ag Positive External Quality Controls have verified performance with BD Veritor™ COVID-19 Rapid Antigen Test, Quidel Sofia 2 Flu + SARS Antigen FIA, Abbott
- [SARS-CoV-2 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/redxfloq-sars-cov-2-positive-swab/) - Microbix SARS-CoV-2-Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2-Positive External Quality Controls have verified performance with Abbott ID NOW™ COVID-19 Assay, BD Max™ SARS-CoV-2 Assay, Cepheid Xpert® Xpress SARS-CoV-2 assay,
- [SARS-CoV-2 Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-positive/) - Microbix SARS-CoV-2-Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated SARS-CoV-2 whole genome nucleic acid and human cells suspended in ThinPrep® PreservCyt®. Microbix SARS-CoV-2-Positive External Quality Controls have verified performance with Cepheid Xpert® Xpress SARS-CoV-2 Assay, Cepheid Xpert® Xpress SARS-CoV-2/ Flu/RSV Assay, BD MAX™ SARS-CoV-2 Assay,
- [Rhinovirus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/rhinovirus-positive-swab-red) - Microbix Rhinovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Rhinovirus whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix Rhinovirus Positive Swab External Quality Controls have verified performance with Seegene Respiratory Panel 3, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE® Respiratory/Sore Throat
- [Rhinovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/rhinovirus-positive-red) - Microbix Rhinovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Rhinovirus whole genome nucleic acid and human cells suspended in a proprietary buffer. Microbix Rhinovirus Positive External Quality Controls have verified performance with Seegene Respiratory Panel 3 Assay, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE® Respiratory/Sore Throat (R/ST)
- [Respiratory Syncytial Virus Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-rsv-positive-swab-low-level/) - Microbix Respiratory NAAT RSV Positive Swab (Low Level) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Respiratory Syncytial Virus (RSV) and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT RSV Positive Swab (Low Level) External Quality Controls have verified performance with Cepheid Xpert® Xpress
- [Respiratory Syncytial Virus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-viral-panel/respiratory-naat-rsv-positive-swab/) - Microbix Respiratory NAAT RSV Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Respiratory Syncytial Virus (RSV) and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT RSV Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress® SARS-COV-2/Flu/RSV/Assay, BD MAX™ Respiratory
- [Respiratory Syncytial Virus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/rsv-positive-swab-red-s-07-01) - RSV Positive Swab - RED-S-07-01
- [Respiratory Syncytial Virus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/rsv-positive-red-07-01) - RSV Positive - RED-07-01
- [Influenza B Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-b-positive-swab-low-level/) - Microbix Respiratory NAAT Influenza B Positive Swab (Low Level) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza B Positive Swab (Low Level) External Quality Controls have verified performance with Cepheid Xpert®
- [Influenza B Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-b-positive-swab/) - Microbix Respiratory NAAT Influenza B Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza B Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress® SARS-COV-2/Flu/RSV/Assay, BD MAX™
- [Influenza B Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-b-positive-swab-red-s-14-01) - Influenza B Positive Swab - RED-S-14-01
- [Influenza B Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-b-positive-red-14-01) - Microbix Influenza B Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus suspended in a proprietary buffer. Microbix Influenza B Positive External Quality Controls have verified performance with BD Veritor™ System, Abbott BinaxNOW®, Quidel Sofia 2 FIA, Cepheid GeneXpert®, Roche cobas® LIAT system,
- [Influenza A Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-a-positive-swab-low-level/) - Microbix Respiratory NAAT Influenza A Positive Swab (Low Level) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza A Positive Swab (Low Level) External Quality Controls have verified performance with Cepheid Xpert®
- [Influenza A Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-a-positive-swab/) - Microbix Respiratory NAAT Influenza A Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus and human cells desiccated on a Copan FLOQSwab®. Microbix NAAT Influenza A Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress® SARS-COV-2/Flu/RSV/Assay, BD MAX™ Respiratory
- [Influenza A Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-positive-swab-red-s-13-01) - Influenza A Positive Swab - RED-S-13-01
- [Influenza A Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-positive-red-13-01) - Influenza A Positive - RED-13-01
- [Human Metapneumovirus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/human-metapneumovirus-positive-swab-red) - Microbix Human Metapneumovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Human Metapneumovirus whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix Human Metapneumovirus Positive Swab External Quality Controls have verified performance with Seegene Respiratory Panel 2, BIOFIRE® Respiratory Panel 2.1,
- [Human Metapneumovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/human-metapneumovirus-positive-red) - Microbix Human Metapneumovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Human Metapneumovirus whole genome nucleic acid and human cells suspended in a proprietary buffer. Microbix Human Metapneumovirus Positive External Quality Controls have verified performance with Seegene Respiratory Panel 2 Assay, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE®
- [Enterovirus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/enterovirus-positive-swab-red) - Microbix Enterovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Enterovirus whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix Enterovirus Positive Swab External Quality Controls have verified performance with Seegene Respiratory Panel 2, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE® Respiratory/Sore Throat
- [Enterovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/enterovirus-positive-red) - Microbix Enterovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Enterovirus whole genome nucleic acid and human cells suspended in a proprietary buffer. Microbix Enterovirus Positive External Quality Controls have verified performance with Seegene Respiratory Panel 2 Assay, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE® Respiratory/Sore Throat (R/ST)
- [Group A Strep Positive Swab (M1) (Low Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/group-a-strep-positive-swab-m1-2/) - Ensure accurate assay validation and verification with our group A strep external quality control positive swabs. Ideal for PCR test instrument verification, R&D, and training in infectious disease testing.
- [Group A Strep Positive Swab (M2) (Medium Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/group-a-strep-positive-swab-m2-2/) - Microbix Group A Strep Positive Swab (M2) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Streptococcus pyogenes and human cells desiccated on a Copan FLOQSwab®. Microbix Group A Strep Positive Swab (M2) External Quality Controls have verified performance with Quidel Sofia Strep A FIA, BD Veritor™
- [Group A Strep Positive Swab (High Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/group-a-strep-positive-swab-2/) - Microbix Group A Strep Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Streptococcus pyogenes desiccated on a Copan FLOQSwab®. Microbix Group A Strep Positive Swab External Quality Controls have verified performance with Quidel Sofia Strep A FIA Assay, BD Veritor™ Group A Strep, Cepheid
- [Respiratory Viral Panel 1 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-viral-panel-1-positive-swab) - Microbix Respiratory Viral Panel 1 Positive Swab External Quality Controls are unassayed, hole-workflow samples that simulate clinical specimens. These products are formulated with Human Metapneumovirus, Rhinovirus, Enterovirus, and Seasonal Coronavirus NL63 whole genome nucleic acids and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory Viral Panel 1 Positive Swab External Quality Controls have verified
- [Respiratory Viral Panel 1 Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-viral-panel-1-positive) - Microbix Respiratory Viral Panel 1 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Human Metapneumovirus, Rhinovirus, Enterovirus, and Seasonal Coronavirus NL63 whole genome nucleic acids and human cells suspended in a proprietary buffer. Microbix Respiratory Viral Panel 1 Positive External Quality Controls have verified performance with
- [Respiratory NAAT RSV and SARS-CoV-2 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-rsv-and-sars-cov-2-positive-swab-2/) - Microbix Respiratory NAAT RSV and SARS-CoV-2 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Respiratory Syncytial Virus (RSV), SARS-CoV-2 whole genome nucleic acid, and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT RSV and SARS-CoV-2 Positive Swab External Quality Controls have verified
- [Respiratory NAAT Influenza B and SARS-CoV-2 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-b-and-sars-cov-2-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Respiratory NAAT Influenza B and RSV Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-b-and-rsv-positive-swab-2/) - Microbix Respiratory NAAT Influenza B and RSV Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus, Respiratory Syncytial Virus (RSV), and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza B and RSV Positive Swab External Quality Controls have verified
- [Respiratory NAAT Influenza A and SARS-CoV-2 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-a-and-sars-cov-2-positive-swab-2/) - Microbix Respiratory NAAT Influenza A and SARS-CoV-2 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus, SARS-CoV-2 whole genome nucleic acid, and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza A and SARS-CoV-2 Positive Swab External Quality Controls have
- [Respiratory NAAT Influenza A and RSV Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-a-and-rsv-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Respiratory NAAT Influenza A and Influenza B Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-a-and-influenza-b-positive-swab/) - Microbix Respiratory NAAT Influenza A and Influenza B Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A Virus, Influenza B virus, and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza A and Influenza B Positive Swab External Quality Controls have
- [Influenza A and Influenza B Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-influenza-b-positive-vp-13-02) - Microbix Influenza A and Influenza B Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus and Influenza B virus suspended in a proprietary buffer. Microbix Influenza A and Influenza B Positive External Quality Controls have verified performance with Abbott BinaxNOW® Flu A&B Card,
- [Seasonal Coronavirus NL63 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/seasonal-coronavirus-nl63-positive-swab) - Microbix Seasonal Coronavirus NL63 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Seasonal Coronavirus NL63 whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix Seasonal Coronavirus NL63 Positive Swab External Quality Controls have verified performance with Seegene Respiratory Panel 3, BIOFIRE®
- [Rhinovirus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/rhinovirus-positive-swab) - Microbix Rhinovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Rhinovirus whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix Rhinovirus Positive Swab External Quality Controls have verified performance with Seegene Respiratory Panel 3, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE® Respiratory/Sore Throat
- [Rhinovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/rhinovirus-positive) - Microbix Rhinovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Rhinovirus whole genome nucleic acid and human cells suspended in a proprietary buffer. Microbix Rhinovirus Positive External Quality Controls have verified performance with Seegene Respiratory Panel 3 Assay, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE® Respiratory/Sore Throat (R/ST)
- [Respiratory Syncytial Virus Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-rsv-positive-swab-low-level-2/) - Microbix Respiratory NAAT RSV Positive Swab (Low Level) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Respiratory Syncytial Virus (RSV) and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT RSV Positive Swab (Low Level) External Quality Controls have verified performance with Cepheid Xpert® Xpress
- [Respiratory Syncytial Virus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-rsv-positive-swab-2/) - Microbix Respiratory NAAT RSV Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Respiratory Syncytial Virus (RSV) and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT RSV Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress® SARS-COV-2/Flu/RSV/Assay, BD MAX™ Respiratory
- [Respiratory Syncytial Virus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/rsv-positive-swab-vp-s-07-01) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Respiratory Syncytial Virus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/rsv-positive-vp-07-01) - RSV Positive - VP-07-01
- [Influenza B Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-b-positive-swab-low-level-2/) - Microbix Respiratory NAAT Influenza B Positive Swab (Low Level) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza B Positive Swab (Low Level) External Quality Controls have verified performance with Cepheid Xpert®
- [Influenza B Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-b-positive-swab-2/) - Microbix Respiratory NAAT Influenza B Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza B Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress® SARS-COV-2/Flu/RSV/Assay, BD MAX™
- [Influenza B Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-b-positive-swab-vp-s-14-01) - Microbix Influenza B Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus desiccated on a Copan FLOQSwab®.
- [Influenza B Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-b-positive-vp-14-01/) - Influenza B Positive - VP-14-01
- [Influenza A Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-a-positive-swab-3/) - Microbix Respiratory NAAT Influenza A Positive Swab (Low Level) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus and human cells desiccated on a Copan FLOQSwab®. Microbix Respiratory NAAT Influenza A Positive Swab (Low Level) External Quality Controls have verified performance with Cepheid Xpert®
- [Influenza A Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-positive-swab-vp-s-13-01) - Microbix Influenza A Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus desiccated on a Copan FLOQSwab®. Microbix Influenza A Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV Assay, Sekisui Silaris™ Influenza A&B assay, Quidel Sofia 2
- [Influenza A Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-positive-vp-13-01/) - Influenza A Positive - VP-13-01
- [Human Metapneumovirus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/human-metapneumovirus-positive-swab) - Microbix Human Metapneumovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Human Metapneumovirus whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix Human Metapneumovirus Positive Swab External Quality Controls have verified performance with Seegene Respiratory Panel 2, BIOFIRE® Respiratory Panel 2.1,
- [Human Metapneumovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/human-metapneumovirus-positive) - Microbix Human Metapneumovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Human Metapneumovirus whole genome nucleic acid and human cells suspended in a proprietary buffer. Microbix Human Metapneumovirus Positive External Quality Controls have verified performance with Seegene Respiratory Panel 2 Assay, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE®
- [Enterovirus Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/enterovirus-positive-swab) - Microbix Enterovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Enterovirus whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix Enterovirus Positive Swab External Quality Controls have verified performance with Seegene Respiratory Panel 2, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE® Respiratory/Sore Throat
- [Enterovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/enterovirus-positive) - Microbix Enterovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Enterovirus whole genome nucleic acid and human cells suspended in a proprietary buffer. Microbix Enterovirus Positive External Quality Controls have verified performance with Seegene Respiratory Panel 2 Assay, BIOFIRE® Respiratory Panel 2.1, SPOTFIRE® Respiratory/Sore Throat (R/ST)
- [NAAT Negative Swab (PROCEEDx™FLOQ®)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/naat-negative-swab-proceedxtmfloq/) - Microbix SARS-CoV-2 Negative Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells desiccated on a Copan FLOQSwab®. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D applications. It is classified as Research Use Only (RUO).
- [SARS-CoV-2 Positive Swab (Ultra Low)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-sars-cov-2-positive-swab-ultra-low/) - Microbix Respiratory NAAT SARS-CoV-2 Positive Swab (Ultra Low) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and
- [Respiratory Negative Swab (REDx™FLOQ®)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/negative-swab-proceedxfloq/) - Our negative swab samples provide reliable control standards for laboratory testing protocols to ensure accurate results and quality assurance.
- [SARS-CoV-2 Negative](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-negative-2/) - Microbix SARS-CoV-2 Negative External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells suspended in ThinPrep® PreservCyt®. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D applications. It is classified as Research Use Only (RUO). Specifications Format:
- [Negative Sample (MDx)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/negative-sample-mdx/) - Microbix Negative Sample (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated human cells suspended in a proprietary buffer. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D applications. It is classified as Research Use Only
- [Negative Sample](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/negative-sample) - Our Negative Sample RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [SARS-CoV-2/FluA&B/RSV Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-fluab-rsv-positive-swab) - Microbix SARS-CoV-2/Flu A&B/RSV (Covid 19) Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. Contact us today for more information.
- [Influenza B and Rotavirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-b-rotavirus-positive) - Microbix Influenza B and Rotavirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus and Rotavirus suspended in a proprietary buffer. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D applications. It is
- [Influenza B and Adenovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-b-adenovirus-positive) - Microbix Influenza B and Adenovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus and Adenovirus suspended in a proprietary buffer. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D applications. It is
- [Influenza B and RSV Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-b-rsv-positive) - Microbix Influenza B and RSV Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus and Respiratory Syncytial Virus suspended in a proprietary buffer. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D applications.
- [Influenza A and Rotavirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-rotavirus-positive) - Microbix Influenza A and Rotavirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus and Rotavirus suspended in a proprietary buffer. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D applications. It is
- [Influenza A and Adenovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-adenovirus-positive) - Microbix Influenza A and Adenovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus and Adenovirus suspended in a proprietary buffer. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D applications. It is
- [Influenza A and RSV Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-rsv-positive) - Microbix Influenza A and RSV Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus and Respiratory Syncytial Virus (RSV) suspended in a proprietary buffer. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D
- [Adenovirus and Rotavirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/adenovirus-rotavirus-positive) - Microbix Adenovirus and Rotavirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Adenovirus and Rotavirus suspended in a proprietary buffer. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and R&D applications. It is classified as Research
- [SARS-CoV-2 B.1.1.529 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-b.1.1.529-positive-swab-2/) - Microbix SARS-CoV-2 B.1.1.529 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 B.1.1.529 whole genome and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 B.1.1.529 Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV Assay, Seegene Allplex™ 2019-nCov Assay, Seegene
- [SARS-CoV-2 B.1.617 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-b.1.617-positive-swab/) - Microbix SARS-CoV-2 B.1.617 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 B.1.617 whole genome and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 B.1.617 Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV Assay, EliTech Group SARS-CoV-2 Extended ELITe
- [SARS-CoV-2 P.1 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-p.1-positive-swab-2/) - Microbix SARS-CoV-2 P.1 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 P.1 whole genome and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 P.1 Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress® SARS-CoV-2/ Flu/RSV Assay, Seegene Allplex™ SARS-CoV-2 Variants
- [SARS-CoV-2 B.1.351 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-b.1.351-positive-swab-2/) - Microbix SARS-CoV-2 B.1.351 Positive Swab External Quality Controls are unassayed whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 whole genome and human cells, desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 B.1.351 Positive Swab External Quality Controls have verified performance with Abbott Alinity m SARS-CoV-2 Assay, Quidel Lyra SARS-CoV-2 Assay, BD Max™
- [SARS-CoV-2 B.1.1.7 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-b.1.1.7-positive-swab-2/) - Microbix SARS-CoV-2 B.1.1.7 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 B.1.1.7 whole genome and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2 B.1.1.7 Positive Swab External Quality Controls have verified performance with Abbott Alinity m SARS-CoV-2 Assay, Quidel Lyra SARS-CoV-2 Assay, BD
- [SARS-CoV-2 Ag Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-ag-positive-swab-vp-s-19-02-2/) - Microbix SARS-CoV-2-Ag Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 nucleocapsid (N) protein desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2- Ag Positive External Quality Controls have verified performance with BD Veritor™ COVID-19 Rapid Antigen Test, Quidel Sofia 2 Flu + SARS Antigen FIA, Abbott
- [SARS-CoV-2 Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/proceedxfloq-sars-cov-2-swab-2/) - Microbix SARS-CoV-2-Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with SARS-CoV-2 whole genome nucleic acid and human cells desiccated on a Copan FLOQSwab®. Microbix SARS-CoV-2-Positive External Quality Controls have verified performance with Abbott ID NOW™ COVID-19 Assay, BD Max™ SARS-CoV-2 Assay, Cepheid Xpert® Xpress SARS-CoV-2 assay,
- [SARS-CoV-2 Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/sars-cov-2-positive-2/) - Microbix SARS-CoV-2-Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated SARS-CoV-2 whole genome nucleic acid and human cells suspended in ThinPrep® PreservCyt®. Microbix SARS-CoV-2-Positive External Quality Controls have verified performance with Cepheid Xpert® Xpress SARS-CoV-2 Assay, Cepheid Xpert® Xpress SARS-CoV-2/ Flu/RSV Assay, BD MAX™ SARS-CoV-2 Assay,
- [Respiratory Syncytial Virus Positive Swab (Ultra Low)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-rsv-positive-swab-ultra-low/) - Microbix Respiratory NAAT RSV Positive Swab (Ultra Low) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Respiratory Syncytial Virus (RSV) and human cells desiccated on a Copan FLOQSwab®. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and
- [Respiratory Syncytial Virus Positive (MDx)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-syncytial-virus-positive-mdx) - Microbix RSV Positive (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Respiratory Syncytial Virus (RSV) and human cells suspended in a proprietary buffer. Microbix RSV Positive (MDx) External Quality Controls have verified performance with BD MAX™ Respiratory Viral Panel, Roche cobas® LIAT system, Cepheid Xpert®
- [Parainfluenza 3 Virus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/parainfluenza-3-positive/) - Microbix Parainfluenza 3 Virus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Parainfluenza virus type 3 and human cells suspended in a proprietary buffer. Microbix Parainfluenza 3 Positive External Quality Controls have verified performance on various IVD assays, such as Luminex NxTAG® Respiratory Pathogen Panel,
- [Influenza B Positive Swab (Ultra Low)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-b-naat-positive-swab-ultra-low/) - Microbix Respiratory NAAT Influenza B Positive Swab (Ultra Low) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus and human cells desiccated on a Copan FLOQSwab®. Intended UseThe product is intended for verification and validation studies, manufacturing quality management systems (QMS), operator training, and
- [Influenza B Positive (MDx)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-b-positive-mdx) - Microbix Influenza B Positive (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza B virus and human cells suspended in a proprietary buffer. Microbix Influenza B Positive (MDx) External Quality Controls have verified performance with BD MAX™ Respiratory Viral Panel, Roche cobas® SARS-CoV-2 & Flu
- [Influenza A Positive Swab (Ultra Low)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-naat-positive-swab-ultra-low/) - Frequently Asked Questions What is the shelf life of your Influenza A NAAT samples?Our RUO PROCEEDx™ Influenza A positive sample products have a shelf life of two years from the date of manufacturing. Do you offer bulk purchase options for your Influenza A NAAT positive swabs?Yes, please contact Microbix’s Customer Service for custom orders. Are
- [Influenza A Positive Swab](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/respiratory-naat-influenza-a-positive-swab-2/) - Microbix Respiratory NAAT Influenza A Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus and human cells desiccated on a Copan FLOQSwab®. Microbix NAAT Influenza A Positive Swab External Quality Controls have verified performance with Cepheid Xpert® Xpress® SARS-COV-2/Flu/RSV/Assay, BD MAX™ Respiratory
- [Influenza A Positive (MDx)](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/influenza-a-positive-mdx) - Microbix Influenza A Positive (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Influenza A virus and human cells suspended in a proprietary buffer. Microbix Influenza A Positive (MDx) External Quality Controls have verified performance with BD MAX™ Respiratory Viral Panel, Roche cobas® SARS-CoV-2 & Flu
- [Adenovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/adenovirus-positive) - Microbix Adenovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Adenovirus suspended in a proprietary buffer. Microbix Adenovirus Positive External Quality Controls have verified performance on various IVD assays, such as SA Scientific SAS™ Adeno Test, and more. Intended UseThe product is intended for verification
- [<i>Campylobacter jejuni</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/campylobacter-jejuni-positive-swab/) - Home / External Quality Controls (Infectious Disease Quality Controls) / Gastrointestinal Panel / Campylobacter jejuni Positive Swab Campylobacter jejuni Positive Swab SKU: VP-S-123-01 Categories: All products, External Quality Controls (Infectious Disease Quality Controls), Gastrointestinal Panel Related products
- [<i>Cryptosporidium parvum</i> Positive Swab (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/cryptosporidium-parvum-positive-swab-mdx) - Cryptosporidium parvum Positive - RED-37-01
- [<i>Cryptosporidium parvum</i> Positive (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/cryptosporidium-parvum-positive-mdx) - Cryptosporidium parvum Positive - RED-37-01
- [<i>Cryptosporidium parvum</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/cryptosporidium-parvum-positive-vp-37-01) - Cryptosporidium parvum Positive - VP-37-01
- [<i>Cryptosporidium parvum</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/cryptosporidium-parvum-positive-red-37-01) - Cryptosporidium parvum Positive - RED-37-01
- [<i>Cryptosporidium parvum</i> Positive (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/cryptosporidium-parvum-positive-mdx-red) - Microbix Cryptosporidium parvum Positive (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Cryptosporidium parvum suspended in a proprietary buffer. Microbix Cryptosporidium parvum Positive External Quality Controls have verified performance with Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite Panel, BioFire® FilmArray® Gastrointestinal Panel, Cepheid Xpert® GI
- [<i>Cryptosporidium parvum</i> Positive Swab (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/cryptosporidium-parvum-positive-swab-mdx-red) - Microbix Cryptosporidium parvum Positive Swab (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Cryptosporidium parvum desiccated on a Copan FLOQSwab®. Microbix Cryptosporidium parvum Positive Swab (MDx) External Quality Controls have verified performance on various IVD assays, such as Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite
- [<i>Campylobacter jejuni</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/campylobacter-jejuni-positive/) - Microbix Campylobacter jejuni Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Campylobacter jejuni suspended in a proprietary buffer. Microbix Campylobacter jejuni Positive External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP on BD
- [<i>Campylobacter</i> Positive Quality Control](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/campylobacter-omp-positive-swab) - Microbix campylobacter OMP Positive Swab External Quality Controls are unassayed, whole workflow samples that simulate clinical specimens. Contact us today for more information.
- [Rotavirus RSV Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/rsv-rotavirus-positive) - Microbix Rotavirus RSV Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated native Respiratory Syncytial Virus and Rotavirus, suspended in a proprietary buffer.
- [Norovirus GII Ag Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gii-ag-positive-swab/) - Microbix Norovirus GII Ag Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Norovirus GII.4 recombinant P domain protein desiccated on a Copan FLOQSwab®. Microbix Norovirus GII Ag Positive Swab External Quality Controls have verified performance on various assays, such as R-Biopharm RIDA®QUICK Norovirus Test, R-Biopharm
- [Norovirus GII Ag Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gii-ag-positive-swab-red/) - Microbix Norovirus GII Ag Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Norovirus GII.4 recombinant P domain protein desiccated on a Copan FLOQSwab®. Microbix Norovirus GII Ag Positive Swab External Quality Controls have verified performance on various assays, such as R-Biopharm RIDA®QUICK Norovirus Test, R-Biopharm
- [Norovirus GI Ag Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gi-ag-positive-swab/) - Microbix Norovirus GI Ag Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Norovirus GI.1 recombinant P domain protein desiccated on a Copan FLOQSwab®. Microbix Norovirus GI Ag Positive Swab External Quality Controls have verified performance on various assays, such as R-Biopharm RIDA®QUICK Norovirus Test, R-Biopharm
- [Norovirus GI Ag Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gi-ag-positive-swab-red/) - Microbix Norovirus GI Ag Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Norovirus GI.1 recombinant P domain protein desiccated on a Copan FLOQSwab®. Microbix Norovirus GI Ag Positive Swab External Quality Controls have verified performance on various assays, such as R-Biopharm RIDA®QUICK Norovirus Test, R-Biopharm
- [REDx™FLOQ<span class="trademark">®</span> SARS-CoV-2 Swab Negative Control](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/naat-negative-swab-proceedxtmfloq-red/) - Microbix NAAT Negative Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells desiccated on Copan FLOQSwab®. Intended Use The product is an unassayed control designed for ongoing external quality control, benchmarking laboratory testing performance, and end-to-end workflow evaluation. Specifications Format: Copan FLOQSwab® Storage Conditions: 2-30°C
- [<i>Yersinia enterocolitica</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/yersinia-enterocolitica-positive-red/) - Microbix Yersinia enterocolitica Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Yersinia enterocolitica suspended in a proprietary buffer. Microbix Yersinia enterocolitica Positive External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and EBP plus
- [<i>Yersinia enterocolitica</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/yersinia-enterocolitica-positive-swab-red/) - Microbix Yersinia enterocolitica Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Yersinia enterocolitica desiccated on a Copan FLOQSwab®. Microbix Yersinia enterocolitica Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and
- [<i>Vibrio parahaemolyticus</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/vibrio-parahaemolyticus-positive-red/) - Microbix Vibrio parahaemolyticus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Vibrio parahaemolyticus suspended in a proprietary buffer. Microbix Vibrio parahaemolyticus Positive External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and EBP plus
- [<i>Vibrio parahaemolyticus</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/vibrio-parahaemolyticus-positive-swab-red/) - Microbix Vibrio parahaemolyticus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Vibrio parahaemolyticus desiccated on a Copan FLOQSwab®. Microbix Vibrio parahaemolyticus Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and
- [<i>Shigella sonnei</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/shigella-sonnei-positive-red/) - Microbix Shigella sonnei Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Shigella sonnei suspended in a proprietary buffer. Microbix Shigella sonnei Positive External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP on BD
- [<i>Shigella sonnei</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/shigella-sonnei-positive-swab-red/) - Microbix Shigella sonnei Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Shigella sonnei desiccated on a Copan FLOQSwab®. Microbix Shigella sonnei Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP
- [<i>Salmonella enteritidis</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/salmonella-enteritidis-positive-red/) - Microbix Salmonella enteritidis Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Salmonella enteritidis suspended in a proprietary buffer. Microbix Salmonella enteritidis Positive External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP on BD
- [<i>Salmonella enteritidis</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/salmonella-enteritidis-positive-swab-red/) - Microbix Salmonella enteritidis Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Salmonella enteritidis desiccated on a Copan FLOQSwab®. Microbix Salmonella enteritidis Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP
- [<i>Plesiomonas shigelloides</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/plesiomonas-shigelloides-positive-red/) - Microbix Plesiomonas shigelloides Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Plesiomonas shigelloides suspended in a proprietary buffer. Microbix Plesiomonas shigelloides Positive External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and EBP plus
- [<i>Plesiomonas shigelloides</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/plesiomonas-shigelloides-positive-swab-red/) - Microbix Plesiomonas shigelloides Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Plesiomonas shigelloides desiccated on a Copan FLOQSwab®. Microbix Plesiomonas shigelloides Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and
- [<i>H. pylori</i> A2143G Clarithromycin Resistant Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/h-pylori-a2143g-clarithromycin-resistant-positive-swab-red/) - Microbix H. pylori A2143G Clarithromycin Resistant Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated H. pylori desiccated on a Copan FLOQSwab® with A2143G point mutation in the 23S rRNA gene. Microbix H. pylori A2143G Clarithromycin Resistant Positive Swab External Quality Controls have verified performance
- [<i>H. pylori</i> Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/h-pylori-positive-swab-low-level-red/) - Microbix H. pylori Positive Swab (Low Level) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated H. pylori desiccated on a Copan FLOQSwab®. Microbix H. pylori Positive Swab (Low Level) External Quality Controls have verified performance on various assays, such as Seegene Novaplex™ H. pylori & ClariR
- [<i>H. pylori</i> Positive Swab (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/h-pylori-positive-swab-mdx-red/) - Microbix H. pylori Positive Swab (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated H. pylori desiccated on a Copan FLOQSwab®. Microbix H. pylori Positive Swab (MDx) External Quality Controls have verified performance on various assays, such as Seegene Novaplex™ H. pylori & ClariR Assay, Mobidiag
- [<i>Clostridium difficile</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/clostridium-difficile-positive-swab-red/) - Microbix Clostridium difficile Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Clostridium difficile desiccated on a Copan FLOQSwab®. Microbix Clostridium difficile Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Cdiff Assay, BioFire® FILMARRAY® Gastrointestinal Panel, R-Biopharm
- [<i>Campylobacter jejuni</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/campylobacter-jejuni-positive-swab-red/) - Microbix Campylobacter jejuni Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Campylobacter jejuni desiccated on a Copan FLOQSwab®. Microbix Campylobacter jejuni Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP
- [REDx™FLOQ<span class="trademark">®</span> SARS-CoV-2 Swab Negative Control](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/naat-negative-swab-proceedxtmfloq-red-2/) - Microbix NAAT Negative Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells desiccated on Copan FLOQSwab®. Intended Use The product is an unassayed control designed for ongoing external quality control, benchmarking laboratory testing performance, and end-to-end workflow evaluation. Specifications Format: Copan FLOQSwab® Storage Conditions: 2-30°C
- [<i>Giardia lamblia</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/giardia-lamblia-positive-vp-38-01) - Giardia lamblia Positive - VP-38-01
- [<i>Giardia lamblia</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/giardia-lamblia-positive-vp-38-01-red) - Microbix Giardia lamblia Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Giardia lamblia suspended in a proprietary buffer. Microbix Giardia lamblia Positive External Quality Controls have verified performance with Meridian Bioscience ImmunoCard STAT® Crypto/Giardia Rapid Assay, BioFire® FilmArray® Gastrointestinal Panel, and more. Intended Use The
- [Rotavirus Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/rotavirus-positive-2) - Microbix Rotavirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Rotavirus suspended in a proprietary buffer. Microbix Rotavirus Positive External Quality Controls have verified performance on various immunoassays such as SAS Rotavirus Test, and more. Intended Use The product is an unassayed control designed for
- [Enteric Viral Panel Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-viral-panel-positive/) - Microbix Enteric Viral Panel Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic whole-genome Adenovirus, Astrovirus, Norovirus GI, Norovirus GII, Sapovirus, and Rotavirus suspended in a proprietary buffer. Microbix Enteric Viral Panel Positive External Quality Controls have verified performance on various IVD assays, such as BD
- [Enteric Viral Panel Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-viral-panel-positive-red/) - Microbix Enteric Viral Panel Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic whole-genome Adenovirus, Astrovirus, Norovirus GI, Norovirus GII, Sapovirus, and Rotavirus suspended in a proprietary buffer. Microbix Enteric Viral Panel Positive External Quality Controls have verified performance on various IVD assays, such as BD
- [Enteric Viral Panel Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-viral-panel-positive-swab-red/) - Microbix Enteric Viral Panel Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Adenovirus, Astrovirus, Norovirus GI & GII, Sapovirus, and Rotavirus desiccated on a Copan FLOQSwab®. Microbix Enteric Viral Panel Positive Swab External Quality Controls have verified performance on various IVD assays, such
- [Enteric Viral Panel Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-viral-panel-positive-swab/) - Microbix Enteric Viral Panel Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Adenovirus, Astrovirus, Norovirus GI & GII, Sapovirus, and Rotavirus desiccated on a Copan FLOQSwab®. Microbix Enteric Viral Panel Positive Swab External Quality Controls have verified performance on various IVD assays, such
- [Sapovirus Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/sapovirus-positive/) - Microbix Sapovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Sapovirus suspended in a proprietary buffer. Microbix Sapovirus Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™ GI-Viral Assay
- [Sapovirus Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/sapovirus-positive-red/) - Microbix Sapovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Sapovirus suspended in a proprietary buffer. Microbix Sapovirus Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™ GI-Viral Assay
- [Sapovirus Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/sapovirus-positive-swab/) - Microbix Sapovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Sapovirus desiccated on a Copan FLOQSwab®. Microbix Sapovirus Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™
- [Sapovirus Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/sapovirus-positive-swab-red/) - Microbix Sapovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Sapovirus desiccated on a Copan FLOQSwab®. Microbix Sapovirus Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™
- [Rotavirus Quality Control](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/rotavirus-positive) - Microbix Rotavirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Rotavirus suspended in a proprietary buffer. Contact us for more information.
- [Rotavirus Positive (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/rotavirus-positive-mdx/) - Microbix Rotavirus Positive (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Rotavirus suspended in a proprietary buffer. Microbix Rotavirus Positive (MDx) External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel Assay, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene
- [Rotavirus Positive (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/rotavirus-positive-mdx-red/) - Microbix Rotavirus Positive (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Rotavirus suspended in a proprietary buffer. Microbix Rotavirus Positive (MDx) External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel Assay, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene
- [Rotavirus Positive Swab (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/rotavirus-positive-swab-mdx/) - Microbix Rotavirus Positive Swab (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Rotavirus desiccated on a Copan FLOQSwab®. Microbix Rotavirus Positive Swab (MDx) External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel,
- [Rotavirus Positive Swab (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/rotavirus-positive-swab-mdx-red/) - Microbix Rotavirus Positive Swab (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Rotavirus desiccated on a Copan FLOQSwab®. Microbix Rotavirus Positive Swab (MDx) External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel,
- [Norovirus GII Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gii-positive/) - Microbix Norovirus GII Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Norovirus GII suspended in a proprietary buffer. Microbix Norovirus GII Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene
- [Norovirus GII Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gii-positive-red/) - Norovirus GI Microbix Norovirus GII Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Norovirus GII suspended in a proprietary buffer. Microbix Norovirus GII Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal
- [Norovirus GI Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gi-positive/) - Microbix Norovirus GI Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Norovirus GI suspended in a proprietary buffer. Microbix Norovirus GI Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene
- [Norovirus GI Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gi-positive-red/) - Microbix Norovirus GI Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Norovirus GI suspended in a proprietary buffer. Microbix Norovirus GI Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene
- [Norovirus GII Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gii-positive-swab/) - Microbix Norovirus GII Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Norovirus GII desiccated on a Copan FLOQSwab®. Microbix Norovirus GII Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal
- [Norovirus GII Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gii-positive-swab-red/) - Microbix Norovirus GII Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Norovirus GII desiccated on a Copan FLOQSwab®. Microbix Norovirus GII Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal
- [Norovirus GI Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gi-positive-swab-red/) - Microbix Norovirus GI Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Norovirus GI desiccated on a Copan FLOQSwab®. Microbix Norovirus GI Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal
- [Norovirus GI Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/norovirus-gi-positive-swab/) - Microbix Norovirus GI Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Norovirus GI desiccated on a Copan FLOQSwab®. Microbix Norovirus GI Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal
- [Astrovirus Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/astrovirus-positive/) - Microbix Astrovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Astrovirus suspended in a proprietary buffer. Microbix Astrovirus Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™ GI-Viral Assay
- [Astrovirus Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/astrovirus-positive-red/) - Microbix Astrovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Astrovirus suspended in a proprietary buffer. Microbix Astrovirus Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™ GI-Viral Assay
- [Astrovirus Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/astrovirus-positive-swab/) - Microbix Astrovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Astrovirus desiccated on a Copan FLOQSwab®. Microbix Astrovirus Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™
- [Astrovirus Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/astrovirus-positive-swab-red/) - Microbix Astrovirus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic, whole-genome Astrovirus desiccated on a Copan FLOQSwab®. Microbix Astrovirus Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™
- [Adenovirus F40/41 Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/adenovirus-f40-41-positive/) - Microbix Adenovirus F40/41 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic whole-genome Adenovirus suspended in a proprietary buffer. Microbix Adenovirus F40/41 Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™
- [Adenovirus F40/41 Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/adenovirus-f40-41-positive-red/) - Microbix Adenovirus F40/41 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic whole-genome Adenovirus suspended in a proprietary buffer. Microbix Adenovirus F40/41 Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel, Seegene Novaplex™
- [Adenovirus F40/41 Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/adenovirus-f40-41-positive-swab/) - Microbix Adenovirus F40/41 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic whole-genome Adenovirus desiccated on a Copan FLOQSwab®. Microbix Adenovirus F40/41 Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel,
- [Adenovirus F40/41 Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/adenovirus-f40-41-positive-swab-red/) - Microbix Adenovirus F40/41 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic whole-genome Adenovirus desiccated on a Copan FLOQSwab®. Microbix Adenovirus F40/41 Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Enteric Viral Panel, BioFire® FILMARRAY® Gastrointestinal Panel,
- [<i>H. pylori</i> Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/h-pylori-positive-swab-low-level/) - Microbix H. pylori Positive Swab (Low Level) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated H. pylori desiccated on a Copan FLOQSwab®. Microbix H. pylori Positive Swab (Low Level) External Quality Controls have verified performance on various assays, such as Seegene Novaplex™ H. pylori & ClariR
- [<i>H. pylori</i> A2143G Clarithromycin Resistant Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/h-pylori-a2143g-clarithromycin-resistant-positive-swab/) - Microbix H. pylori A2143G Clarithromycin Resistant Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated H. pylori desiccated on a Copan FLOQSwab® with A2143G point mutation in the 23S rRNA gene. Microbix H. pylori A2143G Clarithromycin Resistant Positive Swab External Quality Controls have verified performance
- [<i>Clostridium difficile</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/clostridium-difficile-positive-red/) - Microbix Clostridium difficile Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Clostridium difficile suspended in a proprietary buffer. Microbix Clostridium difficile Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Cdiff Assay, BioFire® FILMARRAY® Gastrointestinal Panel, R-Biopharm RIDA®UNITY C.
- [<i>Clostridium difficile</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/clostridium-difficile-positive/) - Microbix Clostridium difficile Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Clostridium difficile suspended in a proprietary buffer. Microbix Clostridium difficile Positive External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Cdiff Assay, BioFire® FILMARRAY® Gastrointestinal Panel, R-Biopharm RIDA®UNITY C.
- [<i>C. difficile</i> GDH/Toxin A/Toxin B Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/c-difficile-gdh-toxin-a-toxin-b-positive-swab-2/) - Our C.difficile GDH/Toxin A/ Toxin B Positive Swab RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [<i>Yersinia enterocolitica</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/yersinia-enterocolitica-positive/) - Microbix Yersinia enterocolitica Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Yersinia enterocolitica suspended in a proprietary buffer. Microbix Yersinia enterocolitica Positive External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and EBP plus
- [<i>Yersinia enterocolitica</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/yersinia-enterocolitica-positive-swab/) - Microbix Yersinia enterocolitica Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Yersinia enterocolitica desiccated on a Copan FLOQSwab®. Microbix Yersinia enterocolitica Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and
- [<i>Vibrio parahaemolyticus</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/vibrio-parahaemolyticus-positive/) - Microbix Vibrio parahaemolyticus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Vibrio parahaemolyticus suspended in a proprietary buffer. Microbix Vibrio parahaemolyticus Positive External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and EBP plus
- [<i>Vibrio parahaemolyticus</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/vibrio-parahaemolyticus-positive-swab/) - Microbix Vibrio parahaemolyticus Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Vibrio parahaemolyticus desiccated on a Copan FLOQSwab®. Microbix Vibrio parahaemolyticus Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and
- [<i>Shigella sonnei</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/shigella-sonnei-positive/) - Microbix Shigella sonnei Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Shigella sonnei suspended in a proprietary buffer. Microbix Shigella sonnei Positive External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP on BD
- [<i>Shigella sonnei</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/shigella-sonnei-positive-swab/) - Microbix Shigella sonnei Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Shigella sonnei desiccated on a Copan FLOQSwab®. Microbix Shigella sonnei Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP
- [<i>Salmonella enteritidis</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/salmonella-enteritidis-positive/) - Microbix Salmonella enteritidis Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Salmonella enteritidis suspended in a proprietary buffer. Microbix Salmonella enteritidis Positive External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP on BD
- [<i>Salmonella enteritidis</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/salmonella-enteritidis-positive-swab/) - Microbix Salmonella enteritidis Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Salmonella enteritidis desiccated on a Copan FLOQSwab®. Microbix Salmonella enteritidis Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP
- [<i>Plesiomonas shigelloides</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/plesiomonas-shigelloides-positive/) - Microbix Plesiomonas shigelloides Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Plesiomonas shigelloides suspended in a proprietary buffer. Microbix Plesiomonas shigelloides Positive External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and EBP plus
- [<i>Plesiomonas shigelloides</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/plesiomonas-shigelloides-positive-swab/) - Microbix Plesiomonas shigelloides Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Plesiomonas shigelloides desiccated on a Copan FLOQSwab®. Microbix Plesiomonas shigelloides Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and
- [<i>H. pylori</i> Positive Swab (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/h-pylori-positive-swab-mdx/) - Microbix H. pylori Positive Swab (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated H. pylori desiccated on a Copan FLOQSwab®. Microbix H. pylori Positive Swab (MDx) External Quality Controls have verified performance on various assays, such as Seegene Novaplex™ H. pylori & ClariR Assay, Mobidiag
- [<i>Clostridium difficile</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/clostridium-difficile-positive-swab/) - Microbix Clostridium difficile Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Clostridium difficile desiccated on a Copan FLOQSwab®. Microbix Clostridium difficile Positive Swab External Quality Controls have verified performance on various IVD assays, such as BD MAX™ Cdiff Assay, BioFire® FILMARRAY® Gastrointestinal Panel, R-Biopharm
- [<i>Giardia lamblia</i> Positive Swab (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/giardia-lamblia-positive-swab-mdx-red) - Microbix Giardia lamblia Positive Swab (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Giardia lamblia desiccated on a Copan FLOQSwab®. Microbix Giardia lamblia Positive Swab (MDx) External Quality Controls have verified performance on various IVD assays, such as Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite
- [<i>Entamoeba histolytica</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/entamoeba-histolytica-positive-red) - Microbix Entamoeba histolytica Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Entamoeba histolytica partial genome suspended in a proprietary buffer. Microbix Entamoeba histolytica Positive External Quality Controls have verified performance with Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite Panel, BioFire® FilmArray® Gastrointestinal Panel, and more. Intended
- [<i>Entamoeba histolytica</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/entamoeba-histolytica-positive-swab-red) - Microbix Entamoeba histolytica Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic Entamoeba histolytica partial genome desiccated on a Copan FLOQSwab®. Microbix Entamoeba histolytica Positive Swab External Quality Controls have verified performance on various IVD assays, such as Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite
- [<i>Giardia lamblia</i> Positive (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/giardia-lamblia-positive-mdx-red) - Microbix Giardia lamblia (MDx) Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Giardia lamblia suspended in a proprietary buffer. Microbix Giardia lamblia Positive External Quality Controls have verified performance with Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite Panel, BioFire® FilmArray® Gastrointestinal Panel, Cepheid Xpert® GI
- [Enteric Parasite Panel Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-parasite-panel-positive-red) - Microbix Enteric Parasite Panel Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Cryptosporidium parvum, Giardia lamblia, and synthetic Entamoeba histolytica partial genome suspended in a proprietary buffer. Microbix Enteric Parasite Panel Positive External Quality Controls have verified performance with Seegene GI-Parasite Assay, BD MAX™ Enteric
- [Enteric Parasite Panel Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-parasite-panel-positive-swab-red) - Microbix Enteric Parasite Panel Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Cryptosporidium parvum, Giardia lamblia, and synthetic Entamoeba histolytica partial genome desiccated on a Copan FLOQSwab®. Microbix Enteric Parasite Panel Positive Swab External Quality Controls have verified performance with Seegene GI-Parasite Assay, BD
- [<i>Cryptosporidium parvum</i> + <i>Giardia lamblia</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/cryptosporidium-parvum-giardia-lamblia-positive-vp-37-02-red) - Microbix Cryptosporidium parvum and Giardia lamblia Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Cryptosporidium parvum and Giardia lamblia suspended in a proprietary buffer. Microbix Cryptosporidium parvum and Giardia lamblia Positive External Quality Controls have verified performance with Meridian Bioscience™ Immunocard STAT® Crypto/Giardia Rapid Assay,
- [Negative Sample](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/negative-sample-red) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Enteric Bacterial Panel 1 Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-bacterial-panel-1-positive-swab-red/) - Microbix Enteric Bacterial Panel 1 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Campylobacter jejuni, Salmonella enteritidis, Shigella sonnei, and Shiga-toxin producing E. coli (STEC) desiccated on a Copan FLOQSwab®. Microbix Enteric Bacterial Panel 1 Positive Swab External Quality Controls have verified performance on
- [Enteric Bacterial Panel 1 Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-bacterial-panel-1-positive-red/) - Microbix Enteric Bacterial Panel 1 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Campylobacter jejuni, Salmonella enteritidis, Shigella sonnei, and Shiga-toxin producing E. coli (STEC) suspended in a proprietary buffer. Microbix Enteric Bacterial Panel 1 Positive External Quality Controls have verified performance on various IVD
- [Enteric Bacterial Panel 2 Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-bacterial-panel-2-positive-swab-red/) - Microbix Enteric Bacterial Panel 2 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Vibrio parahaemolyticus, Yersinia enterocolitica, Enterotoxigenic E. coli, and Plesiomonas shigelloides desiccated on a Copan FLOQSwab®. Microbix Enteric Bacterial Panel 2 Positive Swab External Quality Controls have verified performance on various IVD
- [Enteric Bacterial Panel 2 Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-bacterial-panel-2-positive-red/) - Microbix Enteric Bacterial Panel 2 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Vibrio parahaemolyticus, Yersinia enterocolitica, Enterotoxigenic E. coli, and Plesiomonas shigelloides suspended in a proprietary buffer. Microbix Enteric Bacterial Panel 2 Positive External Quality Controls have verified performance on various IVD assays, such
- [Rotavirus Quality Control](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/rotavirus-positive-red) - u003ch2 style=u0022text-align: center;u0022u003eu003cstrongu003eFrequently Asked Questionsu003c/strongu003eu003c/h2u003e What is the shelf life of your Rotavirus positive control?u003cpu003eOur RUO PROCEEDx™ Rotavirus positive sample products have a shelf life of two years from the date of manufacturing. u003c/pu003e Do you provide technical support if I encounter an issue with your control samples?u003cpu003eYes, please u003ca href=u0022https://microbix.com/contactu0022u003econtact Customer Serviceu003c/au003e for technical
- [<i>Campylobacter jejuni</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/campylobacter-jejuni-positive-red/) - Microbix Campylobacter jejuni Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Campylobacter jejuni suspended in a proprietary buffer. Microbix Campylobacter jejuni Positive External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and EBP on BD
- [Enterotoxigenic E. coli Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enterotoxigenic-e-coli-positive-swab-red/) - Microbix Enterotoxigenic E. coli Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Enterotoxigenic E. coli desiccated on a Copan FLOQSwab®. Microbix Enterotoxigenic E. coli Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on
- [Enterotoxigenic E. coli Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enterotoxigenic-e-coli-positive-red/) - Microbix Enterotoxigenic E. coli Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Enterotoxigenic E. coli suspended in proprietary buffer. Microbix Enterotoxigenic E. coli Positive External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and
- [<i>H. pylori</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/h-pylori-positive-swab-red/) - Microbix H. pylori Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with H. pylori recombinant outer membrane protein desiccated on a Copan FLOQSwab®. Microbix H. pylori Positive Swab External Quality Controls have verified performance on various assays, such as CerTest H. Pylori test kit, and more.
- [Shiga toxin-producing E. coli Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/shiga-toxin-producing-e-coli-positive-swab-red/) - Microbix Shiga toxin-producing E. coli Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated STEC desiccated on a Copan FLOQSwab®. Microbix Shiga toxin-producing E. coli Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD
- [Shiga toxin-producing E. coli Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/shiga-toxin-producing-e-coli-positive-red/) - Microbix Shiga toxin-producing E. coli Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated STEC suspended in a proprietary buffer. Microbix Shiga toxin-producing E. coli Positive External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and
- [<i>Cryptosporidium parvum</i> + <i>Giardia lamblia</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/cryptosporidium-parvum-giardia-lamblia-positive-vp-37-02) - Cryptosporidium parvum + Giardia lamblia Positive - VP-37-02
- [Enteric Parasite Panel Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-parasite-panel-positive) - Microbix Enteric Parasite Panel Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Cryptosporidium parvum, Giardia lamblia, and synthetic Entamoeba histolytica partial genome suspended in a proprietary buffer. Microbix Enteric Parasite Panel Positive External Quality Controls have verified performance with Seegene GI-Parasite Assay, BD MAX™ Enteric
- [Enteric Parasite Panel Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-parasite-panel-positive-swab) - Microbix Enteric Parasite Panel Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Cryptosporidium parvum, Giardia lamblia, and synthetic Entamoeba histolytica partial genome desiccated on a Copan FLOQSwab®. Microbix Enteric Parasite Panel Positive Swab External Quality Controls have verified performance with Seegene GI-Parasite Assay, BD
- [<i>Giardia lamblia</i> Positive (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/giardia-lamblia-positive-mdx) - Microbix Giardia lamblia (MDx) Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Giardia lamblia suspended in a proprietary buffer. Microbix Giardia lamblia Positive External Quality Controls have verified performance with Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite Panel, BioFire® FilmArray® Gastrointestinal Panel, Cepheid Xpert® GI
- [<i>Giardia lamblia</i> Positive Swab (MDx)](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/giardia-lamblia-positive-swab-mdx) - Microbix Giardia lamblia Positive Swab (MDx) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Giardia lamblia desiccated on a Copan FLOQSwab®. Microbix Giardia lamblia Positive Swab (MDx) External Quality Controls have verified performance on various IVD assays, such as Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite
- [<i>Entamoeba histolytica</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/entamoeba-histolytica-positive) - Microbix Entamoeba histolytica Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Entamoeba histolytica partial genome suspended in a proprietary buffer. Microbix Entamoeba histolytica Positive External Quality Controls have verified performance with Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite Panel, BioFire® FilmArray® Gastrointestinal Panel, and more. Intended
- [<i>Entamoeba histolytica</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/entamoeba-histolytica-positive-swab) - Microbix Entamoeba histolytica Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with synthetic Entamoeba histolytica partial genome desiccated on a Copan FLOQSwab®. Microbix Entamoeba histolytica Positive Swab External Quality Controls have verified performance on various IVD assays, such as Seegene GI-Parasite Assay, BD MAX™ Enteric Parasite
- [Enteric Bacterial Panel 2 Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-bacterial-panel-2-positive/) - Microbix Enteric Bacterial Panel 2 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Vibrio parahaemolyticus, Yersinia enterocolitica, Enterotoxigenic E. coli, and Plesiomonas shigelloides suspended in a proprietary buffer. Microbix Enteric Bacterial Panel 2 Positive External Quality Controls have verified performance on various IVD assays, such
- [Enteric Bacterial Panel 2 Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-bacterial-panel-2-positive-swab/) - Microbix Enteric Bacterial Panel 2 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Vibrio parahaemolyticus, Yersinia enterocolitica, Enterotoxigenic E. coli, and Plesiomonas shigelloides desiccated on a Copan FLOQSwab®. Microbix Enteric Bacterial Panel 2 Positive Swab External Quality Controls have verified performance on various IVD
- [Enteric Bacterial Panel 1 Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-bacterial-panel-1-positive/) - Microbix Enteric Bacterial Panel 1 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Campylobacter jejuni, Salmonella enteritidis, Shigella sonnei, and Shiga-toxin producing E. coli (STEC) suspended in a proprietary buffer. Microbix Enteric Bacterial Panel 1 Positive External Quality Controls have verified performance on various IVD
- [Enteric Bacterial Panel 1 Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enteric-bacterial-panel-1-positive-swab/) - Microbix Enteric Bacterial Panel 1 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Campylobacter jejuni, Salmonella enteritidis, Shigella sonnei, and Shiga-toxin producing E. coli (STEC) desiccated on a Copan FLOQSwab®. Microbix Enteric Bacterial Panel 1 Positive Swab External Quality Controls have verified performance on
- [<i>H. pylori</i> Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/h-pylori-positive-swab/) - Our H. pylori Positive Swab RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [<i>C.difficile</i> GDH Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/c-difficile-gdh-positive-swab) - Microbix C.difficile GDH Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with Glutamate Dehydrogenase (GDH) desiccated on a Copan FLOQSwab®.
- [Shiga toxin-producing E. coli Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/shiga-toxin-producing-e-coli-positive/) - Microbix Shiga toxin-producing E. coli Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated STEC suspended in a proprietary buffer. Microbix Shiga toxin-producing E. coli Positive External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD MAX™ and
- [Shiga toxin-producing E. coli Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/shiga-toxin-producing-e-coli-positive-swab/) - Microbix Shiga toxin-producing E. coli Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated STEC desiccated on a Copan FLOQSwab®. Microbix Shiga toxin-producing E. coli Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Enteric Bacterial Panel on BD
- [Enterotoxigenic E. coli Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enterotoxigenic-e-coli-positive/) - Microbix Enterotoxigenic E. coli Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Enterotoxigenic E. coli suspended in proprietary buffer. Microbix Enterotoxigenic E. coli Positive External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on BD MAX™ and
- [Enterotoxigenic E. coli Positive Swab](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/enterotoxigenic-e-coli-positive-swab/) - Microbix Enterotoxigenic E. coli Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Enterotoxigenic E. coli desiccated on a Copan FLOQSwab®. Microbix Enterotoxigenic E. coli Positive Swab External Quality Controls have verified performance on various IVD assays, such as the Extended Enteric Bacterial Panel on
- [<i>Cryptosporidium parvum</i> + <i>Giardia lamblia</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/cryptosporidium-parvum-giardia-lamblia-positive-red-37-02) - Cryptosporidium parvum + Giardia lamblia Positive - RED-37-02
- [<i>Giardia lamblia</i> Positive](https://microbix.com/products/external-quality-controls/gastrointestinal-pathogen-panel/giardia-lamblia-positive-red-38-01) - Microbix Giardia lamblia Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Giardia lamblia suspended in a proprietary buffer. Microbix Giardia lamblia Positive External Quality Controls have verified performance with Meridian Bioscience ImmunoCard STAT® Crypto/Giardia Rapid Assay, BioFire® FilmArray® Gastrointestinal Panel, and more. • Format: Vial:
- [Chlamydophila Pneumoniae Antigen](https://microbix.com/products/antigens/respiratory/chlamydophila-pneumoniae/) - Microbix Native C. (Chlamydia) Pneumoniae Antigen preparation contains a high concentration of the bacteria suspended in SPG buffer. Contact us today for more information.
- [Bacterial Vaginosis Positive External Quality Controls](https://microbix.com/products/external-quality-controls/vaginal-infection-panel/bacterial-vaginosis/) - Microbix Bacterial Vaginosis Panel Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Gardnerella vaginalis, Megasphaera 1, BVAB2, Lactobacillus crispatus, Lactobacillus jensenii, Atopobium vaginae, Trichomonas vaginalis and human cells desiccated on a Copan FLOQSwab®.
- [Control Elution Buffer, 1mL](https://microbix.com/products/ceb/control-elution-buffer-1ml/) - Home / Control Elution Buffer / Control Elution Buffer, 1mL Control Elution Buffer, 1mL SKU: VP-S-123-01 Categories: All products, External Quality Controls (Infectious Disease Quality Controls), Gastrointestinal Panel Related products Frequently Asked Questions What is the shelf life of your elution buffer? The shelf life of our Control Elution Buffer (CEB) is 18 months from
- [SARS-CoV-2 Negative Swab (REDx™FLOQ®)](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/sars-cov-2-negative-swab-redxtmfloq/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [CT/NG/TV Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/sti-panel/ct-ng-tv-positive-swab/) - Microbix CT/NG/TV Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain inactivated Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and human cells, desiccated on a Copan FLOQSwab®. Microbix CT/NG/TV Positive External Quality Controls have verified performance with Cepheid Xpert® CT/NG Assay, Cepheid Xpert®
- [Mycoplasma genitalium Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-positive-swab/) - Microbix Mycoplasma genitalium Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain whole genome Mycoplasma genitalium and human cells, desiccated on a Copan FLOQSwab®.
- [Trichomonas vaginalis Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/sti-panel/trichomonas-vaginalis-positive-swab/) - Microbix Trichomonas vaginalis Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Trichomonas vaginalis and human cells, desiccated on a Copan FLOQSwab®.
- [ONBOARDx™ High-Risk HPV Verification and Validation Samples Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-high-risk-hpv-kit-ruo/) - Microbix HPV Verification and Validation Samples are designed for assay qualification, verification, and validation workflows. These unassayed samples contain inactivated human epithelial cells with HPV genomic material to ensure test accuracy and compliance.
- [Adenovirus, Grade 2](https://microbix.com/products/antigens/respiratory/adenovirus-grade-2) - Home / Antigens / Respiratory Antigens / Adenovirus, Grade 2 Adenovirus, Grade 2 SKU: VP-S-123-01 Categories: All products, External Quality Controls (Infectious Disease Quality Controls), Gastrointestinal Panel Related products
- [Rubella Antigen (BR2S)](https://microbix.com/products/antigens/torch/rubella-br2s) - Microbix Rubella B2RS Antigen is predominantly whole virions suspended in NTE with sucrose. The preparation is free of detergent. Residual non-viral protein may come from host tissue and culture medium. Contact us for more information.
- [Chlamydia trachomatis + Neisseria gonorrhoeae External Quality Control](https://microbix.com/products/external-quality-controls/sti-panel/chlamydia-trachomatis-neisseria-gonorrhoeae-positive-red-12-m2) - Microbix Respiratory Negative Swab Samples are unassayed, whole-workflow controls that simulate non-reactive respiratory specimens. Formulated with inactivated human cells, they enable laboratories to confirm assay precision and reliability.
- [HSV 1 Positive](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-positive-red-02-m1) - HSV 1 Positive - RED-02-M1
- [HSV1&2/VZV/<i>T. pallidum</i> Positive Swab](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv12-vzv-syphilis-positive-swab-red-s-03-m1/) - Microbix HSV 1&2/VZV/T. pallidum Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Herpes Simplex Virus 1, Herpes Simplex Virus 2, Varicella Zoster Virus, cells containing Treponema pallidum genome, and human cells desiccated on a Copan FLOQSwab®.
- [HPV 16/18/45 Positive Control Samples](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-16-18-45-positive-vp-62-m1) - Microbix HPV 16/18/45 External Quality Controls are unassayed, whole-workflow samples formulated with inactivated human epithelial cells containing HPV 16/18/45 whole genome nucleic acid suspended in ThinPrep® PreservCyt®.
- [HPV 66 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-66-positive-vp-62-66) - Microbix HPV 66 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain HPV 66 whole genome and human cells, suspended in ThinPrep® PreservCyt®.
- [HPV 52 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-52-positive-vp-62-52) - Microbix HPV 52 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain HPV 52 whole genome nucleic acid and human cells suspended in ThinPrep® PreservCyt®.
- [HPV 51 Positive - IVD REDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-51-positive/) - Microbix HPV 51 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain HPV 51 whole genome nucleic acid and human cells suspended in ThinPrep® PreservCyt®.
- [HPV 31 Positive - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-31-positive/) - Microbix HPV 31 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated human epithelial cells with integrated and episomal HPV 31 genetic material, suspended in ThinPrep® PreservCyt®.
- [High-risk HPV Negative (HPV 67)](https://microbix.com/products/external-quality-controls/hpv-panel/high-risk-hpv-negative-hpv-67-red-62-67/) - Microbix high-risk HPV Negative (HPV 67) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain HPV 67 whole genome nucleic acid and human cells suspended in ThinPrep® PreservCyt®.
- [HPV 39 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-39-positive/) - Microbix HPV 39 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated human epithelial cells with integrated and episomal HPV 39 genetic material, suspended in ThinPrep® PreservCyt®.
- [EBV Antigen - Viral Capsid Concentrate](https://microbix.com/products/antigens/childhood-disease/ebv-purified-antigen-vcaglycoprotein-b-gb-balf4-concentrate) - Microbix EBV Antigen contains more than 90% virus specific protein. Residual non-viral protein comes from host tissue and culture medium. Contact us today for more information.
- [HPV 45 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/redx-hpv-45-positive-control) - Microbix HPV 45 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated human epithelial cells with integrated and episomal HPV 45 genetic material, suspended in ThinPrep® PreservCyt®.
- [Chlamydia trachomatis + Neisseria gonorrhoeae Positive](https://microbix.com/products/external-quality-controls/sti-panel/chlamydia-trachomatis-neisseria-gonorrhoeae-positive-vp-12-m2) - Microbix Chlamydia trachomatis and Neisseria gonorrhoeae Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Chlamydia trachomatis, Neisseria gonorrhoeae and human cells suspended in ThinPrep® PreservCyt®.
- [RSV + Adenovirus Positive](https://microbix.com/products/external-quality-controls/respiratory-viral-panel/adenovirus-rsv-positive) - Microbix RSV and Adenovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Adenovirus and Respiratory Syncytial Virus suspended in a proprietary buffer.
- [HSV 2 External Quality Control](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-2-positive-2/) - Microbix HSV-2 External Quality Controls are unassayed, whole-workflow samples containing inactivated Herpes Simplex Virus Type 2 and human cells desiccated on Copan FLOQSwabs® to support accurate and reliable HSV-2 assay performance.
- [EBV Viral Capsid Ag, Purified](https://microbix.com/products/antigens/childhood-disease/ebv-purified-antigen-vca-glycoprotein-b-gb-balf4) - EBV Purified Antigen 'VCA' (glycoprotein B, gB, BALF4)
- [Measles Antigen (Grade 2)](https://microbix.com/products/antigens/childhood-disease/measles-grade-2) - Microbix Measles Antigen (Grade 2) features a high concentration of virus and viral components, ideal for immunoassays like EIA. Contact us today to learn more.
- [Mumps, Grade 2](https://microbix.com/products/antigens/childhood-disease/mumps-grade-2/) - Microbix Mumps Grade 2 Antigen Preparation contains a high concentration of virus and viral components as well as some cellular material suspended in 1969B. Contact us today for more information.
- [Mycoplasma Pneumoniae, Grade 2](https://microbix.com/products/antigens/respiratory/mycoplasma-pneumoniae-grade-2/) - Microbix Mycoplasma Pneumoniae Grade 2 Antigen Preparation contains soluble mycoplasma components in PBS. Contact us today for more information.
- [RSV](https://microbix.com/products/antigens/respiratory/rsv-vero/) - Microbix Native RSV Antigen Preparation contains a high concentration of virus and viral components as well as some cellular material in HEPS and Magnesium Sulphate. Contact us today for more information.
- [Cytomegalovirus, Grade 2](https://microbix.com/products/antigens/torch/cytomegalovirus-grade-2) - Microx Cytomegalovirus Antigen Grade 2 Preparation contains CMV antigens from all parts of the virus cycle of replication including early and late antigens, nuclear antigen, cytoplasmic antigen, structural and non-structural proteins. Contact us today for more information.
- [Influenza A Antigen](https://microbix.com/products/antigens/respiratory/influenza-a-grade-2/) - Microbix Native Influenza A Antigen preparation contains a high concentration of viral antigens as well as some egg proteins. Contact us today for more information.
- [Chlamydia trachomatis Positive - VP-12-01](https://microbix.com/products/external-quality-controls/sti-panel/chlamydia-trachomatis-positive-vp-12-01) - Microbix Chlamydia trachomatis Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated native Chlamydia trachomatis suspended in a proprietary buffer. Microbix Chlamydia trachomatis Positive External Quality Controls have verified performance on some of the following IVD platforms: Cepheid GeneXpert®, Quidel Quickvue®, and Sekisui OSOM® • Format:
- [Candida Panel Positive Swab](https://microbix.com/products/external-quality-controls/vaginal-infection-panel/candida-panel-positive-swab) - This PROCEEDx RUO product is formulated with inactivated Candida albicans, Candida glabrata, Candida kwse and human cells desiccated on a Copan FLOQSwab®. Microbix Candida Panel Positive Swab External Quality Controls have verified performance with Seegene Novaplex™ Candidiasis Assay, BD MAX™ Vaginal Panel Assay, Cepheid Xpert® Xpress MVP assay, and more. Intended Use: The product is
- [QUANTDx™ Herpes Simplex Virus Type 1 Reference Material](https://microbix.com/products/reference-materials/meningitis-panel/quantdx-herpes-simplex-virus-type-1-reference-material/) - This Product contains Inactivated Herpes Simplex Virus Type 1 (HSV-1) suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Herpes Simplex Virus Type 2 Reference Material](https://microbix.com/products/reference-materials/meningitis-panel/quantdx-herpes-simplex-virus-type-2-reference-material/) - This Product contains Inactivated Herpes Simplex Virus Type 2 (HSV-2) suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Mycoplasma genitalium (A2058T mutation) Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-mycoplasma-genitalium-a2058t-mutation-reference-material/) - This Product contains Mycoplasma genitalium whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx Giardia lamblia Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-giardia-lamblia-reference-material/)
- [QUANTDx Entamoeba histolytica partial genome Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-entamoeba-histolytica-partial-genome-reference-material/)
- [QUANTDx Cryptosporidium parvum Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-cryptosporidium-parvum-reference-material/)
- [QUANTDx Sapovirus Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-sapovirus-reference-material/)
- [QUANTDx Rotavirus Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-rotavirus-reference-material/)
- [QUANTDx Norovirus GII Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-norovirus-gii-reference-material/)
- [QUANTDx Norovirus GI Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-norovirus-gi-reference-material/)
- [QUANTDx Astrovirus Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-astrovirus-reference-material/)
- [QUANTDx Adenovirus 41 Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-adenovirus-41-reference-material/)
- [QUANTDx Yersinia enterocolitica Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-yersinia-enterocolitica-reference-material/)
- [QUANTDx Vibrio parahaemolyticus Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-vibrio-parahaemolyticus-reference-material/)
- [QUANTDx Shigella sonnei Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-shigella-sonnei-reference-material/)
- [QUANTDx Salmonella enteritidis Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-salmonella-enteritidis-reference-material/)
- [QUANTDx Plesiomonas shigelloides Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-plesiomonas-shigelloides-reference-material/)
- [QUANTDx Shiga toxin-producing E. coli (E.coli O157) Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-shiga-toxin-producing-e-coli-e-coli-o157-reference-material/)
- [QUANTDx Enterotoxigenic E. coli O78:H11 Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-enterotoxigenic-e-coli-o78h11-reference-material/)
- [QUANTDx Campylobacter jejuni Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-campylobacter-jejuni-reference-material/)
- [QUANTDx Clostridium difficile Reference Material](https://microbix.com/products/reference-materials/gastrointesinal-panel/quantdx-clostridium-difficile-reference-material/)
- [QUANTDx™ Varicella Zoster Virus Reference Material](https://microbix.com/products/reference-materials/meningitis-panel/quantdx-varicella-zoster-virus-reference-material/) - This Product contains Inactivated Varicella Zoster Virus suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Monkeypox Virus (West African) Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-monkeypox-virus-west-african-reference-material/) - This Product contains Monkeypox virus whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Haemophilus ducreyi Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-haemophilus-ducreyi-reference-material/) - This Product contains Inactivated Haemophilus ducreyi suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Treponema pallidum partial genome Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-treponema-pallidum-partial-genome-reference-material/) - This Product contains Treponema pallidum partial genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Herpes Simplex Virus Type 2 Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-herpes-simplex-virus-type-2-reference-material/) - This Product contains Inactivated Herpes Simplex Virus Type 2 (HSV-2) suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Herpes Simplex Virus Type 1 Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-herpes-simplex-virus-type-1-reference-material/) - This Product contains Inactivated Herpes Simplex Virus Type 1 (HSV-1) suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Neisseria gonorrhoeae (S91F mutation) Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-neisseria-gonorrhoeae-s91f-mutation-reference-material/) - This Product contains Neisseria gonorrhoeae whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Mycoplasma genitalium (S83I parC mutation) Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-mycoplasma-genitalium-s83i-parc-mutation-reference-material/) - This Product contains Mycoplasma genitalium whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Mycoplasma genitalium (A2059T mutation) Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-mycoplasma-genitalium-a2059t-mutation-reference-material/) - This Product contains QUANTDx™ Mycoplasma genitalium (A2059T mutation) Reference Material. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Mycoplasma genitalium (A2058C mutation) Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-mycoplasma-genitalium-a2058c-mutation-reference-material/) - This Product contains Mycoplasma genitalium whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Mycoplasma genitalium (A2059C mutation) Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-mycoplasma-genitalium-a2059c-mutation-reference-material/) - This Product contains Mycoplasma genitalium whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Mycoplasma genitalium (A2058G mutation) Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-mycoplasma-genitalium-a2058g-mutation-reference-material/) - This Product contains Mycoplasma genitalium whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Mycoplasma genitalium (A2059G mutation) Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-mycoplasma-genitalium-a2059g-mutation-reference-material/) - This Product contains Mycoplasma genitalium whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Mycoplasma genitalium Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-mycoplasma-genitalium-reference-material/) - This Product contains Mycoplasma genitalium whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Trichomonas vaginalis Reference Material](https://microbix.com/products/uncategorized/quantdx-trichomonas-vaginalis-reference-material/) - This Product contains Inactivated Trichomonas vaginalis suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Neisseria gonorrhoeae Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-neisseria-gonorrhoeae-reference-material/) - This Product contains Inactivated Neisseria gonorrhoeae suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Chlamydia trachomatis Reference Material](https://microbix.com/products/reference-materials/sti-panel-reference-materials/quantdx-chlamydia-trachomatis-reference-material/) - This Product contains Inactivated Chlamydia trachomatis suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Seasonal coronavirus NL63 Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-seasonal-coronavirus-nl63-reference-material/) - This Product contains Seasonal coronavirus NL63 whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Enterovirus Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-enterovirus-reference-material/) - This Product contains Enterovirus whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Rhinovirus Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-rhinovirus-reference-material/) - This Product contains Rhinovirus whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use.
- [QUANTDx™ Human metapneumovirus Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-human-metapneumovirus-reference-material/) - This Product contains Human metapneumovirus whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Streptococcus pyogenes Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-streptococcus-pyogenes-reference-material/) - This Product contains Inactivated Streptococcus pyogenes suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ SARS-CoV-2 Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-sars-cov-2-reference-material/) - This Product contains Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) whole genome cDNA suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Adenovirus Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-adenovirus-reference-material/) - This Product contains Inactivated Adenovirus suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Influenza B Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-influenza-b-reference-material/) - This Product contains Inactivated Influenza B virus suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Influenza A (H5N1) Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-influenza-a-h5n1-reference-material/) - This Product contains Influenza A (H5N1) virus whole genome suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Influenza A (H3N2) Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-influenza-a-h3n2-reference-material/) - This Product contains Inactivated Influenza A virus suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Influenza A (H1N1) Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-influenza-a-h1n1-reference-material/) - This Product contains inactivated Influenza A virus supplied in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ Respiratory Syncytial Virus Type A Reference Material](https://microbix.com/products/reference-materials/respiratory-panel/quantdx-respiratory-syncytial-virus-type-a-reference-material/) - This Product contains Inactivated Respiratory Syncytial Virus (RSV) suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer and Strain Information, please contact us
- [QUANTDx™ HPV 66 Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-hpv-66-reference-material/) - This Product contains Inactivated cells that contain HPV 66 suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Strain: HPV type 66 Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer Information, please contact us.
- [QUANTDx™ HPV 52 Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-hpv-52-reference-material/) - This Product contains Inactivated cells that contain HPV 52 suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Strain: HPV type 52 Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer Information, please contact us.
- [QUANTDx™ HPV 51 Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-hpv-51-reference-material/) - This Product contains Inactivated cells that contain HPV 51 suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Strain: HPV type 51 Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer Information, please contact us.
- [QUANTDx™ HPV 45 Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-hpv-45-reference-material/) - This Product contains Inactivated cells that contain HPV 45 suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Strain: HPV type 45 Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer Information, please contact us.
- [QUANTDx™ HPV 39 Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-hpv-39-reference-material/) - This Product contains Inactivated cells that contain HPV 39 suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Strain: HPV type 39 Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer Information, please contact us.
- [QUANTDx™ HPV 33 Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-hpv-33-reference-material/) - This Product contains Inactivated cells that contain HPV 33 suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Strain: HPV type 33 Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer Information, please contact us.
- [QUANTDx™ HPV 31 Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-hpv-31-reference-material/) - This Product contains Inactivated cells that contain HPV 31 suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Strain: HPV type 31 Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer Information, please contact us.
- [QUANTDx™ HPV 18 Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-hpv-18-reference-material/) - This Product contains Inactivated cells that contain HPV 18 suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Strain: HPV type 18 Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer Information, please contact us.
- [QUANTDx™ HPV 16 Reference Material](https://microbix.com/products/reference-materials/hpv-panel-reference-materials/quantdx-hpv-16-reference-material/) - This Product contains Inactivated cells that contain HPV 16 suspended in a preservative buffer. It is intended for Research Use Only (RUO) and not for Human or Diagnostic use. Strain: HPV type 16 Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Buffer Information, please contact us.
- [QUANTDx™ Syncephalastrum racemosum Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-syncephalastrum-racemosum-reference-material/) - This Product contains Inactivated Inactivated Syncephalastrum racemosum suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Lomentospora prolificans Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-lomentospora-prolificans-reference-material/) - This Product contains Inactivated Lomentospora prolificans (formerly known as Scedosporium prolificans) suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Scedosporium apiospermum Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-scedosporium-apiospermum-reference-material/) - This Product contains Inactivated Scedosporium apiospermum suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Rhizopus oryzae Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-rhizopus-oryzae-reference-material/) - This Product contains Inactivated Rhizopus oryzae suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Rhizopus microsporus Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-rhizopus-microsporus-reference-material/) - This Product contains Inactivated Rhizopus microsporus suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Rhizomucor pusillus Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-rhizomucor-pusillus-reference-material/) - This Product contains Inactivated Rhizomucor pusillus suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Rhizomucor miehei Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-rhizomucor-miehei-reference-material/) - This Product contains Inactivated Rhizomucor miehei suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Mucor racemosus Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-mucor-racemosus-reference-material/) - This Product contains Inactivated Mucor racemosus suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Mucor indicus Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-mucor-indicus-reference-material/) - This Product contains Inactivated Mucor indicus suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Histoplasma capsulatum Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-histoplasma-capsulatum-reference-material/) - This Product contains Inactivated Histoplasma capsulatum suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Mucor circinelloides Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-mucor-circinelloides-reference-material/) - This Product contains Inactivated Mucor circinelloides suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Lichtheimia corymbifera Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-lichtheimia-corymbifera-reference-material/) - This Product contains Inactivated Lichtheimia corymbifera suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Neocosmospora solani Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-neocosmospora-solani-reference-material/) - This Product contains Inactivated Neocosmospora solani (formerly known as Fusarium solani) suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Fusarium oxysporum Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-fusarium-oxysporum-reference-material/) - This Product contains Inactivated Fusarium oxysporum suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Cunninghamella bertholletiae Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-cunninghamella-bertholletiae-reference-material/) - This Product contains Inactivated Cunninghamella bertholletiae suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Cryptococcus neoformans Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-cryptococcus-neoformans-reference-material/) - This Product contains Inactivated Cryptococcus neoformans suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Cryptococcus gattii Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-cryptococcus-gattii-reference-material/) - This Product contains Inactivated Cryptococcus gattii suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Candida auris Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-candida-auris-reference-material/) - This Product contains Inactivated Candida auris suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Blastomyces dermatidis Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-blastomyces-dermatidis-reference-material/) - This Product contains Inactivated Blastomyces dermatidis suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Aspergillus terreus Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-aspergillus-terreus-reference-material/) - This Product contains Inactivated Aspergillus terreus suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Aspergillus niger Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-aspergillus-niger-reference-material/) - This Product contains Inactivated Aspergillus niger suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [QUANTDx™ Aspergillus fumigatus Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-aspergillus-fumigatus-reference-material/) - This Product contains Inactivated Aspergillus fumigatus suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer information, please contact us.
- [QUANTDx™ Aspergillus flavus Reference Material](https://microbix.com/products/reference-materials/fungal-panel/quantdx-aspergillus-flavus-reference-material/) - This Product contains inactivated Aspergillus flavus suspended in a preservative buffer, intended for Research use only (RUO). Storage Conditions: Frozen; ≤-70ºC Volume: 1mL For Strain and Buffer Information, please contact us.
- [HSV 2 and T. pallidum Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-2-and-t-pallidum-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 1 Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-positive-swab/) - Our HSV 1 Positive Swab – IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HSV 1 Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-positive-swab-low-level/) - Our HSV 1 Positive Swab (Low Level) products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 1 Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-positive-swab-2/) - Our HSV 1 Positive Swab – RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 1 & HSV 2 Positive](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-hsv-2-positive-2/) - Our HSV 1 & HSV 2 Positive products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 1 and VZV Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-and-vzv-positive-swab/) - Our HSV 1 and VZV Positive Swab – IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HSV 1 and VZV Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-and-vzv-positive-swab-2/) - Our HSV 1 and VZV Positive Swab – RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 1 and T. pallidum Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-and-t-pallidum-positive-swab/) - Our HSV 1 and T. pallidum Positive Swab – IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HSV 1 and T. pallidum Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-and-t-pallidum-positive-swab-2/) - Our HSV 1 and T. pallidum Positive Swab – RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 1 and HSV 2 Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-and-hsv-2-positive-swab/) - Our HSV 1 and HSV 2 Positive Swab – IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HSV 1 and HSV 2 Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-and-hsv-2-positive-swab-2/) - Our HSV 1 and HSV 2 Positive Swab – RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Mycoplasma Genitalium AMR A2059G Positive Sample](https://microbix.com/products/antigens/sti/product/mycoplasma-genitalium-amr-a2059g-positive) - Our Mycoplasma Genitalium AMR A2059G Positive Sample RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ FLOQ®Campylobacter Panel Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-floqcampylobacter-panel-swab-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ FLOQ®Campylobacter Panel Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-floqcampylobacter-panel-swab-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ FLOQ®C. <i>difficile</i> Panel Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-floqc-difficile-panel-swab-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ FLOQ®genital Ulcer Panel Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-floqgenital-ulcer-panel-swab-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ HPV Positive Sample Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-hpv-positive-sample-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ FLOQ® FLU Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-floq-flu-kit-ruo-2/) - Contains: PROCEEDx™FLOQ® Influenza A Positive swab x10 PROCEEDx™FLOQ® Influenza B Positive swab 10 PROCEEDx™ FLOQ® Respiratory Negative swab x4
- [ONBOARDx™ RSV Kit 2 (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardxfloq-rsv-swab-kit-vp-sk-rsv-02) - Contains: PROCEEDx™FLOQ® RSV Positive Swab x 20 PROCEEDx™FLOQ® Respiratory Swab Negative Sample x 4 VP-SK-RSV-02
- [ONBOARDx™ RSV Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardxfloq-rsv-swab-kit-vp-sk-rsv-01) - Contains: PROCEEDx™FLOQ® RSV Positive Swab x 10 PROCEEDx™FLOQ® Respiratory Swab Negative Sample x 2 VP-SK-RSV-01
- [ONBOARDx™FLOQ® Respiratory Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardxfloq-respiratory-swab-kit-ruo) - Contains: PROCEEDx™FLOQ® SARS-CoV-2 Antigen Positive swab x5 PROCEEDx™FLOQ® Influenza A Positive swab x5 PROCEEDx™FLOQ® Influenza B Positive swab x5 PROCEEDx™ FLOQ® RSV Positive swab x5 VP-SK-RESPAG-02
- [ONBOARDx™FLOQ® SARS-CoV-2 Antigen Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardxfloq-sars-cov-2-antigen-swab-kit-vp-sk-cov2ag-01) - Contains: PROCEEDx™FLOQ® SARS-CoV-2 Antigen Positive swab x 10 PROCEEDx™FLOQ® SARS-CoV-2 Negative swab x 2 VP-SK-CoV2AG-01
- [ONBOARDx™FLOQ® Respiratory Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardxfloq-respiratory-swab-kit-ruo-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™FLOQ® Respiratory Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-respiratory-swab-kit-ruo) - Contains: PROCEEDx™FLOQ® SARS-CoV-2 Positive swab x3 PROCEEDx™FLOQ® Influenza A Positive swab x3 PROCEEDx™FLOQ® Influenza B Positive swab x3 PROCEEDx™ FLOQ® RSV Positive swab x3 VP-SK-RESP-01
- [ONBOARDx™ FLOQ® SARS-CoV-2 Variant Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-floq-sars-cov-2-variant-swab-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ FLOQ® SARS-CoV-2 Variant Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardxfloq-sars-cov-2-variant-swab-kit) - Contains: PROCEEDx™FLOQ® SARS-CoV-2 B.1.1.7 Positive swab x 3 PROCEEDx™FLOQ® SARS-CoV-2 B.1.351 Positive swab x 3 PROCEEDx™FLOQ® SARS-CoV-2 P.1 Positive swab x 3 PROCEEDx™FLOQ® SARS-CoV-2 WT Positive swab x 3 VP-SK-CVAR-01
- [ONBOARDx™ FLOQ®RVP Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-floqrvp-swab-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Trichomonas vaginalis Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/trichomonas-vaginalis-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Trichomonas vaginalis and Mycoplasma genitalium Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/sti-panel/trichomonas-vaginalis-and-mycoplasma-genitalium-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [Trichomonas vaginalis and Mycoplasma genitalium Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/trichomonas-vaginalis-and-mycoplasma-genitalium-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [STI Negative - IVD REDx™](https://microbix.com/products/external-quality-controls/sti-panel/sti-negative/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [STI Negative - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/sti-negative-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Neisseria gonorrhoeae Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/sti-panel/neisseria-gonorrhoeae-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [Neisseria gonorrhoeae Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/neisseria-gonorrhoeae-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Mycoplasma genitalium Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Mycoplasma genitalium A2058C Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2058c-positive-swab-vp-s-63-06) - Mycoplasma genitalium A2058C Positive Swab - VP-S-63-06
- [Mycoplasma genitalium A2058C Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2058c-positive-swab-red-s-63-06) - Mycoplasma genitalium A2058C Positive Swab - RED-S-63-06
- [CT/NG/TV Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/ct-ng-tv-positive-swab-2/) - Microbix CT NG TV Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain inactivated Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and human cells, desiccated on a Copan FLOQSwab®.
- [CT/NG/TV/MG Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/ct-ng-tv-mg-positive-swab-3/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [CT/NG/TV/MG Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/sti-panel/ct-ng-tv-mg-positive-swab-2/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [Chlamydia trachomatis Positive Swab (IVD REDx™)](https://microbix.com/products/external-quality-controls/sti-panel/chlamydia-trachomatis-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [Chlamydia trachomatis Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/chlamydia-trachomatis-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Chlamydia trachomatis and Neisseria gonorrhoeae Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/sti-panel/chlamydia-trachomatis-and-neisseria-gonorrhoeae-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [Chlamydia trachomatis and Neisseria gonorrhoeae Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/sti-panel/chlamydia-trachomatis-and-neisseria-gonorrhoeae-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ High-Risk HPV Positive Sample Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-high-risk-hpv-positive-sample-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ High-Risk HPV Positive Sample Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-high-risk-hpv-positive-sample-kit-ruo-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ FLOQ®RVP Swab Kit (RUO PROCEEDx™)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-floqrvp-swab-kit-ruo-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HPV 51 Positive - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-51-positive-2/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HPV 39/51/52 Positive - IVD REDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-39-51-52-positive-red-62-m3/) - HPV 39/51/52 Positive - RED-62-M3
- [HPV 39/51/52 Positive - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-39-51-52-positive-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HPV 31 Positive - IVD REDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-31-positive-2/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HPV 18 Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-18-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HPV 18 Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-18-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HPV 16 Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-16-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HPV 16 Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-16-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HPV 16/18/45 Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-16-18-45-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HPV 16/18/45 Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-16-18-45-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Varicella Zoster Virus Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/varicella-zoster-virus-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [Varicella Zoster Virus Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/varicella-zoster-virus-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Treponema Pallidum Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/treponema-pallidum-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [Treponema Pallidum Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/treponema-pallidum-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [T. pallidum and VZV Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/t-pallidum-and-vzv-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [T. pallidum and VZV Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/t-pallidum-and-vzv-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [STI Negative - HPV Panel](https://microbix.com/products/external-quality-controls/hpv-panel/sti-negative/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [STI Negative](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/sti-negative/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Monkeypox West African Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/monkeypox-west-african-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [Monkeypox West African Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/monkeypox-west-african-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV1/HSV2/VZV Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv1-hsv2-vzv-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HSV1/HSV2/VZV Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv1-hsv2-vzv-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 2 Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-2-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HSV 2 Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-2-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 2 and VZV Positive Swab - IVD REDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-2-and-vzv-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HSV 2 and VZV Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-2-and-vzv-positive-swab-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 2 and T. pallidum Positive Swab - RUO PROCEEDx™](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-2-and-t-pallidum-positive-swab/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [ONBOARDx™FLOQ® SARS-CoV-2 Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardxfloq-sars-cov-2-swab-kit) - Contains: PROCEEDx™FLOQ® SARS-CoV-2 Positive swab x 8 PROCEEDx™FLOQ® SARS-CoV-2 Negative swab x 4 VP-SK-CoV2-01
- [ONBOARDx™ FLOQ® FLU Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-floq-flu-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™FLOQ® SARS-CoV-2 Antigen Swab Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardxfloq-sars-cov-2-antigen-swab-kit-vp-sk-cov2ag-02) - Contains: PROCEEDx™FLOQ® SARS-CoV-2 Antigen Positive swab x 15 PROCEEDx™FLOQ® SARS-CoV-2 Negative swab x 5 VP-SK-CoV2AG-02
- [HPV 39/51/52 Positive Swab](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-39-51-52-positive-swab__trashed/) - Microbix HPV 39/51/52 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain HPV type 39, 51, and 52 whole genome nucleic acid, and human cells desiccated on a Copan FLOQSwab®. Microbix HPV 39/51/52 Positive Swab External Quality Controls have verified performance with
- [HPV 31/33/66 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-31-33-66-positive-vp-62-m2) - Microbix HPV 31/33/66 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain HPV type 31, 33, and 66 whole genome nucleic acid, and human cells desiccated on a Copan FLOQSwab®. Microbix HPV 31/33/66 Positive Swab External Quality Controls have verified performance with
- [HPV 45 Positive Swab](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-45-positive-swab/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™FLOQ® Vaginal Infection Panel Swab Kit (RUO)](https://microbix.com/products/uncategorized/onboardxfloq-vaginal-infection-panel-swab-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™FLOQ® Enteric Bacterial Panel 1 Swab Kit (RUO)](https://microbix.com/products/uncategorized/onboardxfloq-enteric-bacterial-panel-1-swab-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ Enteric Bacterial Panel 2 Kit (RUO)](https://microbix.com/products/uncategorized/onboardx-enteric-bacterial-panel-2-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ Enteric Bacterial Panel 1 Kit (RUO)](https://microbix.com/products/uncategorized/onboardx-enteric-bacterial-panel-1-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [ONBOARDx™ C. difficile Positive Sample Kit (RUO)](https://microbix.com/products/uncategorized/onboardx-c-difficile-positive-sample-kit-ruo/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [<i>Neisseria gonorrhoeae</i> Positive](https://microbix.com/products/external-quality-controls/sti-panel/neisseria-gonorrhoeae-positive-vp-17-m1) - Neisseria gonorrhoeae Positive - VP-17-M1
- [<i>Mycoplasma genitalium</i> Positive](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-positive-vp-63-01) - Mycoplasma genitalium Positive - VP-63-01
- [<i>Mycoplasma genitalium A2059C</i> Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2059c-positive-swab-vp-s-63-04) - Mycoplasma genitalium A2059C Positive Swab - VP-S-63-04
- [HPV 33 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-33-positive-vp-62-33) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HPV 16 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-16-positive-2/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Varicella Zoster Virus Positive Swab (Low Level)](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/varicella-zoster-virus-positive-swab-low-level/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [<i>Treponema pallidum</i> 47kDa Positive Swab](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/treponema-pallidum-47kda-positive-swab/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Negative Sample](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/negative-sample/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV1&2/VZV/<i>T. pallidum</i> Positive Swab](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv12-vzv-syphilis-positive-swab-vp-s-03-m1/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [HSV 2 Positive Swab (Low level)](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-2-positive-swab-low-level/) - Intended Uses Our RUO PROCEEDx™ products are used for assay verification/validation, training, and R&D purposes. Products are for research use only (RUO).
- [Mycoplasma genitalium Positive - RED-63-01](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-positive-red-63-01) - Mycoplasma genitalium Positive - RED-63-01
- [<i>Mycoplasma genitalium A2058T</i> Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2058t-positive-swab-red-s-63-05) - Mycoplasma genitalium A2058T Positive Swab - RED-S-63-05
- [HPV 33 Positive - RED-62-33](https://microbix.com/products/external-quality-controls/sti-panel/hpv-33-positive/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HPV 52 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-52-positive-red-62-52/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HPV 31/33/66 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-31-33-66-positive-red-62-m2/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [HPV 16/18/45 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-16-18-45-positive-red-62-m1/) - Intended Uses Our IVD REDx™ products are unassayed controls that can be used for ongoing external quality control, benchmarking laboratory testing performance, operator training & competency, and end-to-end workflow evaluation.
- [Haemophilus ducreyi Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/haemophilus-ducreyi-positive-swab-2/) - Microbix Haemophilus ducreyi Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Haemophilus ducreyi and human cells, desiccated on a Copan FLOQSwab®. Microbix Haemophilus ducreyi Positive Swab External Quality Controls have verified performance with Seegene Allplex™ Genital Ulcer Assay, Bosch Vivalytic STI Assay, and more.
- [Haemophilus ducreyi Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/haemophilus-ducreyi-positive-swab/) - Microbix Haemophilus ducreyi Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Haemophilus ducreyi and human cells, desiccated on a Copan FLOQSwab®. Microbix Haemophilus ducreyi Positive Swab External Quality Controls have verified performance with Seegene Allplex™ Genital Ulcer Assay, Bosch Vivalytic STI Assay, and more.
- [HPV 31/33/66 Positive Swab](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-31-33-66-positive-swab/) - Microbix HPV 31/33/66 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain HPV type 31, 33, and 66 whole genome nucleic acid, and human cells desiccated on a Copan FLOQSwab®. Microbix HPV 31/33/66 Positive Swab External Quality Controls have verified performance with
- [HPV 45 Positive Swab](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-45-positive-swab-2/) - Microbix HPV 45 Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated human epithelial cells with integrated and episomal HPV 45 genetic material desiccated on a Copan FLOQSwab®. Microbix HPV 45 Positive Swab External Quality Controls have verified performance with Cepheid Xpert® HPV Assay, BD
- [Control Elution Buffer, 3mL](https://microbix.com/products/ceb/control-elution-buffer-3ml/) - This 3mL product is a swabs elution buffer stable from 2-30°C, which can sustain the detectability of pathogens during elution and following storage. The formulation of control elution buffer for pathogens includes protein for stabilization, antibiotics to minimize bacterial and fungal contamination, and a buffer to maintain a neutral pH.
- [P3H3 Cell Extract](https://microbix.com/products/antigens/childhood-disease/antigens-childhood-disease/p3h3-cell-extract-ebv/) - Description: P3H3 Cell Extract contains a high concentration of Epstein-Barr Virus antigens, including VCA, EBNA, EA-D, and EA-R. Strain: P3H3 Human Burkitt’s Lymphoma cells Buffer: Tris with NP40, sodium deoxycholate and PMSF EL-16-03
- [Rubella BR2S](https://microbix.com/products/antigens/childhood-disease/rubella-br2s) - Rubella BR2S Antigen - Childhood disease
- [NAAT Negative Swab (PROCEEDx™FLOQ®)](https://microbix.com/products/external-quality-controls/hpv-panel/naat-negative-swab-proceedxtmfloq/) - Microbix Adenovirus Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Adenovirus suspended in a proprietary buffer. Microbix Adenovirus Positive External Quality Controls have verified performance on various IVD assays, such as SA Scientific SAS™ Adeno Test, and more.. • Format: Vial; 1.0 mL • Storage
- [High-risk  HPV Negative (HPV 67) - VP-62-67](https://microbix.com/products/external-quality-controls/hpv-panel/high-risk-hpv-negative-hpv-67-vp-62-67) - Microbix high-risk HPV Negative (HPV 67) External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain HPV 67 whole genome nucleic acid and human cells suspended in ThinPrep® PreservCyt®. Microbix high-risk HPV Negative External Quality Controls have verified performance with Abbott RealTime High Risk HPV
- [HPV 66 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-66-positive-red-62-66/) - Microbix HPV 66 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated cells that contain HPV 66 whole genome and human cells, suspended in ThinPrep® PreservCyt®. Microbix HPV 66 Positive External Quality Controls have verified performance with Cepheid Xpert® HPV Assay, BD Onclarity™ HPV Assay, Seegene
- [HPV 45 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/proceedx-hpv-45-positive-sample-mdx) - PROCEEDx™ HPV 45 Positive Sample (MDx)
- [HPV 18 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-18-positive-vp-62-18) - HPV 18 Positive - VP-62-18 External Quality Controls
- [HPV 18 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-18-positive-red-62-18) - HPV 18 Positive - RED-62-18 - External Quality Controls
- [HPV 16 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-16-positive-red-62-16) - Microbix HPV 16 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. Contact us today for more information.
- [HSV 2 Positive](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-2-positive/) - Microbix HSV 2 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Herpes Simplex Virus 2 and human cells suspended in a proprietary buffer. Microbix HSV 2 Positive External Quality Controls have verified performance with Roche cobas® 4800, Hologic Aptima®, Meridian Bioscience Alethia®, Luminex ARIES®, DiaSorin
- [<i>Mycoplasma genitalium A2058T</i> Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2058t-positive-swab-vp-s-63-05) - Mycoplasma genitalium A2058T Positive Swab - VP-S-63-05
- [<i>Mycoplasma genitalium A2059C</i> Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2059c-positive-swab-red-s-63-04) - Mycoplasma genitalium A2059C Positive Swab - RED-S-63-04
- [<i>Mycoplasma genitalium</i> A2058G Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2058g-positive-swab-vp-s-63-03) - Mycoplasma genitalium A2058G Positive Swab - VP-S-63-03
- [<i>Mycoplasma genitalium</i> A2058G Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2058g-positive-swab-red-s-63-03) - Mycoplasma genitalium A2058G Positive Swab - RED-S-63-03
- [<i>Mycoplasma genitalium A2059G</i> Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2059g-positive-swab-red-s-63-02) - Mycoplasma genitalium A2059G Positive Swab - RED-S-63-02
- [<i>Mycoplasma genitalium A2059G</i> Positive Swab](https://microbix.com/products/external-quality-controls/sti-panel/mycoplasma-genitalium-a2059g-positive-swab-vp-s-63-02) - Mycoplasma genitalium A2059G Positive Swab - VP-S-63-02
- [<i>Trichomonas vaginalis</i> Positive](https://microbix.com/products/external-quality-controls/sti-panel/trichomonas-vaginalis-positive-red-61-01) - Trichomonas vaginalis Positive - RED-61-01
- [<i>Trichomonas vaginalis</i> Positive](https://microbix.com/products/external-quality-controls/sti-panel/trichomonas-vaginalis-positive-vp-61-01) - Trichomonas vaginalis Positive - VP-61-01
- [<i>Neisseria gonorrhoeae</i> Positive](https://microbix.com/products/external-quality-controls/sti-panel/neisseria-gonorrhoeae-positive-red-17-m1) - Neisseria gonorrhoeae Positive - RED-17-M1
- [<i>Chlamydia trachomatis</i> Positive](https://microbix.com/products/external-quality-controls/sti-panel/chlamydia-trachomatis-positive) - Microbix Chlamydia trachomatis Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated native Chlamydia trachomatis suspended in a proprietary buffer. Microbix Chlamydia trachomatis Positive External Quality Controls have verified performance with Cepheid GeneXpert®, Quidel Quickvue®, Sekisui OSOM®, and more • Format: Vial; 1.0 mL • Storage
- [<i>Chlamydia trachomatis</i> Positive (MDx)](https://microbix.com/products/external-quality-controls/sti-panel/chlamydia-trachomatis-positive-mdx-vp-12-m1) - Chlamydia trachomatis Positive (MDx) - VP-12-M1
- [ONBOARDx™ Respiratory Kit](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-respiratory-kit-ruo) - Contains SARS-CoV-2 Positive (0.5mL) vial x 3 Influenza A Positive (1mL) vial x 3 Influenza B Positive (1mL) vial x 3 RSV Positive (1mL) vial x 3
- [ONBOARDx™ SARS-CoV-2 Kit (RUO)](https://microbix.com/products/external-quality-controls/onboardx-kits/onboardx-sars-cov-2-kit) - Contains: PROCEEDx™ SARS-CoV-2 Positive (0.5mL) vial x 8 PROCEEDx™ SARS-CoV-2 Negative (0.5mL) vial x 4 VP-K-CoV2-01
- [EBV Viral Capsid Concentrate](https://microbix.com/products/antigens/torch/ebv-purified-antigen-vcaglycoprotein-b-gb-balf4-concentrate) - This preparation contains more than 90% virus specific protein. The predominant form of the antigen is purified protein suspended in 20mM Tris-HCl with 3M MgCl2; pH 7.4. The preparation is free of detergent. Residual non-viral protein comes from host tissue and culture medium. This preparation is a more concentrated form of EL-16-06 with a protein
- [EBV Viral Capsid Ag, Purified](https://microbix.com/products/antigens/torch/ebv-purified-antigen-vca-glycoprotein-b-gb-balf4) - EBV Purified Antigen 'VCA' (glycoprotein B, gB, BALF4) ToRCH
- [Varicella-Zoster, Grade 2](https://microbix.com/products/antigens/childhood-disease/varicella-zoster-grade-2) - Description: The resulting antigen preparation contains a high concentration of virus and viral components as well as some cellular material suspended in EMEM with some serum proteins. Strain: VZ-10 Buffer: EMEM EL-03-02
- [Toxoplasma gondii, Grade IgM](https://microbix.com/products/antigens/torch/toxoplasma-gondii-igm-grade) - Description: Toxoplasma Antigen, IgM Grade is produced by subjecting Toxoplasma tachyzoites to membrane fractionation, which allows for surface antigen isolation, specifically Toxoplasma p30. Strain: RH Buffer: 2% N-octyt–D-glucopyranoside (OGP) in Phosphate Buffered Saline pH 7.4 EL-18-08
- [Toxoplasma gondii, Grade IgG](https://microbix.com/products/antigens/torch/toxoplasma-gondii) - Description: Native Toxoplasma gondii antigens are obtained by extracting and subsequently centrifuging Toxoplasma tachyzoites from infected cell cultures. Strain: RH Buffer: 1% Triton x-100, Phosphate Buffered Saline pH 7.4 EL-18-07
- [<i>Chlamydophila (Chlamydia) trachomatis</i>, Grade 2](https://microbix.com/products/antigens/sti-antigens/chlamydophila-chlamydia-trachomatis-grade-2) - Description: C. trachomatis grade 2 antigen contains a high concentration of elementary bodies and chlamydial components in PBS. The preparation contains no preservative or detergent. Residual host cellular material is present. Strain: C. trachomatis LGV type II strain 434 Buffer: Phosphate buffered saline pH 7.2 EL-12-02
- [Rotavirus Grade 3](https://microbix.com/products/antigens/gastrointestinal-and-other-antigens-microbix-biosystems-infectious-disease-antigens-qaps/rotavirus/) - Description: Rotavirus native antigen is isolated from cultured MA104 cells that were infected with the Simian rotavirus SA11 strain. Strain: Simian rotavirusSAll, ICW 00.060.0.03.001.00.201.001 Buffer: MA1O4 cells EL-35-03
- [Influenza B](https://microbix.com/products/antigens/respiratory/influenza-b-antigen/) - Description: Influenza B native antigen is derived from semi-purified cell culture lysate with a high titre of Influenza B particles. Cells were infected with the Influenza B/Hong Kong 5/72 strain. Strain: Hong Kong 5/72 Buffer: EMEM EL-14-03
- [Influenza A H3N2](https://microbix.com/products/antigens/respiratory/influenza-a-h3n2-antigen/) - Description: Native influenza A virus preparation contains a high concentration of viral antigens as well as some egg proteins (allantoic fluid). Strain: H3N2 Subtype Buffer: PBS EL-13-03
- [Parainfluenza 2, Grade 2](https://microbix.com/products/antigens/respiratory/parainfluenza-2-grade-2/) - Description: TNative Parainfluenza 2 virus antigen preparation contains a high contains a high concentration of virus and virus components as well as some cellular material suspended in Tissue Culture Media. Strain: Greer Buffer: Tissue Culture Media EL-09-02
- [SARS-CoV-2 Negative Swab (REDxTMFLOQ®)* NAAT Negative Swab (PROCEEDxTMFLOQ®)](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/sars-cov-2-negative-swab-redxtmfloq-naat-negative-swab-proceedxtmfloq-3/) - Microbix NAAT Negative Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells desiccated on Copan FLOQSwab®. • Format: Copan FLOQSwab® • Storage Conditions: 2-30°C • Assay Compatibility: MDx * Product is formulated with human cells desiccated on swabs and can be used in context of
- [HPV 33 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-33-positive/) - Microbix HPV 33 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated human epithelial cells with integrated and episomal HPV 33 genetic material, suspended in ThinPrep® PreservCyt®. Microbix HPV 33 Positive External Quality Controls have verified performance with Cepheid Xpert® HPV Assay, Roche cobas® 4800 and
- [HPV 31 Positive](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-31-positive/) - Microbix HPV 31 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated human epithelial cells with integrated and episomal HPV 31 genetic material, suspended in ThinPrep® PreservCyt®. Microbix HPV 31 Positive External Quality Controls have verified performance with Abbott RealTime High Risk HPV Assay, Cepheid Xpert®
- [SARS-CoV-2 Negative Swab (REDxTMFLOQ®)* NAAT Negative Swab (PROCEEDxTMFLOQ®)](https://microbix.com/products/external-quality-controls/sti-panel/sars-cov-2-negative-swab-redxtmfloq-naat-negative-swab-proceedxtmfloq-2/) - Microbix NAAT Negative Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells desiccated on Copan FLOQSwab®. • Format: Copan FLOQSwab® • Storage Conditions: 2-30°C • Assay Compatibility: MDx * The product is formulated with human cells desiccated on swabs and can be used in context
- [SARS-CoV-2 Negative Swab (REDxTMFLOQ®)* NAAT Negative Swab (PROCEEDxTMFLOQ®)](https://microbix.com/products/external-quality-controls/sti-panel/sars-cov-2-negative-swab-redxtmfloq-naat-negative-swab-proceedxtmfloq/) - Microbix NAAT Negative Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells desiccated on Copan FLOQSwab®. • Format: Copan FLOQSwab® • Storage Conditions: 2-30°C • Assay Compatibility: MDx * The product is formulated with human cells desiccated on swabs and can be used in context
- [Trichomonas vaginalis Positive - VP-61-02](https://microbix.com/products/external-quality-controls/sti-panel/trichomonas-vaginalis-positive-vp-61-02) - Microbix Trichomonas vaginalis Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated native Trichomonas vaginalis, and human fibroblast cells suspended in a proprietary buffer. Microbix Trichomonas vaginalis Positive External Quality Controls have verified performance on various IVD platforms such as the Cepheid GeneXpert®. • Format: Vial;
- [Hepatitis A](https://microbix.com/products/antigens/sti/hepatitis-a) - Hepatitis A virus (Strain HM-175) is cultured in fetal Rhesus monkey kidney cells. The virus is purified using an extraction procedure and inactivated using formaldehyde. The resulting product contains purified intact HAV virions with minimal cellular debris. Hepatitis A virus is a non-enveloped, icosahedral virion with a single stranded RNA genome. Only one serotype of
- [ONBOARDx™FLOQ® InfuenzaA&B Swab kit](https://microbix.com/products/antigens/respiratory/product/onboardxfloq-infuenzaab-swab-kit) - Contains: PROCEEDx™FLOQ® Influenza A Positive swab x 20 PROCEEDx™FLOQ® Influenza B Positive swab x 20 PROCEEDx™FLOQ® Respiratory Swab Negative Sample x 8 Download Technical Information Sheet VP-SK-FLU-02
- [HSV 1 Positive - VP-02-M1](https://microbix.com/products/external-quality-controls/genital-ulcer-panel/hsv-1-positive-vp-02-m1) - Microbix HSV 1 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated native Herpes Simplex Virus 1 and human fibroblast cells suspended in a proprietary buffer. Contact us for more information.
- [<em>Borrelia Burgdorferi (Lyme Disease)</em>](https://microbix.com/products/antigens/infectious-disease/borrelia-burgdorferi-lyme-disease/) - Microbix Lyme Disease Antigen (Borrelia Burgdorferi) native antigen is isolated from the B31 strain cultured in BSK 11 medium. Contact us today for more information.
- [HPV 39 Positive - VP-62-39](https://microbix.com/products/external-quality-controls/hpv-panel/hpv-39-positive-vp-62-39) - Microbix HPV 39 Positive External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated human epithelial cells with integrated and episomal HPV 39 genetic material, suspended in ThinPrep® PreservCyt®. Microbix HPV 39 External Quality Controls have verified performance on some of the following IVD assays: Cepheid Xpert® HPV
- [Parainfluenza 3, Grade 2](https://microbix.com/products/antigens/respiratory/parainfluenza-3-grade-2/) - Description: The resulting antigen preparation contains a high concentration of virus and virus components as well as some cellular material suspended in Tissue Culture Media. Strain: C243 Buffer: Tissue Culture Media Download Technical Information Sheet EL-10-02
- [Herpes Simplex 2, Grade 2](https://microbix.com/products/antigens/sti-antigens/herpes-simplex-2-grade-2) - Description: Grade 2 antigen contains a high concentration of virus particles and components in tissue culture medium containing a low concentration of bovine serum. The preparation contains no preservative or detergent. Some residual host cellular material is present. Strain: MS Buffer: Tissue culture medium EL-23-02
- [Herpes Simplex 1, Grade 2](https://microbix.com/products/antigens/torch/herpes-simplex-1-grade-2) - Description: Herpes Simplex 1 Grade 2 antigen contains a high concentration of virus particles and components in tissue culture medium containing a low concentration of bovine serum. The preparation contains no preservative or detergent. Some residual host cellular material is present. Strain: MacIntyre Buffer: Tissue culture medium EL-02-02
- [Dengue 2](https://microbix.com/products/antigens/dengue/dengue-2) - Description: A purified preparation of native Dengue 2 virus particles suitable for use in assays for detection of presence of antibodies against Dengue 2 virus, and as a positive control for the presence of the Dengue 2 virus antigens in a sample. The product is formulated in a buffer that should not interfere with conjugation

## Categories

- [Uncategorized](https://microbix.com/resources/category/uncategorized/)
- [Presentation](https://microbix.com/resources/category/presentation/)
- [News Releases](https://microbix.com/resources/category/resources/news-releases/)
- [Upcoming Events](https://microbix.com/resources/events/upcoming-events)
- [Blog](https://microbix.com/resources/category/blog/)
- [Media Featured Investor Info](https://microbix.com/resources/category/media-featured-investor-info/)
- [Events](https://microbix.com/resources/category/events/)
- [Media Featured Upcoming Events](https://microbix.com/resources/category/media-featured-upcoming-events/)
- [Media Features News Releases](https://microbix.com/resources/category/media-features-news-releases/)
- [Media Featured Global](https://microbix.com/resources/category/media-featured-global/)
- [Media Featured Podcast](https://microbix.com/resources/category/media-featured-podcast/)
- [Media Featured Financial Reports](https://microbix.com/resources/category/media-featured-financial-reports/)
- [Media Featured Poster Publication](https://microbix.com/resources/category/media-featured-poster-publication/)
- [Media Featured White Paper](https://microbix.com/resources/category/media-featured-white-paper/)
- [Resources](https://microbix.com/resources/category/resources/)

## Tags

- [Chlamydia](https://microbix.com/resources/tag/chlamydia/)
- [controls for molecular platforms](https://microbix.com/resources/tag/controls-for-molecular-platforms/)
- [diagnostic accuracy](https://microbix.com/resources/tag/diagnostic-accuracy/)
- [external quality assessment](https://microbix.com/resources/tag/external-quality-assessment/)
- [external quality controls](https://microbix.com/resources/tag/external-quality-controls/)
- [gonorrhea](https://microbix.com/resources/tag/gonorrhea/)
- [hpv](https://microbix.com/resources/tag/hpv/)
- [mycoplasma genitalium](https://microbix.com/resources/tag/mycoplasma-genitalium/)
- [NAATs](https://microbix.com/resources/tag/naats/)
- [point of care testing for STI](https://microbix.com/resources/tag/point-of-care-testing-for-sti/)
- [ready-to use](https://microbix.com/resources/tag/ready-to-use/)
- [syphilis](https://microbix.com/resources/tag/syphilis/)

## Certification Categories

- [International](https://microbix.com/resources/certification-category/international/)
- [European Union](https://microbix.com/resources/certification-category/european-union/)
- [Canada / North America](https://microbix.com/resources/certification-category/canada-north-america/)

## Product categories

- [Uncategorized](https://microbix.com/product-category/uncategorized/)
- [Antigens](https://microbix.com/product-category/antigens/)
- [All products](https://microbix.com/product-category/all-products/)
- [ToRCH Antigens](https://microbix.com/product-category/antigens/torch/)
- [Respiratory Antigens](https://microbix.com/product-category/antigens/respiratory-antigens/)
- [Dengue Antigens](https://microbix.com/product-category/antigens/dengue/)
- [Childhood Disease](https://microbix.com/product-category/antigens/childhood-disease/)
- [Gastrointestinal and Other Antigens | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/product-category/antigens/gastrointestinal-and-other-antigens-microbix-biosystems-infectious-disease-antigens-qaps/)
- [STI Antigens](https://microbix.com/product-category/antigens/sti-antigens/)
- [External Quality Controls (Infectious Disease Quality Controls)](https://microbix.com/product-category/external-quality-controls/)
- [PROCEEDx™ (RUO) | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/product-category/external-quality-controls/proceedx-ruo-microbix-biosystems-infectious-disease-antigens-qaps/)
- [Respiratory Viral Panel](https://microbix.com/product-category/external-quality-controls/respiratory-viral-panel/)
- [Gastrointestinal Panel](https://microbix.com/product-category/external-quality-controls/gastrointestinal-pathogen-panel/)
- [STI Panel](https://microbix.com/product-category/external-quality-controls/sti-panel/)
- [Negative](https://microbix.com/product-category/external-quality-controls/negative/)
- [HPV Panel](https://microbix.com/product-category/external-quality-controls/hpv-panel/)
- [REDx™ Controls | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/product-category/external-quality-controls/redx-controls-microbix-biosystems-infectious-disease-antigens-qaps/)
- [COVID-19 Products | Microbix Biosystems | Infectious Disease Antigens & QAPs](https://microbix.com/product-category/external-quality-controls/covid-19-products-microbix-biosystems-infectious-disease-antigens-qaps/)
- [ONBOARDx™ Kits](https://microbix.com/product-category/external-quality-controls/onboardx-kits/)
- [COPAN FLOQSwabs®](https://microbix.com/product-category/external-quality-controls/copan-floqswabs/)
- [Control Elution Buffer](https://microbix.com/product-category/ceb/)
- [Vaginal Infection Panel](https://microbix.com/product-category/external-quality-controls/vaginal-infection-panel/)
- [Reference Materials](https://microbix.com/product-category/reference-materials/)
- [Respiratory Panel](https://microbix.com/product-category/reference-materials/respiratory-panel/)
- [HPV Panel](https://microbix.com/product-category/reference-materials/hpv-panel-reference-materials/)
- [Fungal Panel](https://microbix.com/product-category/reference-materials/fungal-panel/)
- [STI Panel](https://microbix.com/product-category/reference-materials/sti-panel-reference-materials/)
- [Meningitis Panel](https://microbix.com/product-category/reference-materials/meningitis-panel/)
- [Gastrointesinal Panel](https://microbix.com/product-category/reference-materials/gastrointesinal-panel/)

## Product tags

- [Single Analyte Products](https://microbix.com/product-tag/single-analyte-products/)